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Several clinical studies for non-invasive estimation of tis-
sue hemodynamics by the combination of two diffuse opti-
cal techniques, time-resolved and diffuse correlation spec-
troscopy, were carried out in collaboration with local hospi-
tals. These led to the first application of hybrid diffuse optics
in the characterization of healthy and pathological human
thyroid tissue and the initiation of a European Horizon 2020
research project aiming at significantly improving the current
thyroid cancer screening process.
The advantages of the hybrid diffuse optical device allowed
to gain information on cerebral oxygen metabolism and im-
proved estimation of cerebral blood flow. Data was collected
from patients without brain diseases as well as healthy vol-
unteers in clinical and surgical environments. The diffuse
optical measurements were shown to correlate with the bis-
pectral index, a widely used anesthesia monitor in the clinic.
The optically derived parameters demonstrated the conser-
vation of physiological coupling between cerebral blood flow
and oxygen metabolism in patients under propofol-induced
anesthesia.
Additional studies focused on the investigation ofmicrovas-
cular cerebral physiology in response to common challenges
in surgical procedures. These were simulated on healthy sub-
jects and studied in depth.
Overall, this work pushes the limits of the clinical transla-




















Varios estudios clínicos para estimar de forma no invasi-
va los parámetros hemodinámicos del tejido humano han si-
do realizados gracias a la combinación de dos técnicas de
óptica difusa, “time-resolved spectroscopy” y “diffuse corre-
lation spectroscopy”, en un instrumento único, manejable y
compacto. Esta combinación ha dado luz a una aplicación
única para utilizar dichas técnicas en la diferenciación entre
tejido tiroideo sano y patológico. Además, estas mediciones
han iniciado un proyecto de investigación dentro del marco
“European Horizon 2020”, enfocado en una mejora del pro-
cedimiento en la detección y caracterización del cáncer de
tiroides.
Las ventajas del uso del dispositivo híbrido de óptica difu-
sa han permitido tanto la obtención de información sobre el
metabolismo cerebral, como una mejora en la estimación de
su flujo sanguíneo. Se han obtenido datos tanto de pacientes
sin patologías cerebrales como de voluntarios sanos en un
entorno clínico y durante cirugías. Estas mediciones se han
comparado con el índice bispectral, que es un factor impor-
tante y frecuentemente usado en la monitorización y control
de la administración de anestesia en los hospitales, mostran-
do una fuerte correlación entre ellos. Las mediciones de óp-
tica difusa han mostrado la conservación del acoplamiento
fisiológico entre flujo sanguíneo cerebral y metabolismo de
oxígeno en un estado de anestesia inducido por propofol.
Estudios adicionales han investigado la fisiología cerebral
microvascular y sus fluctuaciones durante cirugías practica-
das con anestesia general. Estos cambios fueron simulados
y estudiados meticulosamente con voluntarios sanos.
En resumen, esta tesis amplia los límites de la óptica difusa
tanto en la detección de patologías como durante cirugías, y
muestra el gran potencial de estos sistemas ópticos para su
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BFI blood flow index
BOLD blood-oxygen-level dependent
BP blood pressure
BPdia diastolic blood pressure
BPsys systolic blood pressure
CAR cerebral autoregulation
Ca arterial oxygen concentration
CBF cerebral blood flow
CBFV cerebral blood flow velocity
CBFVdia diastolic cerebral blood flow velocity
CBFVmean mean cerebral blood flow velocity
CBFVsys systolic cerebral blood flow velocity
CDE correlation diffusion equation




CNS central nervous system
Cp plasma concentration
CPP cerebral perfusion pressure
CSF cerebral spinal fluid
CT computed tomography
CVR cerebrovascular resistance
Ct tissue oxygen concentration
Cv venous oxygen concentration
CW continuous wave
DCS diffuse correlation spectroscopy
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DOS diffuse optical spectroscopy
DWS diffusing wave spectroscopy
DTOF distribution time of flight
EEG electroencephalogram
ECG electrocardiogram
ESS elastic scattering spectroscopy
EtCO2 end-tidal CO2
ExpO2 exhaled O2
FiO2 fraction of inspired oxygen
fMRI functional magnetic resonance imaging
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LDF laser Doppler flowmetry
LED light emitting diode
LSF laser speckle flowmetry
LME linear mixed effects
MAP mean arterial pressure
MCA middle cerebral artery
mCBF microvascular cerebral blood flow
MRI magnetic resonance imaging
NIRS near-infrared spectroscopy
O2 oxygen
OEF oxygen extraction fraction
PCA posterior cerebral artery
PaCO2 arterial partial pressure of carbon dioxide
PEEP positive end-expiratory pressure
PET positron emission tomography
pH acidity/alkalinity scale for an aqueous solution
PMT photo multiplier tube
PO2 partial pressure of oxygen
Pt tissue permeability
PtO2 tissue oxygen pressure
RBC red blood cells
rBIS relative bispectral index
rCBF relative cerebral blood flow
rCMRO2 relative cerebral metabolic rate of oxygen
rOEF relative oxygen extraction fraction
RR respiration rate
RTE radiation transport equation
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SPECT single photon emission computed tomography
SO2 oxygen saturation
SaO2 arterial oxygen saturation
ScO2 capillary oxygen saturation
SjvO2 jugular venous oxygen saturation
SpO2 peripheral arterial oxygen saturation
SrO2 regional oxygen saturation
StO2 tissue oxygen saturation
SvO2 venous oxygen saturation
SPAD single photon avalanche photodiode
STT superficial tissue thickness
SV stroke volume
SVR systemic vascular resistance
SI stroke index
SNR signal-to-noise ratio
SVR systemic vascular resistance
T temperature
TBI traumatic brain injury
TC thyroid cancer
TCD transcraneal Doppler
TCSPC time-correlated single photon counting
THC total hemoglobin concentration
TIVA total intravenous anesthesia
TN thyroid nodule
TOF time of flight
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TRS time-resolved spectroscopy
TT tissue thickness
TTD total tissue depth
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US ultrasound
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WHO World Health Organization
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g scattering anisotropy factor
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“Medicine is not only a science; it is also an art. It does notconsist of compounding pills and plasters; it deals with the veryprocesses of life, which must be understood before they may beguided.” [Paracelsus, 1493-1541]
A large part of today’s achievements in patient care and
monitoring are the result of clinical research and the investi-
gation of physiological processes of the human body. It is the
constant urge to save and improve lives that drives medical
research. Physics and the use of light in particular has been
able to significantly contribute and will continue to do so as
new technologies emerge. The use of light enables physi-
cians and researchers to look inside the human body non-
invasively and study physiological processes in both healthy
and diseased populations. By monitoring blood flow, blood
oxygen contents and oxygen metabolism continuously we
can characterize different organs in a healthy or pathological
state.
1.1 THE NEED FOR NEW APPROACHES IN THE CL IN IC
Information on cell metabolism can enable both monitor-
ing cancer therapy and improvements in cancer diagnosis
and therapy. Current techniques are generally either inva-
sive, expensive or require movement of the patient to the
device rather than bringing the device to the patient’s bed-
side. A clinical device that allows point-of-care testing and
easy integration in existing cancer screening processes could
significantly improve therapy outcome by providing informa-
tion on relevant tissue parameters. Standard thyroid cancer
screening, which faces a high prevalence of thyroid nodules,
the sensitivity and specificity of the first point-of-care, non-
invasive screeningmethod, ultrasound (US), is quite poor. Sen-
sitivity ranges from 17-87 % and specificity from 39-95 % de-
pending on the type of the malignant nodules [205, 215, 287,
223, 10]. Even in combination with a biopsy, sensitivity and











existing screening strategies necessitate improvements in the
accurate identification of lesions. Non-invasive methods, en-
abling the accurate characterisation of lesions, have the po-
tential to both improve therapeutic outcomes as well as re-
duce the number of unnecessary biopsies or surgeries.
In the case of the brain, we face an autoregulatory mech-
anism, cerebral autoregulation (CAR) [264], which balances
pressures in the brain produced by changes in the mean ar-
terial pressure (MAP) and with the counteracting part, the











Figure 1.1: The concept of cerebral autoregulation (CAR): Blood
pumped from the heart with a certain pressure supplies
the brain. The pressure of the cerebral spinal fluid (CSF),
acting on the brain from the “outside”. The difference
between the two pressures is expressed as the cere-
bral perfusion pressure (CPP). It can vary over a wide
range, while maintaining CBF constant by vasodilatation
or vasoconstriction.
Blood supplies the brain with an adequate amount of oxy-
gen in order to maintain its functioning. The cerebral blood
flow (CBF) is maintained constant over a range of cerebral
perfusion pressures by adjusting the blood vessel diameter
in the brain [288, 167]. This process is called CAR.
i
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1.1 THE NEED FOR NEW APPROACHES IN THE CL IN IC 5
In a non-healthy brain the autoregulation mechanism can
be impaired because of blood vessels bursting (hemorrhagic
stroke) or brain swelling due to high pressures, both of which
can result in an insufficient supply of oxygen. (Traumatic
brain injury (TBI) is one major cause of CAR impairment. It
has become so prevalent that it is often called the “silent epi-
demic of the third millennium”. Despite from being the first
cause of death and disability in the world, it is the number
one cause for people under 45 years of age, number seven
for disability in the European Union and its relevance in the
elderly population is increasing [194]. Approximately 100 per
100.000 inhabitants each year experience severe injuries due
to traumatic brain injury (TBI) resulting in hospitalization or
death. Although there has been a significant overall mortal-
ity reduction in the last 25 years, at the same time there has
not been a significant change in the number of TBI survivors
suffering from neurological sequelae in TBI [146]. Moreover,
the World Health Organization (WHO) has projected that in
the year 2020 the major cause of TBI, traffic accidents, will be
one of the top three of overall causes of diseases and injuries
worldwide.
Ischemic stroke is the leading cause of morbidity and long
term disability in the United States and Europe and is among
the leading causes of death [189, 110, 194]. In developed coun-
tries it is the leading cause of mortality for patients over 75
years of age and the second leading cause of dementia, be-
hind only Alzheimer’s disease. Stroke care costs are projected
to reach trillions of Euros over the next five decades and the
disease is already responsible for about 5 % of total health-
care costs. Stroke accounts for nearly 10 % of deaths in the
western hemisphere. While subarachnoid hemorrhage (SAH)
represents only 7 % of all strokes, it has a fatality rate of 37.5
% within in 30 days, increasing to 50 % in total. Addition-
ally, 50 % of survivors suffer from a permanent neurological
deficit [308].
While a strong ethical exigence to enhance TBI and stroke
care exists, the high incidence of stroke and its immenseman-
agement costs necessitate advances in treatment and diag-
nosis as well. Advanced multi-modality measurements of
cerebral hemodynamics and metabolism have the potential
to fill this need. Even modest benefits will lead to a signifi-
cant improvement of the lives of hundreds of thousands of
people and a significant reduction in health care costs.
i
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Optimal management of TBI patients requires advanced,
multi-modality neuromonitoring, that is ideally non-invasive
and reflects microvascular cerebral hemodynamics as well as
metabolism in real time. The latter is not possible with the
current modalities. The availability of a safe, non-invasive de-
vice, which can be placed at the bed-side in a neurointensive
care unit and provides clinicians with this information has the
potential to lead to drastic improvements in health-care by al-
lowing a personalized management approach.
Information on (cerebral) hemodynamics can be provided
by several methods, each associated with different degrees
of cost, portability, localization (macro- versus microvascu-
lar level) and invasiveness. A portable non-invasive option
is Doppler US and its variations, power Doppler US, color
Doppler flowmetry. Making use of the Doppler effect this
US technique provides information on blood flow. It widely
used in the study of CBF and allows the investigation of CAR.
There, it is often called transcraneal Doppler (TCD) and mea-
sures the cerebral blood flow velocity (CBFV) [2]. Nonetheless,
it only can give information on flow in larger blood vessels
(macrovasculature), i. e. CBFV in the middle cerebral artery
or anterior cerebral artery [133, 2]. Additionally, it needs in-
sonation windows (thin skull) for proper functioning [199, 180,
24].
Information on blood flow the microvasculature, i. e. the
smaller blood vessels, can be gained by utilizing computed
tomography (CT), Xenon-enhanced computed tomography,
positron emission tomography, single photon emission com-
puted tomography, magnetic resonance imaging and arte-
rial spin labeled perfusion magnetic resonance imaging [247,
334, 261, 85]. There is also blood-oxygen-level dependent
(BOLD) contrast imaging, which uses functional magnetic res-
onance imaging to study vascular reactivity changes based
on the oxy- and deoxy-hemoglobin (Hb and HbO2) levels [233,
232]. BOLD comes with the disadvantage of difficult signal in-
terpretation, low signal-to-noise ratio (SNR) and complex sta-
tistical methods. All of the methods mentioned here are ei-
ther associated with high costs, non-portability, acquire non-
continuous measurements, require radiopharmaceuticals or
only present information on the macrovasculature.
Optical techniques based on the investigation of tissue ab-
sorption and scattering characteristics can be used to study
i
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hemodynamics. These include laser Doppler flowmetry (LDF)
and laser speckle flowmetry (LSF) and - compared to themeth-
ods mentioned above - offer relatively low costs and porta-
bility. Dynamic information about the microvasculature is
provided by measuring the Doppler phase shift in LDF or by
looking at the speckle profile in LSF. However, these mea-
surements are limited to shallow layers and have not found
widespread clinical use [87, 284, 231, 227].
Given the serious limitations of alternative methods as de-
tailed here, diffuse optical techniques represent some of the
most promising approaches to non-invasive (neuro-) moni-
toring.
This thesis is focused on the implementation of two optical
modalities - diffuse correlation spectroscopy (DCS) and time-
resolved spectroscopy (TRS) - in order to assess microvascu-
lar (cerebral) hemodynamics and metabolism in real time in
the clinic. These techniques use point-source illumination
and can probe several centimeters deep into tissue. In this
work, these techniques are used to improve thyroid cancer
screening, investigate cerebral hemodynamics and examine
CAR. The obtained measures are investigated upon their
position dependencies in order to answer questions of in-
creased incidence rates of brain lesions for surgeries carried
out in certain positions. Microvascular DCS and TRS-derived
CBF and brain metabolism is furthermore validated against
established clinical parameters.
1.2 D I F FUSE OPT ICS
Near-infrared spectroscopy (NIRS) has evolved aroundmak-
ing use of the relatively low tissue absorption in the wave-
length range between 650 and 950 nm, which allows the rela-
tively deep non-invasive probing of biological tissue [201, 156].
The probing depth depends on the experimental setup, espe-
cially the technique which is used - whether it is pathlength
resolved or not. The light of a continuous wave laser can
probe ∼ 1 - 1.5 cm in the near-infrared spectrum under typ-
ical conditions of an adult human brain and the sensitivity
of optoeletronics. Other techniques, such as those that use
pulsed laser light and time-resolved detection (the topic of
this thesis), can provide information from greater depths [201].
In the above-mentioned wavelength range, water and lipid
absorption is relatively low enabling photons to travel several
i
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centimeters in tissue and still be detected. Other tissue chro-
mophores, such deoxy-hemoglobin (Hb) and oxy-hemoglobin
(HbO2) become therefore accessible, allowing one to gain in-
formation in regards to their concentration within the tissue.
Today, widely used standard pulseoximetersmake use of this
fact by employing light emitting diodes, photodetectors and
sophisticated algorithms to determine peripheral arterial oxy-
gen saturation and are a direct application of near-infrared
spectroscopy (NIRS) in clinical practice. With relatively low ab-
sorption and high scattering, photons are scattered multiple
times and those travelling over some minimum distance es-
sentially experience a random walk and can be considered
to to have entered the diffusive regime. Photons within this
regime can be modelled using the diffusion approximation,
which takes into account these two main processes - absorp-
tion and scattering.
Different source types can be used with each providing dif-
ferent levels of information per measurement can be used.
The basics will be examined here and are illustrated in Figure
1.2.
In the first scenario, continuous wave (CW) laser light is
injected into the tissue and the measurement of the asso-
ciated attenuation can provide information on tissue oxygen
saturation [271, 228]. This option is used widely in standard
pulseoximeters. By modulating the source intensity, an ad-
ditional parameter can be measured, the phase shift (∆ϕ)
between the incident and detected light introduced by the
medium. The combination of attenuation and ∆ϕ allows the
determination of tissue scattering and absorption properties,
i. e. the absorption (µa) and reduced scattering coefficients
(µ′s) [208, 143, 248, 241]. Absolute scattering and absorption
properties can bemeasured using pulsed lasers together with
hybrid photo multiplier tube detectors and sophisticated sin-
gle photon counting electronics. Due to multiple scattering
events inside the tissue, the emitted laser pulse broadens
and shifts in time. These time domain measurements are
called time-resolved spectroscopy (TRS) and use the distribu-
tion of photons travel times to derive the above-mentioned
optical properties [311, 66, 306, 310, 240, 153] in order to turn
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Figure 1.2: NIRS source types: The top graph shows the CW source
type and illustrates the light attenuation due to the tis-
sue.; Middle graph: Intensity modulated light source
experiences attenuation and a phase shift inside tis-
sue (frequency-domain); Bottom graph: Pulsed light is
broadened by the tissue. The time-of-flight information
of each photon, which varies depending on the tissue
properties, is recorded. Graphs adapted from [26].
1.3 GOALS AND HYPOTHESES
The overall theme of this thesis is the combination of two
diffuse optical techniques for the simultaneous, non-invasive
and continuous estimation microvascular blood oxygen sat-
uration, blood flow and oxygen metabolism. Followed by its
translation into several clinical scenarios With this overall ob-
jective in mind, the work presented here is geared towards
the following goals and hypotheses:
Goal I: Combination of two diffuse optical techniques into
one portable hybrid device.
Hypothesis I.1: It is possible to combine time-resolved
spectroscopy (TRS) and diffuse correlation spectroscopy
(DCS) in one portable device for clinical use.
i
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Hypothesis I.2: Data from TRS and DCS can be ob-
tained in a robust, reliable and stable manner si-
multaneously under clinical conditions.
Goal II: Employing of diffuse optics on the healthy and patho-
logical human thyroid for the first time.
Hypothesis II.1: The human thyroid is accessible by
diffuse optics and can be differentiated from the
surrounding tissues such as the neck muscles.
Hypothesis II.2: The human thyroid is relatively ho-
mogeneous and inter- and intra-individual differ-
ences can be characterized by diffuse optics.
Hypothesis II.3: Thyroid nodules show a detectable
contrast in optical properties and in hemodynamic
variables.
Goal III: Acquire non-invasive optical data in the clinical and
surgical environment using a diffuse optical hybrid de-
vice.
Hypothesis III.1: Hybrid diffuse optics can reliably
be employed in the clinical environment and uti-
lized during surgical procedures.
Goal IV: Obtain an estimation of cerebral metabolism and
blood flow by hybrid diffuse optics and compare these
against the widely used bispectral index.
Hypothesis IV.1: Cerebral metabolism can be con-
tinuously estimated during surgical procedures.
Hypothesis IV.2: Hybrid diffuse optics data corre-
lates with similar measures of brain activity.
Hypothesis IV.3: Hybrid diffuse optics can aid in the
understanding of brain health, inmonitoring depth
i
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of anesthesia and in protecting against anesthesia
related injuries.
Hypothesis IV.4: Hybrid diffuse optics data is use-
ful in the study of cerebral hemodynamics.
Goal V: Investigation of the posture on the cerebral hemo-
dynamics in combination with respiratory challenges.
Hypothesis V.1: Conditions that challenge cerebral
autoregulation during general anesthesia can be
mimicked in awake patients in a reproduceableman-
ner.
Hypothesis V.2: Patient/Volunteer position has an
affect on the brain’s response to altered levels of
gases in the inspired airmixture and/or in response
to challenges involving breathing.
Goal VI: Explore the advantages of the hybridization of time-
resolved and diffuse correlation spectroscopy in the data
analysis.
Hypothesis VI.1: The knowledge of tissue optical
properties retrieved by one modality - here TRS -
has a significant influence on the analysis of tissue
blood flow data obtained by DCS.
1.4 THES IS OUTL INE
This thesis is organised in three parts. The first one lays the
groundwork in terms of background, theory on hemodynam-
ics and diffuse optics and presents the experimental setup.
The second part contains all in-vivo measurements and the
third part summarizes and concludes this work.
Chapter 2 focuses on the light transport in biological tis-
sue, how the diffusion approximation leads to the diffusion
equation (DE) and correlation diffusion equation (CDE) and
presents the solutions for a semi-infinite geometry, which is
used to model the experimental settings used in the mea-
surements presented in this thesis. As a second requisite
i
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for the study and understanding of hemodynamics by diffuse
optics, in Chapter 3, after a short explanation of oxygen trans-
port in tissue, based on blood flow and blood oxygenation,
we will look at how the human brain is supplied with oxygen
and how different oxygen (O2) and carbon-dioxide (CO2) con-
centrations can influence the oxygen affinity of blood and al-
ter CAR. After the theoretical foundations are laid out, the
combination of two diffuse optical techniques, TRS and DCS,
which can be used to retrieve information on Hb, HbO2 and
total hemoglobin concentration (THC), as well as tissue oxy-
gen saturation (StO2) and blood flow (BF), into a single hybrid
device is explained in Chapter 4. The system is characterized
and validated using phantom measurements. This chapter
concludes the first part of this work before moving on to in-vivomeasurements.
Chapter 5 presents in-vivo data. Data from the human thy-
roid is characterised by TRS-derived THC and StO2 content as
well as by BF measurements using DCS. Both, healthy and
pathologic tissue data are examined, opening the door to-
wards the potential application of diffuse optics in thyroid
cancer screening.
Chapter 6 presents in-vivo data focusing on CBF, oxygen ex-
traction fraction (OEF) and cerebral metabolic rate of oxygen
(CMRO2) derived from the hybrid TRS/DCS device and refer-
ences these measurements against the bispectral index (BIS),
an electroencephalographic measure of brain activity. The
measurements are carried out in the surgical room during
propofol-induced anesthesia.
Using the background presented in Chapters 2 and 3, we
look at relative cerebral blood flow (rCBF) responses to hy-
peroxia, hypercapnia and hyperventilation (HV) challenges
in Chapter 7. The alterations due to changing O2 and CO2
blood concentration on parameters such as CBF, CBFV, MAP,
heart rate (HR), cardiac output (CO) and stroke volume (SV)
are studied and checked for influences stemming from sub-
ject position. As responses to HV in Chapter 7 raise the ques-
tion as to whether there are two groups showing opposed
microvascular cerebral blood flow (mCBF) changes, Chapter
8 will look in more detail at the HV challenge and its implica-
tions on mCBF. The HV protocol from Chapter 7 is adopted
and TRS data is acquired as well.
i
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Finally, Chapter 9 examines a head-of-bed procedure in or-
der to determine how µa and µ
′
s from TRS influence the deriva-
tion of the blood flow index (BFI) in DCSmeasurements. Four
different analysis methods are compared using BFI and rCBF
values. This study concludes the second part of this work.
In the third part, final conclusions are drawn. Additional
data related to chapters 5 and 7 is presented in the appendix.
The tables include additional pathologic case studies from
Chapter 5 as well as full correlation tables from the various



















L IGHT INTERACT IONS W ITH
B IOLOG ICAL T ISSUES
Light is used to investigate biological tissue and its hemody-
namic properties including blood flow and chromophore con-
centrations (e. g. deoxyhemoglobin Hb and oxyhemoglobin
HbO2). The underlying theoretical models used here treat
photon propagation as a diffusive process and as such are
generally referred to as diffuse optics.
This chapter focuses on two basic processes, which affect the
light transport in biological tissue: absorption and scattering.
The diffusion equation (DE) will be derived and the correla-
tion diffusion equation (CDE) will be introduced. Two diffuse
optical techniques - time-resolved spectroscopy (TRS) and dif-
fuse correlation spectroscopy (DCS) - will be presented and
shown how their measurements can be related to physiolog-
ically important parameters.
First the forward problem will be described. It refers to a
setup where the optical properties of the medium are known
and are used to calculate the photon density and flux within
the medium. Themeasurements presented in the later chap-
ters refer to the opposite scenario. In the inverse problem
the medium’s optical characteristics are calculated based on
the optical measurements at specific locations. Solving the
inverse problem provides information on tissue constituents
and dynamics, such as oxygen content and blood flow.
Figure 2.1: Illustrative image: A standard smartphone flashlight (left
side) serves as a white light source. Placing a finger on










16 L IGHT INTERACT IONS W ITH B IOLOG ICAL T ISSUES
An illustrative example of photon diffusion in biological tis-
sues is given in Figure 2.1. Only red (and near-infrared) pho-
tons of a white light source (a standard smartphone flash-
light) can be observed after passing through the finger. This
photo demonstrates that light in the red region of the spec-
trum can pass through several cm of biological tissue, but is
strongly diffuse after doing so. The fact, that the entire finger
cap is illuminated and light can still be observed after several
cm is due to the high scattering and relatively low absorption
in biological tissue in these wavelengths.
2.1 L IGHT ABSORPT ION
The absorption spectrumof the primary chromophores con-
tained in biological tissue are presented in Figure 2.2. The
relatively low absorption in the near-infrared (650 - 950 nm)
is often referred to as the “physiological window“ [156]. It is
the relatively low absorption in this range as compared to
the rest of the spectrum that explains the red color of the fin-
ger in Figure 2.1, which was illuminated using a white (broad-
band) light source.
In the absorption process the energy from a photon is con-
verted into another form, which in our case is generally ther-
mal energy. This process is wavelength of light (λ) dependent
and the extent of absorption will depend on both the mo-
lar extinction coefficient of the chromophore (ε) [M-1 cm-1] as
well as its concentration (ζ) [mol/m3]. The absorption coef-
ficient (µa) [cm
-1] provides a quantitative measure of absorp-







The primary tissue chromophores within biological tissue
at the wavelengths of interest (650 - 950 nm) are deoxy- (Hb),
oxyhemoglobin (HbO2), water and lipid. Melanine is nearly
constant in this region. At other wavelengths additional chro-
mophores may become important and need to be included.
From the derived oxy- and deoxyhemoglobin concentrations
one can calculate the total hemoglobin concentration (THC)
i
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Figure 2.2: Absorption coefficients (µa(λ)) for deoxy- and oxyhe-
moglobin (Hb, HbO2), water, lipid and melanine plotted
as a function of wavelength of light (λ). The low absorp-
tion between λ = 650 and 950 nm is referred to as the
“physiological window”.
[M] and tissue oxygen saturation (StO2) [%], which is a mix-
ture of arterial and venous blood saturation. These parame-
ters provide information on the tissue condition and can be
used to calculate oxygen metabolism.
2.2 L IGHT SCAT TER ING
A light scattering event occurs when a photon hits a tar-
get and changes its trajectory. Photon propagation in biolog-
ical tissues obeys many such events and is therefore a multi-
ple scattering process. In biologic tissue the scattering mean
free path of photons - the distance a photon travels freely be-
tween two scattering events - is on the scale of hundreds of
µm and therefore, in our experimental setups, orders of mag-
nitude smaller than the actual path the photons reaching the
detector travel. This leads to a high degree of scattering in
when imaging deep in vivo tissue and detected photons are
i
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considered multiply scattered.
The scattering process is dependent on the relative size
and geometry of the scatterer as compared to thewavelength












Figure 2.3: Angular distribution of light scattering: The anisotropy
factor g defines the scattering nature (g< 0: anistropic
back scattering; g = 0: isotropic scattering; g> 0:
anistropic forward scattering). Biological tissue is
strongly foward scattering (g ≈ 0.9)
Two scattering processes - Rayleigh and Mie scattering -
are shown in Figure 2.3. While Rayleigh scattering is valid
for small particles and is isotropic1, Mie scattering is capable
of describing anisotropic scattering, which is typical in biolog-
ical tissues. This is due to the size of the scatterers, so that
photons experience a strong scattering along the forward di-
rection. A phase function is used to describe the resulting
angular distribution of the scattered photons (see also Fig.
2.3). The scattering anisotropy factor (g) is given by the av-
erage cosine of the probability distribution of the scattered
particles and the scattering angle θ.
It is common to describe scattering by the scattering coeffi-
cient (µs) [cm
-1], which is the inverse of the mean free path. In
biological tissue, another parameter is defined, which is the
reduced scattering coefficient (µ′s) [cm
-1]:
µ′s = µs (1− g) (2.2)
1 Rayleigh scattering allows to describe the interaction of air molecules and
visible light and therefore is often used to explain the color of the sky and
color effects at sunset. Scattering on larger particles, i. e. water droplets
in the air, can no longer be described by the Rayleigh approximation and
Mie theory is needed.
i
i






2.3 RAD IAT IVE TRANSPORT 19
Figure 2.4 illustrates the light-tissue interaction process and


















Figure 2.4: Interaction processes between light and a turbid
medium: Photons are injected into a turbid medium,
i. e. biological tissue, (index of refraction n*) and inter-
act with scatterers (filled circles) or absorbers (hollow
circles) therein. µa denotes the absorption coefficient,
µs and µ
′
s the scattering and reduced scattering coeffi-
cient.
2.3 RAD IAT IVE TRANSPORT
Incoherent light transport is described by the radiation trans-
port equation (RTE) [75],
1
ν
∂L(r, Ω̂, t, λ)
∂t
=−∇ · L(r, Ω̂, t, λ)Ω̂ + Q(r, Ω̂, t, λ)
− µa(r, Ω̂, t, λ) L(r, Ω̂, t, λ)
− µs(r, Ω̂, t, λ) L(r, Ω̂, t, λ)
+ µs(r, Ω̂, t, λ)
∫
4π
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where the speed of light in the medium is represented by
ν = c/n∗, with the index of refraction of the medium (n∗). The
light radiance (L) [W cm-2 sr-1] describes the power per area
per Ω̂. The RTE relates changes in L travelling in the Ω̂ direc-
tion to influences due to absorption and scattering via the
corresponding coefficients µa and µs as well as the scattering
phase function (p) [cm-1] and the radiant source power per
volume element (Q) [W cm-3 sr-1] emerging from a source in
Ω̂ direction at (r, t).
Equation 2.3 ensures energy conservation in each infinites-
imal volume element over time. The positive source term is
represented by Q. Each absorption event reduces L, which
explains the negative sign in front of the µaL term. Scattering
can either subtract or add to the signal, so that the µsL term
accounts for the loss of a photon due to scattering and the
Lp integral describes photons who are added due to scatter-
ing happening in the entire solid angle. This becomes more
obvious, taking into account that an integration of p over all
solid angles Ω results in the scattering coefficient (µs).
2.3.1 Photon diffusion theory
The RTE can be simplified using the diffusion approxima-
tion [90, 325, 94, 27, 53]. Assuming that the photon direction
is randomized with only small directional dependence, we
can truncate an expansion of the light radiance L by spherical
harmonics (Yl,m(Ω̂)) from l = 0 to l = N with the coefficients
φl,m(r, t) [53, 147] at N = 1:






J(r, t) · Ω̂ (2.4)
Both contributing terms in this P1 approximation (Equation
2.4) have a physical meaning. The 0th order is defined as the
fluence rate (Φ) [W cm-2], which is defined as the light power
per area moving radially outward from an infinitesimal vol-
ume element at (r, t)
Φ(r, t) =
∫
L(r, Ω̂, t) dΩ (2.5)
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and the first order is the photon flux (J) [W cm-2], which
is the radiance vector sum with its origin at the infinitesimal
volume element at (r, t):
J(r, t) =
∫
L(r, Ω̂, t)Ω̂ dΩ (2.6)
Substituting this into Equation 2.3, carrying out the integral
over all solid angles and assuming that scattering is rotation-
ally symmetric (p(Ω̂, Ω̂′, r, t, λ) = p(Ω̂′, Ω̂, r, t, λ)) and that it
is isotropic (µa(r, Ω̂, t, λ) = µa(r, t, λ)) leads to Equation 2.7,
which is also referred to as continuity relation. It describes





Φ(r, t) +∇J(r, t) + µa(r, t)Φ(r, t) = S(r, t) (2.7)
with the radiant source power concentration (S) [W cm-3]
given by the total power per volume element at position r
and time t propagating radially outwards:
S(r, t) =
∫
Q(r, Ω̂, t) dΩ (2.8)
By furthermore considering isotropic light sources as well
as slow temporal variations [260], the substitution of Equa-
tion 2.4 into Equation 2.3 bears a relation between the pho-
ton flux (J) and the photon fluence rate (Φ), also known as
Fick’s first law of diffusion.
J(r, t) = − 1
3(µa + µ′s)︸ ︷︷ ︸
D(r,t)·ν−1
∇Φ(r, t), (2.9)
with the diffusion coefficient D(r, t) [cm2/s] 2. Fick’s first law
is also used to describe propagations which are not driven by





shown that the photon diffusion coefficient (D) could also be simplified
to [95] D = ν3(µ′s+µa) ≈
ν
3µ′s
. This transformed absorption-independent dif-
fusion coefficient leads to a better agreement between Monte Carlo re-
sults and diffusion theory. This is a result of the P1 approximation, which
requires light isotropy, and the condition µa  µ′s.
i
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external forces, i. e. external electrical fields, such as heat dif-
fusion in a metal.
In the pursuit of an equation, which describes a diffusive
process of photons in a medium and allows an analytical so-
lution, we can combine Fick’s first law of diffusion (Equation




−∇ · [D(r, t)∇Φ(r, t)] + νµa(r, t)Φ(r, t) = νS(r, t)
(2.10)
This equation describes the photon diffusion in diffusive
media (ı.e. biological tissue) under the above mentioned con-
ditions and assumptions. It relates the radiant source power
concentration S to the changes in the photon fluence rate Φ
due to absorption, scattering and time variations.
2.3.2 Boundary conditions
The solution of the DE in an experimental setting depends
on the medium geometry. We are interested in a reflective
geometry so we assume themedium to be semi-infinite. This
means that the medium spans to infinity along the x-y-plane
and from z = 0 to infinity along the z-direction. In the experi-
mental setting the boundary z = 0 then reflects the medium-
air boundary. In this case, boundary conditions need to be
taken into account. We use the extrapolated-zero boundary
condition:
Φ(z) = Φ(0) +
∂Φ
∂ z




z=zb−−→ Φ(zb) = 0 (2.11)
where the zero boundary is set to:
zb = 2 D · (1+Re f f/1−Re f f ) (2.12)
i
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The effective reflection coefficient Re f f is a result of linear
least squares fit [134] and given by:
Re f f ≈− 1.440 · (n∗/n1)−2 + 0.701 · (n∗/n1)−1+
+ 0.0636 · (n∗/n1) + 0.668
(2.13)
n∗ and n1 represent the refractive indices in- and outside
the medium.
The extrapolated-zero boundary condition (Equation 2.11)
forces a zero fluence rate at z = zb. This then leads to:
Φ = 2D
1 + Re f f
1− Re f f
n̂ · ∇Φ (2.14)
This approximation is a simple approach in the model for
the homogeneous semi-infinite medium and is obtained by
a Taylor expansion for the fluence rate around the boundary
(z = 0) truncated after the first order. Formulating this condi-
tion is equal to considering the light source as two isotropic
light sources, a positive one located at one transport mean
free path inside the medium (z = ltr, with z = 0 as the air-
medium interface) and a negative one located at z = −(ltr +
2zb) as shown in Figure 2.5.
2.3.3 Correlation diffusion theory
The unnormalized electrical field (E(r, t)) autocorrelation
function (G1 at position r is defined as
G1(r, τ) = 〈E(r, t) · E∗(r, t + τ)〉 . (2.15)
〈 〉 denotes the ensemble average. unnormalized electri-
cal field autocorrelation function (G1) can be interpreted as a
“correlation fluence rate”.
Similar to the RTE and it’s description of Φ, a correlation
transport equation can be written [27, 84, 4], which describes
the evolution of G1. Using the diffusion approximation, we
then arrive at the correlation diffusion equation (CDE), which
i
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Figure 2.5: Extrapolated zero boundary condition (semi-infinite ge-
ometry): The isotropic nature of the source is modeled
for a semi-infinite geometry by an isotropic light source
at z = ltr inside the medium (refractive index n*) and a
negative isotropic image source at z = −ltr − 2z0 above
the medium (refractive index n1). The source-detector
separation is defined as ρ and z=0 is located at the
medium interface. This illustration is inspired by [170].
describes the diffusion of the light field autocorrelation [30,
27, 28]:
[







G1(r, τ) = νS(r)
(2.16)
The CDE resembles the diffusion equation, but inherits an
additional term with <∆r2 (τ)> representing the mean-square
displacement of the scatterers over the correlation time (τ),
as well as the wavenumber of the light inside the medium
k0 = 2π/λ and the fraction of moving scatterers (α). That addi-
tional term - similarly to the part, which describes the loss of
photons due to absorption - accounts for correlation losses
due to the dynamics in the medium.
The dynamic term <∆r2 (τ)> was found empirically to be
expressed best in biological tissue by <∆r2 (τ)> = 6 Db τ [321,
90, 262, 94, 89, 56, 27], where particle Brownian diffusion co-
efficient (Db) [cm2/s] is the effective diffusion coefficient with
the subscripted “b” indicating that the expression originates
from the Brownian diffusion model. In comparison to the
i
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thermal Brownian diffusion coefficient of cells in blood given
by the Einstein–Smoluchowski relation [99], the diffusion co-
efficient in the 6 Db τ - term is a few orders of magnitude
larger.
This approach gives rise to diffuse correlation spectroscopy,
a technique which provides information about flow inside
a medium. The underlying theory originates from diffusing
wave spectroscopy (DWS) and the description of diffusing tem-
poral fields [27, 28, 30].
2.4 D I F FUSE CORRELAT ION SPECTROSCOPY
The CDE can be solved using the famous Green’s function
approach. We use the same boundary conditions as before
(Section 2.3.2). These lead to the semi-infinite medium solu-
tion for G1 [94, 27]:

















ρ2 + (z− ltr)2
r2 =
√
ρ2 + (z + 2zb + ltr)2.
For the definition of r1 and r2, please refer also to Figure 2.5.
The decay factor from the exponent in Equation 2.17, K(τ),
depends on the correlation time τ. This carries the informa-
tion about the dynamics in the medium.
2.5 T IME -RESOLVED SPECTROSCOPY
In the time domain, short (picosecond) laser pulses are
used and the flight time of diffused photons several mmaway
from the source is recorded. This technique is called time-
resolved spectroscopy (TRS). In this case, the radiant source
i
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power concentration S(r, t) and the photon fluence rateΦ(r, t)
in an infinite homogeneous medium can be written as
S(r, t) = S0 δ(r− r0) δ(t− t0) (2.18)
and









In the semi-infinite geometry (see Sec. 2.3.2) and for large
source-detector separations compared to the extrapolation
distance (ρ  zb), the photon fluence rate Φ(r, z, t) can be
written as [240]:


















Together with Fick’s first law of diffusion (Equation 2.9) we
obtain the following expression for the reflectance (R) at the
medium surface [240]:
R(ρ, t) = |J(r, z = 0, t)|2










Based on the solution of the diffusion model the measure-
ments are then linked to the actual biological tissue prop-
erties. The wavelengths are chosen from the near-infrared
range in the “physiological window” (Figure 2.2) mentioned in
Section 2.1. In addition to that we can choose between differ-
ent source types.
Light from a CW source allows to characterise only the to-
tal light attenuation and provides theminimum amount of in-
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formation one can retrieve in a diffuse optical measurement.
The most complete set of information about the medium
is provided by a pulsed light source which allows to build a
time-of-flight distribution from the diffused photons. This
technique is often referred to as time-resolved spectroscopy
or time domain measurements. It acquires distribution time
of flight (DTOF) curves for different wavelengths so that the
wavelength information can be used to calculate different
chromophore concentrations (see Section 2.1).
There are different approaches to the DTOF evaluation. We
focus on fitting the solution of the diffusion equation to the
measurement. In this process, it is important to correct for
the instrument, since the light pulse in theory is described as
a delta pulse and we are limited by the available laser pulse
widths. Furthermore, optical fibers, detectors and electron-
ics add to the pulse width. The correction is achieved by con-
volution of the instrument response function (IRF), which ac-
counts for thementioned instrument characteristics, and the
solution for the reflectance (R) from the diffusion approxima-
tion for the semi-infinite homogeneous medium [240]. The
results is then fitted to the measured DTOF curve. This yields
the absorption µa and reduced scattering coefficients µ
′
s. Both
curves, the IRF as well as the DTOF are normalized prior to
fitting it to the above-mentioned solution. Typically, the fit
range is adjusted based on the diffusion approximation and
the nature of absorption [229, 169].
For DCS, it is important to state that detectors can only
record the magnitude squared of the electrical field, the ir-
radiance. The unnormalized intensity autocorrelation func-
tion (G2) is defined as
G2(r, τ) = 〈I(r, t) · I(r, t + τ)〉 . (2.22)
The temporal electric field and intensity autocorrelation func-
tions are related by the Siegert relation [183]:
G2 = 〈I〉2 + β |G1|2 (2.23)
Themode parameter (β) depends on the experimental setup
and is affected by the number of detected laser modes or
i
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speckles. It can also be affected by laser characteristics such
as stability and coherence length but assume this is minimal
[21, 254, 198]. The normalized intensity and electrical field
autocorrelation functions (g2 and g1 respectively) are defined
as:
g2(τ) =




〈E(t) · E∗(t + τ)〉
〈E(t) · E∗(t)〉 (2.25)
With the knowledge of β, the measurement of normalized
intensity autocorrelation function (g2) can be converted in
into normalized electrical field autocorrelation function (g1).
The solution of the CDE (Equation 2.17) is then fit to the re-
sulting g1. As mentioned in Section 2.3.3, the mean square
displacement <∆r2 (τ)> in Equation 2.17 is found to be best
approximated by 6Dbτ [60, 90, 46, 262, 50, 346, 94, 96, 44,
341, 340, 92], which gives information about the dynamics
in the medium, e. g. blood flow in biological tissue and to-
gether with the fraction of moving scatterers (α) is therefore
reported often as a blood flow index (BFI).
BFI = α Db (2.26)
2.7 MODELL ING MED IUM RESPONSE IN THE SEM I - INF IN ITE
MED IUM APPROACH
Based on the knowledge from photon and correlation dif-
fusion theory (Sections 2.3.1 and 2.3.3) we will explore the ex-
pected response for different experimental parameters, such
as source-detector separation (ρ), µa, µ
′
s, Db and the index of
refraction of the turbid/medium tissue (n∗).
2.7.1 Time-resolved spectroscopy
As explained in Section 2.5, the R of the medium changes
with ρ, µa and µ
′
s. While ρ can be controlled by the experimen-
talist, µa and µ
′
s are given by themedium and their knowledge
is useful in its characterization. Figures 2.6 and 2.6 illustrate
i
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the changes of R with ρ, µa, µ′s and n∗.


































a) Variation of ρ


































b) Variation of µ′s
Figure 2.6: Reflectance behaviour under source-detector distance
and scattering changes: a) varying ρ between 0.5 cm
and 4.5 cm in steps of 1 cm; b) varying µ′s between 5
cm-1 and 15 cm-1 in steps of 2.5 cm-1
All three parameters have different influence on the actual
shape of the reflectance. The bigger ρ, the more the peak
shifts downwards and to the right (Figure 2.6 a). This is ex-
pected because the photons need more time to travel to the
far distant detector (shift to the right). Along their path more
of them get absorbed by the medium since they travel fur-
ther. A similar behaviour may be observed in variation of µ′s
(Figure 2.6 b)), since a higher degree of scattering results in a
shorter transport mean free path ltr and therefore increases
the time the photons spent in the tissue. For increasing ab-
sorption, e. g. higher µa, changes in the decay of R can be
i
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a) Variation of µa


































b) Variation of n∗
Figure 2.7: Reflectance behaviour under absorption and refractive
index changes: a) varying µa between 0.1 cm
-1 and 0.6
cm-1 in steps of 0.1 cm-1; b) varying n∗ between 1.14 and
1.64 in steps of 0.1
observed (Figure 2.7 a)). n∗ has similar influences on R as µ′s
(Figure 2.7 b)), which related to the fact that scattering is due
changes in the index of refraction. Equation 2.21 as a solu-
tion of the DE in the time-domain describes this exponential
decay behaviour of the reflected signal well.
2.7.2 Diffuse correlation spectroscopy
The second diffuse optical technique used in this thesis is
DCS. In Section 2.4, the solution for the semi-infinite medium
was introduced and here look at the influence of ρ, µa, µ
′
s, n∗
and Db on the correlation curve, i. e. g1. The according graphs
are shown in Figures 2.8 and 2.9.
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c) Variation of µa
Figure 2.8: Autocorrelation g1 behaviour under changes of ρ, µ
′
s and
µa: a) varying ρ between 0.5 cm and 4.5 cm in steps of 1
cm; b) varying µ′s between 5 cm
-1 and 15 cm-1 in steps of
2.5 cm-1; c) varying µa between 0.1 cm
-1 and 0.6 cm-1 in
steps of 0.1 cm-1
With increasing ρ, as shown in Figure 2.8 a), we see that g1
decays faster, which means that the correlation is lost at ear-
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b) Variation of Db
Figure 2.9: Autocorrelation g1 behaviour under changes of n∗, and
Db: a) varying n∗ between 1.14 and 1.64 in steps of 0.1; b)
varying Db between 1 ×10-12 and 1 ×10-8
lier correlation time (τ). Since the photons spent on average
more in the medium due to the larger distance they have to
travel in order to reach the detector, more scattering events
can occur and therefore correlation is lost at earlier τ. This
is also true for larger µ′s as shown in Figure 2.8 b). Changes
towards larger µ′ss cause a have a similar effect on the correla-
tion and since the refractive index of the medium (n∗) affects
the scattering, we see a related change of g1 upon increas-
ing n∗ (Figure 2.9 a)). With increasing Db, the g1 curve decays
faster as well (Figure 2.9 b)), which in biological tissues is re-
lated a higher blood flow. This parameter together with α is
referred to as the blood flow index (BFI) in this thesis.
i
i






2.8 CONCLUS ION 33
2.8 CONCLUS ION
This chapter only touched the basics of light propagation
is tissues and then presented solutions and strategies in a
manner relevant to the techniques and data analysis utilized
and employed in later chapters. The interested reader can






















In this chapter, the oxygen diffusion in tissue is discussed
in a brief and simple manner. The effects of different gas
concentrations (CO2 and O2) in the blood are presented and
how changes in these concentrations affect the blood perfu-
sion. A compartment model is used to understand how oxy-
gen reaches and penetrates biological tissue. Oxygen uptake
by hemoglobin as well as how the oxygen saturation (SO2) at
the arterial and venous end of the capillary depends on the
arterial partial pressure of carbon dioxide (PaCO2) will also be
explained. cerebral autoregulation (CAR) is introduced and
alterations in cerebral blood flow (CBF) as well as the causes
are examined. The goal is to present the reader with basic
principles needed for a non-clinician to understand the re-
lationship between the measurements and the underlying
physiology.
3.1 OXYGEN TRANSPORT
The body’s vascular system provides the supply of oxygen
to tissue and organs and also takes care of part of the clear-
ance of metabolic byproducts. The system can be divided
into the macro- and microvasculature [312]. While the blood
vessel at themacrovascular levels are large, such as themiddle
cerebral artery (MCA) in the brain, it is the microvasculature
that plays the main role in the oxygen supply and clearance
processes: On the arterial side, oxygen saturated red blood
cells (RBC) are transported through themacrovasculature then
in to themicrovasculature fromwhich oxygen is actually trans-
ported into tissue. Oxygen is then used to produce energy
and the byproducts are then cleared together with the par-
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In order to explain blood oxygen transport in the tissue a
compartment model is often used. We consider the main
blood components RBC and blood plasma. Compartment
models are widely applied in the estimation of drug uptake
and delivery. The simple single compartment model for the
estimation of oxygen metabolism can be seen as an oxygen























Figure 3.1: Compartment model for blood tissue interaction: The
oxygen concentration is abbreviated by C. The plasma
concentration (Cp) oxygen represents the O2 concentra-
tion in the blood plasma. The tissue permeability (Pt)
leads to a certain tissue oxygen concentration (Ct). All
variables are dependent on the distance x each RBC has
travelled in the vessel. Ca and BFa represent the arteri-
ole oxygen concentration and blood flow, Cv and BFv the
venous oxygen concentration and venous blood flow.
Blood with an arterial oxygen concentration Ca on the left
passes through the compartment and on the venous side
has a venous oxygen concentration (Cv). The total vascular
oxygen concentration, which decreases due to the tissue’s
oxygen demand and the distance the RBC travel in the com-
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partment, is described by C(x). The oxygen uptake by the
surrounding tissue results in the tissue oxygen concentration
(Ct). The plasma concentration (Cp) expresses the amount of
oxygen dissolved in the physical solution, i. e. blood plasma.
Its oxygen content in the human body is normally about 2 %,
while the majority of oxygen - the other 98 % - is taken up
by the RBC and attached to a protein called hemoglobin [312].
This molecule contains four separate heme groups each of
which can reversibly bind an oxygen molecule [246].
As discussed previously, one can distinguish between oxy-
and deoxyhemoglobin (HbO2 and Hb) based on their absorp-
tion spectra and this can be used to determine their con-
centrations in the blood. This is generally done using near-
infrared light and is the basis of the standard pulseoximeter.
In this thesis, we employ this same concept with pulsed laser
sources and photon counting techniques in a time-resolved
spectroscopy (TRS) setup.
Oxygen is released by hemoglobin when a lower partial
pressure of oxygen (PO2) is present in the surrounding tissue
[312, 318]. PO2 in the capillary is higher than in the surround-
ing biological tissue and it is this condition which drives oxy-
gen diffusion into the tissue. This pressure dependent oxy-
gen dissociation from hemoglobin is shown in Figure 3.2 and
is the result of a least-squares fitting to empirical data [318,
162, 280].
The oxygen-hemoglobin dissociation curve is dependent
on the temperature (T), the blood’s pH and the arterial par-
tial pressure of carbon dioxide (PaCO2) [65, 246, 216, 130, 279,
14, 39]. Changes in these factors can cause a left or right
shift to the oxygen-hemoglobin dissociation curve. A smaller
value of T and PaCO2 results in a left shift while a larger value
results in a shift to the right. The opposite effect is seen with
changes in pH. For the description of the oxygen-hemoglobin
dissociation curve we need to take into account the Bohr ef-
fect. The Bohr effect describes the decreasing oxygen affin-
ity of hemoglobin due to increasing CO2 blood concentration.
As a consequence the acidity/alkalinity scale for an aqueous
solution gives a lower pH value. In venous blood this leads
to a slight deviation to the right from the plotted oxygen-
hemoglobin dissociation curve (Figure 3.2) and for arterial
blood it results in a higher pH and lower PaCO2.
i
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Figure 3.2: Oxygen-hemoglobin dissociation curve: It relates the
oxygen saturation (SO2) to the partial pressure PO2 un-
der standard conditions T = 37°C, pH = 7.4 and PaCO2
= 40 mmHg. The partial pressure at SO2 = 50 % (P50),
which is used a measure of health condition, is marked
in grey. Red and blue markings give an idea of the arte-
rial and venous conditions. The graph is created based
on [162].
These have changes further implications for the blood cir-
culation, including flow. The relationships between these pa-
rameters can be studied by changing the contents of the in-
haled gas mixture, which in turn affect PO2 and PaCO2 [207, 7,
296, 130, 165, 167, 292, 258, 163].
3.2 CEREBRAL C IRCULAT ION AND METABOL ISM
Since a large part of the measurements presented in this
thesis includes information on cerebral hemodynamics, in
this Section, some important concepts of brain physiology
are presented. These help in the understanding of the mea-
surements presented in the second part of this thesis.
The brain is critical and delicate organ and as such nature
has provided a couple of elegant design solutions to protect
it. Some of the most important of these solutions are the
circle of Willis and cerebral autoregulation (CAR).
3.2.1 Circle of Willis
The circle of Willis is part of the macrovasculature in the
human brain and can be seen as nature’s backup plan to
avoid ischemic conditions in the brain [188, 312, 303]. If an
artery is occluded or bursts, i. e. a stroke or hemorrhage oc-
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curs, sufficient oxygen supply to all brain regions needs to
insured or re-established. The macro- and microvasculature
are connected, but the structure of the circle of Willis as part
of the macrovasculature allows the body to attempt that the
brain is sufficiently be supplied by blood and oxygen at mi-
crovascular levels although a damage occurs within the circle
of Willis. This regulating ability eases sufficient blood supply
to all regions of the brain and allows us, to place our fiber
optic probes on the human forehead in order to gain infor-
mation on brain hemodynamics. Here, we discuss the circle
of Willis as it is present in humans.
Figure 3.3 a) shows a bottom view sketch of the human
brain with arteries and the circle of Willis forming around the
optic chiasm and in the middle the pituary gland in front the
hypothalamus. The diagram in Figure 3.3 b) gives a closer
look at the arteries forming and supplying the circle of Willis
(i. e. the arterial circle). The angiogram in Figure 3.3 c) shows
this region in an actual brain. This technique relies on the
injection of a radio opaque contrast agent and the use of X-
rays to show a projection of the vertebrobasilar and posterior
cerebral circulation.
Blood supply to the brain is provided by the posterior and
anterior circulation. The middle and frontal brain regions are
taken care of by the anterior circulation, while the brain stem,
the cerebellum and the rear portions of the brain are sup-
plied by the posterior circulation.
The circle of Willis is formed as the internal carotid artery
enters the cranial cavity bilaterally and divides into the ante-
rior and middle cerebral artery (ACA and MCA respectively).
The anterior cerebral arteries are then united by an anteriorcommunicating artery. These connections form the anterior
half (anterior circulation) of the circle of Willis. Posteriorly,
the basilar artery, formed by the left and right vertebral ar-
teries, branches into a left and right posterior cerebral artery
(PCA), forming the posterior circulation. The PCAs complete
the circle of Willis by joining the internal carotid system ante-
riorly via the posterior communicating arteries.
This architecture enables the body to supply the brain with
sufficient blood even when either the posterior or anterior
arteries or their branches are occluded or a hemorrhage oc-
curred. The circle of Willis is therefore a crucial feature in the
correct functioning of the brain under adverse conditions.
i
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Figure 3.3: Illustration of the circle of Willis: a) shows a depiction of
the brain and its basal arteries viewed from the bottom.
b) is a schematic illustration only of the arteries feeding
and forming the circle of Willis. c) shows a cerebral an-
giogram of the posterior part of the circle of Willis with a
posterior-anterior projection of the vertebrobasilar and
posterior cerebral circulation. Figures a) and b) were
taken with permission from the Bartleby.com edition of
[128] and Figure c) was released by the copyright holder
into the public domain and published at [67].
3.2.2 Blood flow
Blood flow is defined as the volume of blood which passes
through a vessel cross section in given a time interval. It is
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influenced by factors such as heart rate (HR),cardiac output,
blood pressure (BP) and vessel diameter. Since the heart acts
as a pump, we can consider HR as the pumping speed, while
BP acts a the pumping force. Imagining the blood vessel as a
tube, we know from fluid dynamics (e. g. the Hagen-Poiseuille
equation), that the tube diameter has a crucial influence on
the flow. In the human body, the blood vessels can dilate and
constrict in response to different PaCO2 levels in the blood. As
an example, the effect of this vasoconstriction or vasodilata-
tion on CBF due to different PaCO2 blood levels is shown in
Figure 3.4.

























Figure 3.4: CBF dependence on PaCO2. This graph is created based
on [258].
3.2.3 Cerebral autoregulation
Cerebral autoregulation (CAR) is a physiological regulatory
mechanism that acts within the brain and its vascular net-
work to ensure constant blood perfusion - and a constant
supply of oxygen - for a broad range of perfusion pressures
[181, 297]. This mechanism compensates for changes in the
local pressures via the cerebrovascular resistance (CVR) [212].
This process can be interrupted - or impaired - for a number
of different reasons, including stroke and traumatic brain in-
jury [122]. The interplay of the cerebral perfusion, the mean
arterial and the intracraneal pressure (CPP, MAP and ICP re-
spectively) is described by [135, 297]:
CPP = MAP− ICP (3.1)
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CAR then refers to ability to maintain cerebral blood flow









A classic graphical representation, commonly used to illus-
trate the CAR process is shown in Figure 3.5.























Figure 3.5: Relationship between CBF and CPP: The constant re-
gion between CPP = 50 - 150 mmHg illustrates the
brain’s ability to autoregulate, that is to maintain a con-
stant CBF. This is achieved via vasodilatation or vaso-
constriction, as illustrated by the grey circles above the
constant region.
An intact CAR process is essential for a healthy brain. In
brain injured patients, an invasive pressure probe monitor-
ing ICP can be used to calculate CPP [290]. CPP values are
needed in order to assess brain perfusion (see also Figure
3.5) and provide the possibility to study CAR in situations
where the process is compromised. On the other hand, com-
bining information on CPPwith a non-invasive assessment of
CBF provides a simple test of the CAR status. Diffuse optics
can provide non-invasive CBF information and are therefore
a promising approach to study CAR.
3.2.3.1 Challenges to cerebral regulation of blood flow
CBF changes can be induced by altering the concentration
of inspired CO2 concentration while a decreased concentra-
tion will act as a vasoconstrictor [207, 242, 196, 305, 257, 7, 64,
296, 216, 289, 114, 3, 256, 130, 167, 258].
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In Figure 3.6, the autoregulation curve from Figure 3.5 is
presented together with the oxygen-hemoglobin dissociation
curve from Figure 3.2 and the relationship between CBF and
PaCO2 under normal conditions (“Normocapnia”) is shown. It
recalls the characteristics of CPP, CBF, PaCO2, PO2 and SO2.
Non-normocapnic conditions are then discussed in continua-
tion.






























































Figure 3.6: Top graph: Effect of PaCO2 on CBF. Left graph: Rela-
tionship betweenCBF andCPP under normocapnic con-
ditions. Right graph: Oxygen hemoglobin dissociation
curve.
The grey dot in the PaCO2 - CBF curve shown in the top
graph in Figure 3.6 illustrates the pressure and flow that is
present in the normocapnic case. As previously shown in
Figure 3.5, we see in the bottom left graph the characteris-
tic plateau region between CPP = 50 mmHg and 150 mmHg,
where the CBF is kept constant by means of vasodilation (for
decreasing CPP) or vasoconstriction (for increasing CPP). The
oxygen hemoglobin dissociation curve - plotted on the bot-
tom right in Figure 3.6 - is the standard curve as shown in
Figure 3.2 and discussed previously. Changes in PaCO2 result
in cases of hypercapnia (HRC) and hypocapnia (HOC) and can
be experimentally achieved by altering the CO2 concentration
in the inspired gas mixture. The hypercapnic case is shown
in Figure 3.7.
Due to higher PaCO2, the blood vessels dilate and CBF in-
creases to around 70 ml/100 g/min. The increased vessel di-
i
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Figure 3.7: Hypercapnic influences cerebral hemodynamics: Top
graph: Effect of PaCO2 on CBF. Left graph: Relation-
ship between CBF and CPP under hypercapnic condi-
tions. Right graph: Oxygen-hemoglobin dissociation
curve with a shift to the right a indicated by the arrow
and caused by a decrease of pH due to an increased
CO2 blood content. Figure partially inspired by [207].
ameter leaves less margin for vessels to account for changes
in the CPP, thus shrinking the tolerable pressure range. As
a consequence of the PaCO2 increase, the pH decreases and
therefore the blood’s oxygen affinity is lowered (Bohr effect).
This results in a shift to the right of the oxygen-hemoglobin
dissociation curve [216]. The above-mentioned CBF increase
accounts for the decreased PO2. In the opposite case, the
HOC condition, oxygen affinity is increased due to higher pH
and CBF is lowered in consequence of lower PaCO2 (see Fig-
ure 3.8).
In this scenario, two possibilities at the rising part of the
CAR curve can be thought of. At the endpoint of the re-
gion where CPP is kept constant the blood vessel are maxi-
mally constricted. Curve number 1 illustrates the case, when
the vessel diameters between normo- and hypocapnic con-
ditions at that point are the same. If that the point of maxi-
mum vasoconstriction is not the same between normo- and
hypocapnia, the plateau region is extended to the right with
the endpoint illustrated by the red dot in curve 2 [207]. The
exact position of the upper limit of the plateau region still
needs to be identified [207].
i
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Figure 3.8: Hypocapnic influences cerebral hemodynamics: Top
graph: Effect of PaCO2 on CBF. Left graph: Relation-
ship between CBF and CPP under hypocapnic condi-
tions. Right graph: Oxygen-hemoglobin dissociation
curve with a shift to the left a indicated by the arrow and
caused by an increase of pH due to lower CO2 blood
content. Figure partially inspired by [207].
Another method to manipulate CBF is to change PO2 by al-
tering the amount of inhaled O2 (InspO2). While a decrease
of O2 leads to an increase in CBF, an increased O2 content in
the inhaled gas mixture may provoke a decrease in CBF. The
latter process is called hyperoxia (HO). All three challenges
discussed here (HRC, HOC and HO) may induce changes in
CBF in the healthy brain and are utilized in the experiments
presented in Chapters 7 and 8.
3.2.4 Cerebral metabolism
In the work presented here, we report the tissue oxygen
saturation (StO2). It is calculated based on the Hb and HbO2
concentrations measured using diffuse optics.
With the tissue compartmentmodel for oxygenmetabolism
described in Section 3.1, we can express the tissue oxygen
saturation (StO2) as a superposition of arterial oxygen satu-










46 OXYGEN TRANSPORT, CEREBRAL HEMODYNAM ICS AND AUTOREGULAT ION
StO2 = k1 · SaO2 + k2 · ScO2 + k3 · SvO2 (3.3)
ScO2 = k4 · SaO2 + k5 · SvO2 (3.4)
The respective sum of the weighting factors ki need to sat-
isfy the condition: k1 + k2 + k3 = k4 + k5 = 1 [70]. These
factors therefore represent the contributions of each com-
partment to the total blood volume.
The oxygen extraction fraction (OEF) can be defined as the
fraction of oxygen released by the RBC and taken up by tis-
sue as the RBC travel from the arterial to the venous side. As-
suming a steady-sate balance between the hemoglobin con-





with the arterial oxygen saturation (SaO2), tissue oxygen
saturation (StO2) and blood volume percentage in venous com-
partment (γ). The parameter γ is defined as:
γ = k3 + k2 · k5 (3.6)
γ has its origin in expressing StO2 as a superposition of
arterial oxygen saturation (SaO2), capillary oxygen saturation
(ScO2) and venous oxygen saturation (SvO2).
The cerebral metabolic rate of oxygen (CMRO2) is depen-
dent on CBF, oxygen extraction fraction (OEF), Ca and can be
written as [70, 141, 145]:
CMRO2 = CBF ·OEF · Ca. (3.7)
Together with Equation 3.5 we then can define the relative
cerebral metabolic rate of oxygen (rCMRO2) as [90, 33, 209,
94, 70]
rCMRO2 = rCBF ·
























In a scenario, where the relation between SaO2, ScO2 and
SvO2 (Equation 3.4) changes, γ does not stay constant (γ 6=





− 1) · 100 (3.9)
based on the formulation presented above.
3.3 SUMMARY
Since we can use diffuse optics to measure hemodynamics
non-invasively, some basic physiological principles are pre-
sented here. As shown in Chapter 2, we can gain informa-
tion on oxy- and deoxyhemoglobin by time-resolved spec-
troscopy. Here, we have discussed oxygen diffusion in tis-
sue based on a compartment model. This puts our measure-
ments of tissue oxygen saturation (StO2) in the later chapters
into perspective and helps in the interpretation of the results.
This also true when we look at the regulation of blood flow,
which can be assessed by diffuse correlation spectroscopy
(DCS) (see Chapter 2) as well as when we compare micro- and
macrovascular circulation. A large part of the measurements
presented in this thesis were acquired to gain information
on cerebral hemodynamics. These can be different at the
micro- and macrovascular levels due to the circle of Willis, as
discussed in Section 3.2.1. The process of CAR and the ef-
fects on it due to different gas concentrations (CO2 and O2) in
the blood have been introduced. These are particularly rel-
evant for the understanding and interpretation of the mea-
surements presented in Chapters 7 and 8, where we study
the response of cerebral hemodynamics during hypercapnia,
hyperoxia and hyperventilation. Furthermore, we will dis-
cuss the relevance of diffuse optics to cancer physiology and
their importance in the interpretation of diffuse optical data
in Chapter 5 for the example application of thyroid cancer.
i
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EXPER IMENTAL SETUP AND
INSTRUMENTAT ION
In this chapter, the experimental setup used for the mea-
surements taken throughout this work is presented and char-
acterized. We are interested in the absolute values of the oxy-
and deoxyhemoglobin concentrations (Hb and HbO2) for tis-
sue characterization and so use a time-resolved spectroscopy
(TRS) system. In order to obtain information on tissue BF we
use a DCS system.
Previous studies have shown the non-practicatility of a si-
multaneous evaluation of µa, µ
′
s and Db from a single g2 curve
[83]. When using multiple small source-detector separations,
such an evaluation can work, but fails at larger source-detec-
tor separations (ρ > 2 cm) [104]. This scenario requires the use
of a hybrid TRS/DCS device and that is what is used through-
out this work. Another advantage of of a hybrid design is,
that the TRS-derived µa can be used together with µ′s to im-
prove analysis of DCS data [149]. This yields a more accu-
rate estimation of the blood flow index (BFI), which is depen-
dent on both parameters. The combination of TRS and DCS
is furthermore advantageous in the calculation of the oxygen
extraction fraction (OEF) and cerebral metabolic rate of oxy-
gen (CMRO2) [90, 33, 209, 94].
Details of the hybrid TRS/DCS device including the probes
and fiber optics are presented here.
4.1 HARDWARE
In the experimental setup, several physical principles for
detection of photons are exploited. Since the interest lies on
single photon detection and their correlation characteristics,
the techniques chosen to reveal information about temporal
distribution of photons and intensity correlations will be dis-
cussed here.
While in DCS photons are counted by an avalanche photo-
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the autocorrelation calculation, in the TRS modality hybrid
photo multiplier tubes (PMTs) are used, due to their large ac-
tive area (see Section 4.1.1). The output signal from the hy-
brid PMT is passed to a time-correlated single photon count-
ing (TCSPC) system (see Section 4.1.2), operated by a PC soft-
ware to build the distribution time of flight (DTOF) curves.
4.1.1 Hybrid photomultiplier tube
A photo multiplier tube (PMT) combines two effects in or-
der to amplify the detection of a photon, the photoelectric
effect [138, 100] and secondary emission [15]. The idea is
similar to an avalanche photodiode (APD), but a PMT has a
larger active area. A photocathode at the beginning of the
PMT absorbs an incoming photon and emits a free electron,
as a consequence of the photoelectric effect [138, 100] (see
also Figure 4.1). Due to a line of dynodes with increasing po-
tential (100-1000 V), the free electron is geared towards one
dynode after another, provoking an electron avalanche. This
avalanche is a result of secondary emission [15], which is the
second of the above-mentioned two effects used in a PMT. At
the end of the PMT, this avalanche hits the anode and creates
a current pulse. As a result of the electron cascade, the cur-
rent is amplified by several orders of magnitude and there-
fore easily detectable.
In a standard PMT, electrons can also be absorbed or re-
flected at the dynode, thus limiting the signal amplification
[18]. This effect can be avoided by using a hybrid PMT. These
use an avalanche diode for electronmultiplication rather than
an arrangement of multiple dynodes. Instead of a secondary
emission as in a PMT, here, photoelectrons are multiplied by
producingmany electron-hole pairs within silicon layer of the
avalanche diode. The electrons of these pairs create more
electron-hole pairs at the p-n-junction in a series of chain re-
actions. These two steps are the heart of signal amplification
in a hybrid PMT.
There are major advantages in the use of a hybrid PMT.
While its efficiency is comparable to that of a single photon
avalanche photodiode (SPAD), the active area is significantly
larger and afterpulsing becomes negligible [20]. Afterpulsing
in PMTs is a result of residual gas ionisation from the pre-
i
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Figure 4.1: Photomultiplier tube: An incoming photon is converted
into an electron (photoelectric effect) [138, 100] and due
to the increasing gain voltage and secondary emission
[15] at each dynode an electron avalanche is created be-
fore hitting the anode at the end of the photo multiplier
tube (PMT).
vious avalanche within the dynode. When no longer using
dynodes rather than an avalanche diode this effect is sig-
nificantly decreased due to the lower ionisation probability
from photoelectrons, which travel in the vacuum inside a hy-
brid PMT. Moreover, the avalanche diodes used in a hybrid
PMT allow for timing resolutions within the picosecond range.
This improvement in timing resolution, the reduced afterpuls-
ing and increased signal-to-noise ratio (SNR) - as a result of an
increased gain in the first step (1000 versus 5-6 in a standard
PMT) - of a hybrid PMT over the conventional PMT makes it
suitable for low-level photon detection with picosecond time
resolution and is therefore often used in time-correlated sin-
gle photon counting (TCSPC) in the field of diffuse optics.
As explained earlier, diffuse optics uses light in the near-
infrared since it allows for the investigation of tissue hemo-
dynamics. It is therefore crucial to choose a photocathode
which has the ability to detect photons within a desired wave-
length range. For the setup presented here, a GaAs cathode
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4.1.2 Time-correlated single photon counter
The TRSmodality records flight times of individual photons
and makes use of a technique called time-correlated single
photon counting (TCSPC). In this technique, individually de-
tected photons from a periodic low-level light signal can be
related to their arrival time. Due to the fact, that the proba-
bility of detecting multiple photons per signal period is small,
the arrival time can be undoubtedly assigned to a time bin
with knowledge of the laser pulse initiation. Based on the pe-
riodicity of the light signal, the time bins are filled according
to the recorded time of flight (TOF) of each photon. This tech-









Figure 4.2: The time-correlated single photon counting (TCSPC)
functional principle: Each laser cycle photon are emit-
ted, sometimes they are detected. The counted photon
pulses are assigned to a time bin and build up theDTOF.
Figure adapted from [19].












In DCSmeasurements, the necessary normalized intensity
autocorrelation function (g2) (see Section 2.6) are calculated
in real-time by a digital correlator (Correlator.com, New Jer-
sey, USA). This correlatormake use of the transistor-transistor
logic (TTL) signal from an APD and time-tags it. Based on
a “multi-tau” scheme, the correlator has several tiers each
with a set number of registers. While the first tier consists of
thirty-two registers, all following tiers have sixteen. The bin
width starts at 160 ns in the first tier, 320 ns in the second
tier and continues to double for every tier. The correlation
time (τ) is the result of an addition of all existing time bins
and the time-tagged TTL signal is used to assign the number
of photon counts within each binning time. As an additional
photon is detected, the existing scheme moves one register,
leaving the first one to be occupied by the additional photon
(see also Figure 4.3). Prior to each move, a g2 curve is calcu-
lated. Once the acquisition time has passed the calculated g2
is saved and a new measurement starts.
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Figure 4.3: The autocorrelator functional principle: Each box is
filled with a photon (γ) detected within the according
time interval. The boxes are shifted to the left and ap-
plied on the photon sequence. Based on the number
of photons detected within each time interval the auto-
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4.2 HYBR ID D I F FUSE OPT ICAL DEV ICE
The two techniques, TRS and DCS, are combined in a sin-
gle instrument. Figure 4.4 gives a schematic of the hybrid
system. The TRS part consists of pulsed lasers with a rep-
etition rate of 50 Mhz at three wavelengths (690, 785 and
830 nm). The three lasers (BHLP-700, Becker & Hickl GmbH,
Berlin, Germany) are connected to two optical switches (3 in-
puts to 1 output and 1 input to 9 outputs) in order to illumi-
nate tissue separately at either two different source detector
separations or locations. The first optical switch is used to
choose one out of the three lasers to be put through to the
second optical switch which passes the laser light on to either
output A or output B. These two outputs allow either two
source-detector separations or two separate measurement
locations. The collected light is guided to a hybrid photo mul-
tiplier detector (HPM-100-50, Becker & Hickl GmbH, Berlin,
Germany). Two separate detectors are used in a way that de-
tector A collects the light from output A and accordingly for
output B. A single photon counting and a detector control
card together with a manufacturer-provided software (SPC-
130, DCC-100 and SPCM, respectively, Becker & Hickl GmbH,
Berlin, Germany) complete the time-correlated single photon
counting (TCSPC) setup. this configuration enables one to ac-
quire the distribution time of flight (DTOF) curves built from
the collection of diffuse photons with varying pathlengths
(see also Section 4.1.2).
The selection of the wavelength of light (λ) is based on the
availability of laser sources as well as the absorption spectra
for the various tissue chromophores as discussed in Section
2.1 and shown again Figure 4.5.
The TRS system is multiplexed with two single longitudinal
mode lasers and four avalanche photodiodes (APDs) to cre-
ate the hybrid device. Figure 4.6 illustrates the simultaneous
acquisition of TRS andDCS data. The source forDCSmeasure-
ments requires a laser with a long coherence length - much
longer than a typical photon path length - and here we use
the DL785-120-SO (CrystaLaser, Reno, NV, USA) laser. For the
detection two sets of four single-photon counting avalanche
photodiodes (Excelitas, Québec, Canada) are added to the
system. Each DCS laser and a set of four single-photon count-
i
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Figure 4.4: Hybrid system schematics showing on the top the time-
resolved spectroscopy (TRS) and on the bottom the
DCS modality. For TRS, three pulsed picosecond lasers
of different wavelengths are coupled into two optical
switches before their light is sent to the tissue. Light col-
lection is done by two separate detectors, which are pro-
tected from DCS light by individual shutters. For DCS,
the light of two CW lasers passes through an attenuator
before it reaches the tissue. Two arrays of four single-
photon counting avalanche photodiodes detect incom-
ing photons from the tissue and are connected to an
eight channel correlator, which calculates intensity au-
tocorrelation functions.






















Figure 4.5: Plotted are the absorption curves for different tissue
chromophores as in Figure 2.2 in the “Physiological win-
dow”. The dominant chromophores (Hb and HbO2) at
the selected TRS wavelengths are marked by the black
circles.
ing avalanche photodiodes is used to acquire data for either
a specific source-detector separation (ρ) or specific probe lo-
i
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cations. This leads to a similar data acquisition as in the TRS
implementation, were optical switches together with two hy-
brid PMT detectors take care of the data recording for differ-
ent ρ (see also Figure 4.9). For further details on the func-
tional principles of both techniques please refer to Sections






























Figure 4.6: TRS andDCS acquire data simultaneously. The intensity
autocorrelation curves were calculated with data col-
lected from one hemisphere, while the system switched
through all three TRS lasers on the opposite frontal
lobe.

































80.0 % 0.1 %
Figure 4.7: Example of a DTOF curve fit by using the IRF input (red)
to calculate the theoretical response with given input
parameters (µa and µ
′
s) and minimizing the χ
2 between
theory and measurement (black). The resulting fitted
curve is plotted in blue. Grey dashed lines highlight the
fit range and the hatched area symbolizes the region
used for background subtraction.
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Figure 4.7 shows an example of a fit to TRS acquired data
with the device. This data is a sample set from the phan-
tom measurements presented in Section 4.2.2.3. The IRF of
the system - plotted in red - is acquired and, as explained in
Section 2.6, convoluted with the semi-infinite homogeneous
medium solution for the reflectance (R) [240] with initial start
parameters of µa = 0.1 cm
-1 and µ′s = 10 cm
-1. This convoluted
theoretical DTOF curve is then fitted to the acquired DTOF
curve - plotted in black. The final results, the blue curve -
yields the final µa and µ
′
s. Prior to the fit the background - rep-









































Figure 4.8: Example of a g2 curve (red), the calculated g1 curve
(black) and the resulting fit to it (blue). Data points
within the hatched were excluded from the fit.
Figure 4.8 shows an example ofDCS data acquired with this
system. The correlator calculated the g2 points for different
correlation times τ - shown in blue. In the data analysis, first
β is calculated based on a weighted mean of the first three
to five data points and then used to convert g2(τ) into g1(τ)
using the Siegert relation [183]. Based on the semi-infinite
medium solution of the correlation diffusion equation (CDE)
presented in Section 2.4 and information about µa and µ
′
s
from the TRS modality the fit to the previously calculated g1
curve is performed - plotted in blue in Figure 4.8.
i
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The entire device is controlled by a PC and custom Visual
Basic routines. These also act as a master program in the
interaction with the manufacturer provided (and above-men-
tioned) SPCM software, which records and stores the DTOF
acquisitions. An external battery pack (SAI 5160 PRO, NEW-
SAI S.L., Badalona, Spain) allows operation of the systemwith-
out a power cord, when moving it in the hospital environ-












Figure 4.9: Hybrid system illustration: Shown on the left is the en-
tire device with the DCS and TRS part of the system in
the bottom and middle part, respectively. A top view
onto the TRS part is shown on the right.
This system was first tested on a series of phantoms (INO
Biomimic®). Following various refinements, improvements
as well as system characterisation it was then employed in
the clinical environment. Phantom data was taken alongside
hospital measurements. This data is presented in Section
4.2.2.3.
4.2.1 Fiber probes
Throughout this thesis several fiber probes have been used
to bring the fibers in contact with the medium, of which the
optical properties were to be measured. All probes were
black and incorporated either 90° bent fiber heads or straight
ones. The principle idea of a fiber probe is shown in Figure
4.10.
From chapter 2 we know, that light emitted in the near-
infrared can penetrate several centimeters into biological tis-
sue. The emitted photons scatter and some get absorbed
i
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Figure 4.10: Diffuse optical probe schematic for the semi-infinite ge-
ometry case.
inside the tissue (see Figure 2.4). Their paths inside the tis-
sue are therefore not straight - illustrated by the white lines
in Figure 4.10. The summation over all those paths leads
to banana shaped region in the semi-infinite geometry case
shown in Figure 4.10, which extends between the source and
the detector. The region is hinted by the red shaded region,
which expands below the fiber probe and depends on ρ. As
a simple rule of thumb, the average penetration depth is ap-
proximated by ρ/2.
In this thesis moslty two diffuse optical modalities were
used. This requires the use of incorporation of several dif-
ferent fibers in the probe. An example, where TRS and DCS
were combined in a single probe, which was used to acquire
the data presented in the next chapter 5, is shown in Figure
4.11.
The fibers were placed in a cross-geometry, such that the
above-mentioned bananas frombothmodalities probes com-
mon region inside the tissue. The 90° fiber heads were incor-
porated into a black foam pad of 4 cm height and width and
the source-detector separation (ρ) was set to 13 mm and 25
mm. Since in the measurements this probe was designed
for data was collected from the subject’s neck, the pad has
a soft surface such that it can adjust slightly to the different
neck anatomies of the subjects.
Apart from the human thyroidmeasurements presented in
Chapter 5, the hybrid setup explained above also was used
in the collection of data from the human brain by placing the
i
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Figure 4.11: Hybrid thyroid probe with cross-geometry: The light
emitted by theDCS source on the left (black cross) is col-
lected by single-mode fibers represented by the filled
circles to the right. TRS emitted light (hollow cross) is
collected by fiber heads placed the hollow circle posi-
tion.
fiber probes in the subject’s forehead. An example of this
probe is shown in Figure 4.12.
This probe was designed around an electroencephalogram
(EEG) probe (BIS sensor, BIS Vista™, Medtronic plc, IRL), which
is also placed on the forehead and whose data needed to be
acquired simultaneously. The probe was used in the mea-
surements presented in Chapter 6 and a variation of it with-
out the space for the BIS sensor was placed on the subject’s
forefront in the studies presented in Chapters 9, 7 and 8. In
the top view in Figure 4.12, we see a compact housing for the
source and detector fiber heads of both modalities. The TRS
fibers are drawn in yellow, while the DCS fibers are colored
in green (source) and white (detector). The probe was 3-D
printed in TangoBlack shore 27material and incorporated in
a head strap which wrapped around the subject’s head. The
same head strap provided additional fixation of the fiber af-
ter one wrap around the head. The fibers were guided away
from the forefront, passing aside the subject’s head and then
towards the hyrbid device. This is indicated by the red and
blue arrow in the bottom view of Figure 4.12, where the stan-
dard ρ (25 mm) for the measurements mentioned above is
also noted.
4.2.2 System stability
An integral part of the hybrid device presented above (Sec-
tion 4.2) is the use of picosecond pulsed light and TCSPC for
i
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Figure 4.12: Hybrid head probe: The top view shows the TRS source
and detector (both yellow), the DCS source (green) and
detector (white) 90° fiber heads. The bigger one refers
to the TRS detector fiber bundle. The side view shows
the fiber protecting cover placed on top and in bottom
view the space for the EEG/BIS sensor can be seen.
White circle represent fiber tip positions, separated by
ρ in both modalites (DCS in red and TRS blue).
constructing the DTOF curves. The accuracy of this TRS part
depends on the laser stability - both in peak position and full
width at half maximum (FWHM) - over time. Only based on
this stability it is possible to do longitudinal measurements.
Sections 4.2.2.1 and 4.2.2.2 focus on this aspect and Section
4.2.2.3 adds the detector stability to this investigation based
on the results of various phantom measurements.
4.2.2.1 Laser timing
One important detail in a multi-wavelength TRS setup is
the correct knowledge of the instrument response function
(IRF), which is the recording of the characteristic photon re-
sponse due to the materials used in the setup and mainly de-
pendent on the laser itself and PMT. Of course, electronics,
fiber optics and simple things, such as actual cable lengths,
i
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have further influence on the IRF shape. As a safety net,
each wavelength and each detector in the TRS setup was
assigned a specific time delay. This allows to identify the
emitting laser wavelength of light and the detector that built
the DTOF based on the recorded peak position and therefore
tells us which is the corresponding IRF to be used in the data
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Figure 4.13: Laser peak position for different wavelengths: The cal-
culated barycenter of each peak is plotted over a 3 year
period. The three wavelengths λ1-3 = 690, 785 and 830
nm are separated by ∼ 2 ns. The dashed grey line is
set at t = 10 ns and separates curves recorded by detec-
tor # 1 (t1 < 10 ns) and 2 (t2 > 10 ns). Further details are
explained in the text.
In order to fit signals from total of three wavelength of
lights (690, 785 and 830 nm) and two hybrid PMT detectors
into one 25 ns recording window, each IRF peak is separated
by ∼ 2 ns. Figure 4.13 illustrates the calculated peak position
from the barycenter of each IRF curve and its evolution over
time (see also Table 4.1).
Since the setup was adapted various times throughout the
curse of this thesis’ work, small jumps in the peak positions
can be observed. Each measurement campaign (thyroid, 1st
brain study, 2nd brain study, etc.) has a specific set of laser
pulse peak positions. In Figure 4.13 these are marked by
numerating the measurement campaigns (# 1-4). The non-
marked regions reflect measurements during maintenance
periods and correspond to no specific measurement cam-
paign. The specific setting of the first campaign is related to
i
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campaign # λ [nm]
peak position [ns]
Detector 1 Detector 2
1
690 2.49 ± 0.01 11.63 ± 0.02
785 5.20 ± 0.02 14.35 ± 0.02
830 7.22 ± 0.01 16.39 ± 0.02
2
690 4.10 ± 0.01 12.56 ± 0.01
785 6.52 ± 0.01 15.02 ± 0.01
830 8.55 ± 0.01 17.01 ± 0.01
3
690 4.30 ± 0.03 12.57 ± 0.01
785 6.71 ± 0.01 15.01 ± 0.01
830 8.75 ± 0.01 17.03 ± 0.02
4 785 6.39 ± 0.02 14.74 ± 0.01
Table 4.1: Laser peak position for different wavelengths and detec-
tors: Means and standard deviations for different time
delay settings for the three wavelengths (690, 785 and
830 nm) from the presented TRS setup.
themeasurements presented in Chapters 5 and 9. Campaign
2 and 3 are linked to the results in Chapter 6 and campaign
4, for which only the 785 nm delay was changed (see Table
4.1), to Chapters 9 and 8. In between campaign, movements
to, from and between hospitals took place.
4.2.2.2 Laser pulse widths
Similar to the time evolution of the peak position, we can
look at the full width at half maximum (FWHM) and its be-
havior over time. Figure 4.14 and Table 4.2 show the FWHM
of each laser recorded with two different hybrid PMT detec-
tors.
The system’s FWHM varies within less than 10% of its re-
spective average values. Comparing average values and me-
dians we observe only slight variations between them with a
maximum value difference of 3.4 ps, which is lies below the
standard deviations (4.2 - 10.4 ps) and within the IQRs (4.4 -
15.9 ps). The slightly higher FWHM from detector 1 (λ1 ∼ 405
ps; λ2 ∼ 345 ps; λ3 ∼ 448 ps compared to λ1 ∼ 301 ps; λ2 ∼
279 ps; λ3 ∼ 386 ps) led to its assignment for measurements
i
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Figure 4.14: Full width half maximum for different wavelengths and
detectors: The graphs are ordered from top to bot-
tom by the three wavelengths of the TRS setup (690,
785 and 830 nm), while the left column shows data
recorded by the detector # 1 and the right one from de-
tector # 2. The black dashed line represents the mean
value and the red dashed lines the ± 2 σ lines.
with a larger source-detector separation (ρ) each time data
from different ρ was acquired.
4.2.2.3 Phantom measurements
In NIRS measurements one focus lies on the hemoglobin
content in in-vivo tissue. Its knowledge can improve contrast
between healthy and pathologic tissue or aids in the determi-
nation of global or local health condition. Information about
blood flow and the ability to combine both provides further
i
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FWHM [ps]
λ [nm]
Detector 1 Detector 2
mean ± standard deviation
690 405.1 ± 8.4 301.0 ± 4.2
785 344.7 ± 9.8 277.5 ± 9.3
830 447.9 ± 10.4 386.4 ± 4.8
median (IQR)
690 404.8 (9.7) 301.5 (4.4)
785 346.4 (7.8) 280.9 (14.7
830 448.1 (15.9) 386.4 (5.4)
Table 4.2: Full width half maximum for different wavelengths and
detectors: Means and standard deviations as well as me-
dians and inter-quartile ranges (IQRs) for the three wave-
lengths (690, 785 and 830 nm) from the presented TRS
setup.
details on the correct functioning of the area of interest. The
blood flow information from the DCS analysis is dependent
on the scattering (µ′s) and absorption characteristics (µa). It is
therefore crucial be able to rely on the correct values derived
by diffuse optical methods. These values can be provided in
a single acquisition by TRS, but it needs to be insured no off-
set is introduced. A standard method for this is the use of
optical phantoms.
As an integral part of the presented setup, data from all
three TRS wavelengths (690, 785 and 830 nm) was taken on
two optical phantoms purchased from INO (Québec, Canada)
and referenced against the manufacturer provided values.
Figure 4.15 shows the results for µa from a sequence of those
measurements on phantom # 1.
The data was taken prior and/or post a clinical measure-
ment and evaluated in the same way for all dates, convolut-
ing the solution from the diffusion equation with the IRF and
then fitted to the acquired DTOF curve. The fitting range was
adjusted to span from 80% of the maximum peak height on
the rising edge down to 0.1% of the maximum peak height
on the falling edge [229, 169]. An example is shown in Figure
4.7. The ranges were chosen based on the fact that we are
only interested in the strongly diffused - so-called later - pho-
i
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Figure 4.15: Absorption coefficients µa for different wavelengths
and detectors: The black dashed line represents the
mean value, the black dotted line the median and the
red dashed lines the ± 2 σ lines. The grey box illustrates
the nominal value (white dotted line) and its 2 σ bound-
aries provided by the manufacturer.
tons, as explained in Section 2.7.1. From the discussion there
we know, that the falling edge of the DTOF curve is highly
dependent in the actual µa of the medium. Further details
on TRS data analysis are presented in Sections 2.5, 2.7.1 and
2.6. The shaded grey areas correspond to the nominal values
provided by the manufacturer and their respective accuracy
i
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(2 σ confidence intervals) [37]. All averages and medians lie
within the nominal value range.
The entire data set for µa and µ
′
s acquired from both phan-
toms over the course of eleven months is presented in Ta-
bles 4.3 and 4.4. Please note that the presented mean and
median values with their respective standard deviations and




Detector 1 Detector 2
Phantom 1 Phantom 2 Phantom 1 Phantom 2
mean ± standard deviation
690 17.59 ± 2.48 9.82 ± 0.63 17.20 ± 3.08 10.13 ± 0.51
785 16.85 ± 1.58 9.14 ± 0.17 16.31 ± 2.01 9.26 ± 0.73
830 15.87 ± 1.06 8.49 ± 0.18 15.24 ± 1.84 8.38 ± 0.30
median (IQR)
690 18.39 (2.20) 9.97 (0.36) 18.23 (2.97) 10.05 (0.28)
785 17.25 (0.91) 9.16 (0.28) 17.01 (1.78) 9.06 (0.24)
830 16.14 (0.78) 8.47 (0.24) 15.82 (1.85) 8.39 (0.13)
Table 4.3: Phantom results for the absorption coefficient (µa) at dif-
ferent wavelengths and detectors: Means and standard
deviations as well as medians and inter-quartile ranges
(IQRs) for the three wavelengths (690, 785 and 830 nm)
from the presented TRS setup. Data was acquired on
two INO Biomimic® phantoms. Data averaged over from
14months.
Although we observe differences between the mean and
median values, they lie within the standard deviations and
IQRs. Between both hybrid PMT detectors, values are com-
parable and show similar trends along the three wavelengths.
In Table 4.4 it seems that the order of µ′s values between 785
nm and 830 nm is disturbed as the lower wavelength shows
higher average values than the higher wavelength. Nonethe-
less, there is no statistically significant difference between
these values. This can also be seen by taking the respective
standard deviations and values for IQR into account. It is as-
sumed that this error is due to the variations over 14months
and since this was not the main goal of the experiment, it
i
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Detector 1 Detector 2
Phantom 1 Phantom 2 Phantom 1 Phantom 2
mean ± standard deviation
690 8.44± 1.43 5.93± 0.59 7.83± 1.61 5.96± 0.45
785 8.75± 1.04 5.88± 0.38 8.11± 1.28 5.85± 0.45
830 8.31± 0.86 5.60± 0.40 7.72± 1.19 5.51± 0.38
median (IQR)
690 8.75 (1.67) 6.03 (0.69) 8.22 (2.16) 6.01 (0.54)
785 8.97 (0.84) 5.82 (0.52) 8.31 (2.10) 5.90 (0.50)
830 8.50 (0.79) 5.54 (0.54) 7.88 (1.89) 5.54 (0.47)
Table 4.4: Phantom results for the reduced scattering coefficient
(µ′s) at different wavelengths and detectors: Means
and standard deviations as well as medians and inter-
quartile ranges (IQRs) for the three wavelengths (690,
785 and 830 nm) from the presented TRS setup. Data
was acquired on two INO Biomimic® phantoms. Data av-
eraged over from 14months.
was not attempted to acquire a higher signal-to-noise ratio
measurement.
Based on the data presented in Figure 4.15 and Tables 4.3,
4.4, we can see that the system provided constant estima-
tion of the phantom properties throughout the curse of one
year. This data is the result of equal data acquisition post
and/or prior to the use of the hybrid TRS/DCS system on the
frontal lobes of brain-healthy patients during surgical proce-
dures. They provide a good measure of stability and further-
more compare well to the manufacturer-provided values.
This chapter concludes the first part of this thesis. After
a general introduction (Chapter 1), the theory of light inter-
action with biological tissue, the forward and inverse prob-
lem (Chapter 2) were discussed. This was followed by a de-
scription of the transport of oxygen in biological tissue and
cerebral hemodynamics/autoregulation (Chapter 3) and this
chapter, which explains the functional principles of the hy-
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The next part focuses on the in-vivomeasurements and the
interpretation of their results based on the knowledge intro-
duced in this first part.
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EXPLOR ING THE POTENT IAL TO
IMPROVE THYRO ID CANCER
SCREEN ING W ITH D I F FUSE
OPT ICS
The first of three parts of this thesis has focused - after
a general introduction to this thesis’ work - on the oxygen
transport to and its diffusion into biological tissue, as well
as the importance of constant blood perfusion in the human
brain and its autoregulatory measures. The theory of diffuse
optics and its real world implementation in a hybridization
of two techniques, time-resolved spectroscopy (TRS) and dif-
fuse correlation spectroscopy (DCS), was presented. Based
on the functional principles, this hybrid TRS/DCS device was
characterised in terms of stability and accuracy.
This chapter is the first one of the second part of this the-
sis, which concentrates on the in-vivo application of said hy-
brid TRS/DCS device. Here, measurements on the human thy-
roid are presented and referenced against sternocleidmas-
toid muscle tissue. The optical values (absorption coefficient
(µa) and reduced scattering coefficient (µ
′
s)) recorded by the
TRS part of the hybrid system are used in the calculation of
total hemoglobin concentration (THC), tissue oxygen satura-
tion (StO2) and the analysis of DCS data, which then provides
a more accurate estimation of blood flow (BF) in terms of a
blood flow index (BFI). Data from a healthy population (n =
22) was thoroughly analysed and interpreted. Nine patholog-
ical cases were studied, but for clarity, only two will be pre-
sented in this chapter and data from the lasting seven cases
is added in the appendix.
This work is the result of a collaboration with Dr. Mireia
Mora, Dr. Felicia Hanzu, Dr. Irene Halperin as well as Dr. Mat-
tia Squarcia and colleagues from the Endocrinology and Radi-
ology Departments at Hospital Clínic and the Institut d’Investi-
gacions Biomèdiques August Pi I Sunyer in Barcelona. The
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thyroid cancer screening and led to a Horizon 2020 project
(http://www.luca-project.eu).
5.1 BACKGROUND
A common pathology in endocrinology are thyroid nodules
(TNs). They vary in size and statistics show that palpable nod-
ules have a prevalence around 5% in women and 1% in men.
These numbers increase to 19-76 % [68, 123] when neck US
is used for screening in addition to palpation. Approximately
5-15 % of these nodules turn out to be thyroid cancer (TC)
[68] which is the most common malignant tumor of the en-
docrine system. The incidence of thyroid cancer is increasing
more rapidly than any other cancer type in themodern world
[205].
With exception of the relatively rare poorly differentiated
and anaplastic forms, TC prognosis is generally good. The 10-
year survival rates - corrected for age and sex - range from
95 % for papillary to 90 % (follicular) and down to 13 % for
the anaplastic TC [285]. While TC has a low overall mortal-
ity, in specific cases of low conventional treatment response,
aggressive behaviour, persistence or recurrence of the dis-
ease and no alternative treatment option, the mortality rate
is substantially higher.
The initial precise characterization and diagnosis of the thy-
roid nodule is critical in order to decide on the course of ac-
tion. The options range from surgical resection to follow-up
or - in the case of presumed TC - an extensive initial sur-
gical procedure. Unfortunately, the current sensitivity and
specificity of the first point-of-care, non-invasive screening
method, ultrasound (US), is quite poor, ranging from 17-87
% in sensitivity and from 39-95 % in specificity depending
on the type of the malignant nodules [205, 215, 287, 223, 10].
Unfortunately, an ultrasound-guided fine-needle aspiration
biopsy (FNAB) – which follows a positive ultrasound screen-
ing result – of the suspicious nodule is also limited in sensitiv-
ity and specificity [68].
In addition to various other parameters (e.g. elastography),
it has been speculated that the inclusion of the nodule hemo-
dynamics, in particular that of microvascular blood flow, may
significantly improve the screening process. In fact, recent
studies have observed that papillary carcinomas are richer
in microvessels (95.75 %) than adenomas (49 %) and capil-
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laries are more frequent in adenomas (9 %) than in carcino-
mas (1 %) [267]. However, ultrasound has limited sensitivity
to microvascular blood flow, and, therefore, complementary
modalities are being sought.
In short, the high prevalence of thyroid nodules and the
above-mentioned limitations of the existing screening strate-
gies call for improvements in strategies to identify lesions. If
successful, these may have an immense socio-economic im-
pact reducing unnecessary FNABs or surgeries and improving
the response to therapies.
Several techniques, such as (time-resolved) fluorescence
[41, 40, 124, 245], Raman [307, 74], elastic scattering spec-
troscopy (ESS) [301] spectroscopy and two-photon excited flu-
orescence (TPEF) [243] in combination with second-harmonic
generation (SHG) [142] using light have been suggested for
improving the cancer, and, in particular, the thyroid cancer
screening process. However, these are invasive techniques
focusing on different aspects of light interaction with tissue.
ESS, TPEF and SHG suggest an improvement of the thyroid
screening process by focusing on the cellular tissue morphol-
ogy which influences the spatial variations in the refractive
index, which in turn result in alterations of photon scatter-
ing. Overall, these methods suggest that there is an optical
contrast between the healthy and pathologic thyroid tissue.
As near-infrared diffuse optical spectroscopy (DOS) is sensi-
tive to the light scattering characteristics of tissues together
with its light absorption spectrum and therefore to the hemo-
dynamics of the tissue microvasculature (see Chapter 2) it
plays an important role in the screening and characteriza-
tion of thyroid nodules for malignancy as well as the over-
all thyroid characterization [94, 62, 59]. Previous applications
of DOS and diffuse correlation spectroscopy in tumor tissue
characterization, specially in optical mammography, and for
the monitoring of the local tissue response to therapy show
the feasibility of these methods in this area [93, 62, 60, 344,
59, 302, 235, 313, 103] . They have, however, not been uti-
lized to characterize the thyroid gland or its pathophysiol-
ogy. Here we hypothesize that the thyroid gland is accessi-
ble to the non-invasive, hand-held DOS/DCS hybrid optical
probes (see Figure 5.1 and b) for the illustration of the thy-
roid gland and its anatomy) and that - in healthy condition -
it is relatively homogeneous. Moreover, due to the increased
microvasculature in TNs [267], they are expected to present
i
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a measurable contrast, facilitating in the end the use of dif-
fuse optics as an additional tool to improve the limited con-
trast of the current standard screening process [205, 215, 287,
223, 10, 68]. The ultimate goal is to help classify the nod-
ules as benign or malignant. Here the goal is to test the
first part of this hypothesis by characterizing the homogene-
ity of the thyroid gland and compare the results to the ad-
jacent neck muscles (sternocleidomastoid) using a custom-
made time-resolved spectroscopy andDCS hybrid instrument
and probe [105]. Furthermore case studies with different thy-
roid pathologies are presented to begin to address the sec-
ond part of the hypothesis. Further studies by diffuse opti-
cal data on thyroid nodules should allow to establish ranges
and relationships between different measurable parameters,
indicating the probability of malignancy.
Themeasurements were guided by ultrasound imaging and
its assessment by expert radiologists and endocrinologists.
We have quantified the depth and the extent of the thyroid
gland and investigated our results to look for correlations be-
tween different physical, demographic and clinical parame-
ters. This approach enabled us to establish a range of typical
healthy thyroid tissue parameters to serve as a reference for
futuremeasurements on thyroid pathologies thus paving the
way towards exploring the utility of this method for improved
thyroid screening.
5.2 MEASUREMENT PROTOCOL
All procedures and devices of this study were approved by
the ethical committee of Hospital Clínic in Barcelona (CEIC
- Comité Ético de Investigación Clínica del Hospital Clínic de
Barcelona). Each subject signed an informed consent and
the study has been conducted according to the principles of
the Declaration of Helsinki. The volunteers were screened by
ultrasound to evaluate the thyroid condition. The presence
of diffuse thyroid diseases, such as hyper- or hypothyroidism,
thyroiditis and Graves’ disease, as well as benign and/or ma-
lign nodules and cervical adenopathies were the main exclu-
sion criteria for the healthy population.
Each subject’s tissue dimensions in the marked probe lo-







































Figure 5.1: Thyroid location and its surroundings: Shown is the loca-
tion of the thyroid, its dimensions and the defined mea-
surement points. Also shown: Locations of the jugu-
lar vein (JV), carotid artery (CA), esophagus (EPG), the
(left) thyroid gland, its position and superficial structures
(sternocleidomastoidmuscle, skin and adipose layers) in
normal neck (right) and rotated neck (left) position, used
for improved thyroid exposure.
We have defined three representative parameters (see Fig-
ure 5.2): the total tissue depth (TTD), superficial tissue thick-
ness (STT) and tissue thickness (TT). The latter is given by the
depth extension of the tissue of interest, i.e., muscle or thy-
roid tissue. This tissue thickness and the superficial tissues
(skin and adipose layers) add up to the total tissue depth,
which is defined by total distance from the skin surface to
the end of the thyroid or muscle tissue.
In order to evaluate the general health condition of sub-
jects, they underwent a basic health screening, which con-
sisted of questions about hypertension, diabetes, hyperlipi-
demia, arterial fibrillation, congestive heart failure, coronary
artery disease, previous myocardial infarction, carotid artery
disease, smoking, lung and/or kidney diseases and the list of
current medications.
Furthermore, we have noted age, height, weight, bodymass
index (BMI), heart rate (HR) and arterial oxygen saturation
(SaO2) before the diffuse optical measurement, as well as the
i
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Figure 5.2: Defined tissue dimension parameters: US image ex-
cerpt from a thyroid gland. TTD is defined by the sum of
the superficial tissues (STT) and the TT. Typical values
vary between different tissue types (see Table 5.3).
systolic and diastolic blood pressure (BPsys, BPdia) before and
after the data recording procedure. These serve as a check
for the subject’s general well-being in addition to the above-
mentioned basic health screening. Moreover, the blood pres-
sure reading prior and after themeasurement procedure pro-
vide further information about the global hemodynamic con-
dition over the course of the experiment.
Themeasurement protocol included of several probe place-
ments on the thyroid and the neck sternocleidomastoid mus-
















Figure 5.3: US-guided probe placements on the human neck:
Three different measurement points per side plus one
on top of the isthmus. Probe size and placement are
shown in relation to the thyroid gland size.
The subjects were laid down with a slight head tilt back-
wards to expose the thyroid. Furthermore, we have used ul-
trasound to explore the optimal way to expose the thyroid
and decided to utilize a head turn, thusmaximizing the acous-
tic window. The subjects were asked to turn their head left
when we were measuring on right side and vice versa (see
Figure 5.1). This procedure wasmonitored by a high frequency
i
i






5.2 MEASUREMENT PROTOCOL 79
ultrasound transducer, which, due to its high spatial resolu-
tion, allowed to identify the different tissue structures. Two
representative ultrasound images are shown in Figure 5.1).
The final locations according to Figure 5.1 and c) were cho-
sen depending on the physiology and identification by ultra-
sound prior to the diffuse optical measurements.
The non-invasivemeasurements employed diffuse light for
two source-detector separations (ρ) - 13 and 25mm - to probe
the tissue properties and the necessary sources and detec-
tors were embedded in a 4 cm x 4 cm soft black foam pad
(see Figure 5.4), which was placed directly on the subject’s
skin. The shorter source-detector separation (ρ) was used in
a subset of eleven subjects, which is half of the study pop-
ulation, as well as the two pathology cases. The details are













Figure 5.4: Thyroid probe: One source and two different detector
locations per modality (DCS and TRS). Cross-geometry
lead to overlapping of the probed regions between
modalities. A shorter source-detector separation (ρ)
was used in a subset of eleven subjects and all pathol-
ogy cases. This probe was previously shown in Figure
4.11.
The static optical properties (absorption and reduced scat-
tering) weremeasuredwith time-resolved spectroscopy (TRS).
As presented in Chapter 2, the computed absorption prop-
erties at each of the three wavelengths were used to calcu-
late oxy- and deoxy-hemoglobin concentrations using extinc-
tion coefficients from the literature [253]. Diffuse correlation
spectroscopy (DCS) was used to monitor blood flow. The vari-
ations in the correlation decay times from the recorded in-
tensity fluctuations translate into the blood flow index (BFI),
which is directly related to microvascular blood flow (see Sec-
tions 2.3.3 and 2.6).
One data set consisted of DCS data acquired for both ρ (13
and 25mm) simultaneously and TRS curves recorded individ-
i
i






80 POTENT IAL OF D I F FUSE OPT ICS IN THYRO ID CANCER SCREEN ING
ually for all wavelengths and ρs with a acquisition time per
individual curve of seven seconds (tTRS25mm = 21s; t
TRS
13mm =
21s; tDCS = 7s). The experimental setup switched automati-
cally between wavelengths and modalities. At each location,
we have recorded three complete data sets leading to a total
acquisition time of∼ 147 seconds per measurement location.
After one complete scan of the subject’s neck - according to
the points marked in Figures 5.1 and 5.3 - a second identical
scan followed.
All measurements on nodule cases were performed at least
48 days after the FNAB, which is considered to be enough
time to avoid contamination of the DOSmeasurements [304].
All subjects were measured with the hybrid diffuse optics
device explained in Section 4.2, using a source-detector sep-
aration of 25mm for both, TRS and DCS. Furthermore, for a
subset of eleven subjects (six females, five males) additional
detectors were introduced for both modalities at a 13 mm
distance from the source into our probe to explore whether
there are any differences in superficial tissues. The probe is
illustrated in Figure 5.4.
Grayscale ultrasound (US) scans were used with the neck in
hyperextension both in neutral position and after right and
left neck rotation using a real-time ultrasonographic scanner
with a 7.5MHz linear transducer connected to a M7Mindray
USmachine (Shenzhen, China). All US examinations were per-
formed by a radiologist and an endocrinologist with exten-
sive experience in thyroid ultrasound (twelve and six years
respectively). The US screening consisted of longitudinal and
transverse scans from the skull base to the supraclavicular
and suprasternal region to identify normal relevant vascu-
lar and muscular cervical structures and to evaluate the thy-
roid gland. As explained above, cases with thyroid nodules,
diffuse thyroid disease and cervical adenopathies were ex-
cluded from the healthy population. Grayscale US was fur-
ther utilized to evaluate the thyroid gland position, the com-
mon carotid arteries and the jugular veins. Similarly, the ster-
nocleidomastoid muscles were identified bilaterally in neu-
tral position and during right and left lateral rotation. This
allowed the evaluation of the normal sternocleidomastoid
muscle situation and its displacement over to the deep cervi-
cal structures during neck movements (see also Fig 5.1). The
distances between the superficial tissue layer and the ante-
rior and posterior border of the muscle belly were recorded.
i
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Moreover, the echo structure and echogenicity of the thyroid
parenchyma were analyzed and the thyroid lobes were mea-
sured in three different dimensions: craneo-caudal, latero-
lateral and antero-posterior. Furthermore, the distances be-
tween the superficial tissue layer and the anterior and poste-
rior border of the thyroid gland weremeasured at themiddle
third of the right and the left lobe.
For each subject, various other ultrasound images were
taken. These images corresponded to the locations of the dif-
fuse optics measurements and provided information on the
depth and thickness of the thyroid and the muscle depend-
ing on the location. An example US image from the thyroid is
shown in Figure 5.2.
5.2.1 Data analysis
5.2.1.1 Time-resolved spectroscopy
As explained in Section 4.2, the time-resolved spectroscopy
setup acquired distribution time of flight curves for three dif-
ferent wavelengths (λ = 690, 785 and 830 nm). Each curve
was normalized and the solution for the diffusion approxima-
tion for the semi-infinite homogeneous medium (see Section
2.5) was fitted to a range from 80 % of the peak value on the
rising edge to 1 % on the tail based on the diffusion approxi-
mation and the nature of absorption.
The measured absorption coefficient (µa) for each wave-
length was used to calculate the oxy- and deoxy-hemoglobin
concentrations, since each µa relates to the different tissue
chromophore concentrations via their respective individual
extinction coefficients (ε) (Eq.2.1). In case of this study we
have considered only three different chromophores, which
were the main contributors to the measured signals at the
above-mentioned wavelengths. The molar absorption coef-
ficients for oxy- and deoxyhemoglobin were retrieved from
[253] and the corresponding ones for water from [132]. The
total hemoglobin concentrations and oxygen saturations for
each data set have been obtained by assuming a negligible
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5.2.1.2 Diffuse correlation spectroscopy data analysis
We know that calculating the autocorrelations from ran-
dom fluctuations in the electric field and the intensity for
different delay times yields information on the dynamics in
the tissue. By fitting the solution of the correlation diffusion
equation for the semi-infinite homogeneous medium to the
computed normalized electric field autocorrelation function
as described in Section 2.3.3, one can obtain information on
the microvascular blood diffusion in the tissue, which is pre-
sented here as a blood flow index (BFI) for the probed region.
For each subject and each measurement location the µa
and µ′s values from the TRS measurement were used in the
DCS analysis.
5.2.2 Statistical analysis
All values reported in Tables 5.1 - 5.6 are mean values aver-
aged over all included healthy subjects plus minus the stan-
dard deviation. The absorption and scattering coefficients
(µa, µ
′
s), total hemoglobin concentration (THC), tissue oxygen
saturation (StO2) and the blood flow index (BFI) were tested
for normality with the “Shapiro-Wilk” test [129] and also cross-
checked by quantile-quantile plots. Both tests were in agree-
ment with each other. This normality test serves as a qual-
ity check and for the suitability of the methods used for fur-
ther statistical analysis. The primary method was the linear
mixed effects (LME) model. The entire statistical analysis was
carried out in R [255]. In general, “p-values” less than 0.05
were considered statistically significant to reject the null hy-
pothesis. Within R, we have used the “nortest” [129] and the
“nLME” [244] packages for our evaluation. LME fitted models
which did not differ significantly from the null model were re-
jected. Furthermore, LME fitted values are used to confirm
the reported mean values. The differences between genders
in the demographical, vital and tissue dimension related pa-
rameters were tested using a two-tailed t-test.
The hemodynamic variables (THC, StO2 and BFI) were in-
vestigated using LME models [244] where the subject num-
ber was considered as a random effect. These LME models
tested for differences between organs, i.e., muscle and thy-
roid, looked for influences by probe location on the thyroid
i
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(“gland location 1” and “gland location 2”, see Figure 5.1 and
c) or between thyroid lobe sides and checked for dependen-
cies on physiological parameters and tissue dimensions (see
Figure 5.2). We fitted each of the LME models with the pa-
rameter under investigation (organ, location, side, physiolog-
ical parameter or tissue dimension) as a fixed effect. We, fur-
thermore, have double checked all our statistically significant
findings by a bootstrapping analysis. In the case of eleven
healthy subjects that were measured with a second source-
detector separation (ρ) of 13 mm, we have used the same
LME models to check for dependencies on organs, sides, lo-
cations and tissue dimensions for that additional data.
5.3 RESULTS
5.3.1 Study population
Twenty-two subjects (ten females and twelve males) out of
a total of thirty-four screened ones were included in the anal-
ysis as the healthy group for this study. The data of three
volunteers was excluded due to technical issues. Nine sub-
jects were diagnosed with pathologies, four of them had a
single or multiple malignant thyroid nodule(s) another four
were classified as benign or had cells of atypical behaviour,
while one patient presented thyroiditis.
The basic health screening confirmed the overall health
condition of the subjects. The demographic parameters from
the healthy study population, such as age, weight, height and
body mass index (BMI) are presented in Table 5.1, while the
vital records including heart rate (HR), arterial oxygen satura-
tion (SaO2), the systolic and diastolic blood pressure (systolic
blood pressure (BPsys), diastolic blood pressure (BPdia)) prior
and post optical measurement are shown in Table 5.2.
Age [yrs] Weight* [kg] Height* [cm] BMI [kg/m2]
All 32 ± 5 69 ± 13 171 ± 8 23.5 ± 3.6
Females 31 ± 4 60 ± 11 164 ± 6 22.2 ± 4.5
Males 32 ± 5 77 ± 9 177 ± 5 24.6 ± 2.5
Table 5.1: Demographic parameters: The demographic parameters
of the population given as mean ± their standard devi-
ation. * denotes a statistically significant difference be-
tween females and males (t-test, p < 0.05).
i
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HR [bpm] SaO2 [%]
BPsys [mmHg] BPdia [mmHg]
prior* post* prior* post
All 73 ± 14 98 ± 1 126 ± 15 127 ± 13 75 ± 10 75 ± 9
Females 75 ± 13 98 ± 1 114 ± 9 119 ± 10 69 ± 9 70 ± 4
Males 71 ± 14 98 ± 1 133 ± 14 132 ± 12 79 ± 8 78 ± 11
Table 5.2: Vital records: The table shows the distribution (mean ±
standard deviation) of the vital records: heart rate (HR),
arterial oxygen saturation (SaO2), systolic and diastolic
blood pressure (BPsys, BPdia). * denotes a statistical sig-
nificant difference between females and males (t-test, p
< 0.05).
The thickness of the superficial and target tissue as well as
the total tissue depth were measured by ultrasound. Their
values are shown in Table 5.3 and illustrated in Figure 5.2.
The whole distance from the skin surface to the deeper bor-
der of the target tissue is considered as the TTD, whereas the
TT is defined by the difference between the total tissue depth
and the corresponding superficial tissue thickness (STT).
Muscle
STT [mm] TT* [mm] TTD* [mm]
All 2.9 ± 0.8 7.5 ± 1.9 10.4 ± 2.2
Females 2.9 ± 0.8 6.8 ± 1.7 9.7 ± 1.9
Males 3.0 ± 0.8 8.1 ± 1.8 11.1 ± 2.2
Thyroid
STT* [mm] TT* [mm] TTD* [mm]
All 7.6 ± 2.3 12.1 ± 4.1 19.7 ± 4.9
Females 6.5 ± 2.0 10.4 ± 2.8 16.9 ± 3.3
Males 8.7 ± 2.0 13.7 ± 4.5 22.4 ± 4.6
Table 5.3: Tissue dimensions recorded by ultrasound: Means and
standard deviations of the tissue dimensions. The defini-
tion of these three parameters is illustrated in Figure 5.2.
The distance from the probe-skin contact to the deeper
end of the target tissue figures as the TTD, whereas the
TT is difference between the total tissue depth and the
superficial tissue thickness (STT). * denotes a statistical











5.3.2 Optical and hemodynamic properties of the healthy pop-ulation
On every measurement location, see Figure 5.1 and c), we
have obtained the absorption (µa) and reduced scattering co-
efficients (µ′s) at three wavelengths employing time-resolved
spectroscopy (TRS) as described in Sections 5.2 and 5.2.1.1. A
representation of these values is shown in Table 5.4 and Ta-
ble 5.5. These mean values and their standard deviations for
each location present the healthy population average. Three
percent of the initial data was excluded due to a low signal-
to-noise ratio.
µa , 690 [cm
-1] µa , 785 [cm
-1] µa , 830 [cm
-1]
Muscle (right) 0.22 ± 0.04 0.21 ± 0.03 0.23 ± 0.03
Gland location 1 (right) 0.30 ± 0.04 0.28 ± 0.04 0.32 ± 0.05
Gland location 2 (right) 0.27 ± 0.04 0.26 ± 0.03 0.30 ± 0.04
Isthmus 0.20 ± 0.02 0.20 ± 0.02 0.22 ± 0.03
Gland location 2 (left) 0.27 ± 0.05 0.26 ± 0.04 0.30 ± 0.05
Gland location 1 (left) 0.28 ± 0.05 0.27 ± 0.04 0.30 ± 0.06
Muscle (left) 0.22 ± 0.04 0.21 ± 0.03 0.24 ± 0.04
Table 5.4: Absorption coefficients (µa) from TRS data: Absorption
coefficients µa (mean ± standard deviation) deducted
from the three wavelengths of the time-resolved spec-
troscopy data. The thyroid gland shows a significantly (p
< 0.05) higher absorption than themuscle at all locations.
µ′s , 690 [cm
-1] µ′s , 785 [cm
-1] µ′s , 830[cm
-1]
Muscle (right) 9.1 ± 0.9 8.1 ± 1.0 7.3 ± 0.9
Gland location 1 (right) 9.2 ± 1.1 7.9 ± 1.3 7.4 ± 1.1
Gland location 2 (right) 8.6 ± 1.2 7.4 ± 1.3 6.9 ± 1.1
Isthmus 9.6 ± 1.0 8.7 ± 1.1 8.0 ± 1.0
Gland location 2 (left) 8.1 ± 1.2 7.0 ± 1.3 6.5 ± 1.2
Gland location 1 (left) 8.8 ± 1.1 7.6 ± 1.3 7.2 ± 1.2
Muscle (left) 9.1 ± 0.9 8.0 ± 0.9 7.3 ± 0.9
Table 5.5: Reduced scattering coefficients (µ′s) from TRS data: Re-
duced scattering coefficients µ′s (mean ± standard devia-
tion) for all three wavelengths obtained by time-resolved
spectroscopy. The recorded data reveals statistically sig-
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In order to relate our optical measurements to the tissue
hemodynamics, we have assumed the lipid contribution to
be negligible and a water content of 78 % [328], which led to
THC and StO2 values as shown in Table 5.6 together with BFI.
THC [µM] StO2 [%]
BFI
[cm2/s] × 10-9
Muscle (right) 100.9 ± 13.7 63.8 ± 3.8 8.1 ± 4.3
Gland location 1 (right) 144.8 ± 21.4 67.4 ± 3.1 13.7 ± 4.5
Gland location 2 (right) 134.7 ± 18.0 68.4 ± 2.7 14.7 ± 6.1
Isthmus 98.0 ± 12.0 67.9 ± 2.0 14.4 ± 7.2
Gland location 2 (left) 131.9 ± 22.2 67.5 ± 2.2 16.0 ± 8.8
Gland location 1 (left) 136.5 ± 26.8 66.6 ± 3.0 15.4 ± 7.3
Muscle (left) 105.7 ± 17.8 65.9 ± 3.4 7.8 ± 1.8
Table 5.6: Calculated hemodynamic parameters: Means and stan-
dard deviation for total hemoglobin concentration (THC),
tissue oxygen saturation (StO2) and blood flow index (BFI)
are shown here for all six measurement locations accord-
ing to the study protocol. Rather strong differences (p <
0.0001) can be observed in the THC and BFI between the
thyroid and themuscle, whereas the StO2 concentrations
show small to almost no variations. Please see the text
for details.
On the right neck side, the THC increases from 100.9 ± 13.7
µM in the muscle to 134.7 ± 18.0 µM (“gland location 2 (right)”)
and 144.8 ± 21.4 µM (“gland location 1 (right)”) in the thyroid
lobe and on the left side from 105.7 ± 17.8 µM in themuscle to
131.9 ± 22.2 µM (“gland location 2 (left)”) and 136.5 ± 26.8 µM
(“gland location 1 (left)”), which represents a 33-44% increase
on the right side and a 25-29 % increase on the left side.
The BFI changes from 8.1 ± 4.3 cm2/s × 10-9 in the right mus-
cle to 13.7 ± 4.5 cm2/s × 10-9 (“gland location 1 (right)”) and 14.7
± 6.1 cm2/s × 10-9 (“gland location 2 (right)”) in the right thyroid
lobe and on the left side from 7.8 ± 1.8 cm2/s × 10-9 in mus-
cle to 15.4 ± 7.3 cm2/s × 10-9 (“gland location 1 (left)”) and 16.0
± 8.8 cm2/s × 10-9 (“gland location 2 (left)”). This is a 70-81 %
blood flow increase from muscle to thyroid on the right neck
side and a 97-105 % higher blood flow in the left thyroid lobe
than the respective muscle.
The StO2 values increase from 63.8 ± 3.8 % in the muscle
to 67.4 ± 3.1 % (“gland location 1 (right)”) and 68.4 ± 2.7 %
(“gland location 2 (right)”) in the thyroid on the right side and
i
i







on the left side from 65.9 ± 3.4 % in the muscle to 66.6 ± 3.0
% (“gland location 1 (left)”) and 67.5 ± 2.2 % (“gland location 2
(left)”) in the thyroid region, which represents a change within
the standard deviations.
A full subject-wise representation of the µa, µ
′
s, THC, StO2
and BFI values can be found in the Tables in A.1, A.2 and A.3.
5.3.2.1 Normality tests
As described in Section 5.2.2, all variables (µa, µ
′
s, THC, StO2
and BFI) have been checked for normality using the “Shapiro-
Wilk” test [129] and cross-checked by quantile-quantile plots.
According to these tests, the BFI values recorded in “gland
location 2 (right and left)”, as well as in the “neck muscle (left)”
location are not normally distributed (p ≤ 0.01).
5.3.2.2 Organ differences
From the corresponding LME model with the organ as a
fixed effect, we have found a statistically significant (p < 0.0001)
increase over all three wavelengths in the recorded absorp-
tion coefficient (µa) at the thyroid locations with respect to
the sternocleidomastoid muscle. The average µa from the
thyroid are: µa, 690 = 0.28 cm
-1; µa, 785 = 0.27 cm
-1; µa, 830 = 0.31
cm-1. In the muscle region we have recorded the following av-
eraged absorption coefficients (µa): µa, 690 = 0.22 cm
-1; µa, 785
= 0.21 cm-1; µa, 830 = 0.24 cm
-1.
The same LME model employed on the scattering charac-
teristics, i.e., the reduced scattering coefficients (µ′s), leads to
statistically significant (p690 < 0.01; p785 < 0.001; p830 < 0.05)
differences between organs. In the thyroid the reduced scat-
tering coefficient (µ′s) values are µ
′
s, 690 = 8.7 cm
-1; µ′s, 785 = 7.5
cm-1; µ′s, 830 = 7.0 cm
-1 and the ones for the muscle are µ′s, 690
= 9.1 cm-1; µ′s, 785 = 8.1 cm
-1; µ′s, 830 = 7.3 cm
-1.
From the LME model with the organ as a fixed effect we
find statistically significant (p < 0.0001) differences for THC,
StO2 and BFI with the average thyroid tissue values of: THC
= 137.1 µM; StO2 = 67.5 % and BFI = 15.0 × 10-9 cm2/s. For the
muscle tissue we get: THC = 103.3 µM; StO2 = 64.9 % and BFI
= 7.9 × 10-9 cm2/s.
i
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5.3.2.3 Side and probe location differences
LME models have been used for further investigation of
possible significant differences in the measured values be-
tween sides and thyroid probe locations.
In terms of left-right symmetry, we see that StO2 differs (p =
0.01) between the right and the left muscle in contrast to the
thyroid glands, where no significant variations were found
in none of the recorded values between the opposed sides.
Here we have set the side information as a fixed effect and re-
trieved a fitted value for StO2 in the left sternocleidomastoid
muscle of 65.9 % and on the right side an oxygen saturation
of 63.8 %.
Apart from the StO2 in the muscle, a LME model with the
probe location on the thyroid as a fixed effect fitted values
which show a statistically significant difference from the zero
model for THC (p < 0.01) and StO2 (p = 0.02). In the gland
location 2 THC and StO2 are 133.3 µM and 68.0 %, while in
gland location 1 they are 125.4 µM and 67.2 %.
5.3.2.4 Age, gender and BMI influences
Furthermore, we have investigated influences from the sub-
ject demographics, such as body mass index (BMI), age and
gender, which revealed a statistically significant dependence
on BMI (p < 0.0001) for all hemodynamic parameters (THC,
StO2 and BFI) and a significant influence of THC by age (p <
0.01) and gender (p = 0.03). THC, StO2, and BFI values de-
crease with higher BMI, as does THC in older subjects. For
female subjects THC is in average 128.2 µM and for the male
subjects 144.7 µM.
5.3.2.5 Dependencies on tissue dimensions
Additionally, we have looked into possible dependencies of
THC, StO2 and BFI on the different tissue thicknesses (superfi-
cial tissue thickness and tissue thickness) and the total tissue
depth (see Figure 5.1) and have found a significant decrease
in THC with increasing superficial tissue thickness (p < 0.01).
5.3.2.6 Short (13mm) source-detector separation
Data for an additional source-detector separation (ρ) of 13
mm has also been recorded for a subset of eleven healthy
i
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subjects (six females, five males) out of the twenty-two in to-
tal. The information from the shorter ρ of 13 mm revealed
different values and dependencies than the ones from a ρ of
25mm.
The same statistical tests for organs, sides, locations and the
three tissue dimension parameters (superficial tissue thick-
ness, tissue thickness and total tissue depth) were performed
on that data subset with this short source-detector separa-
tion as before. Similar to the long ρ data, these tests result
in significant organ differences (p < 0.01) with lower THC, StO2
and BFI in the muscle locations.
StO2 shows not only a significant influence by side (pmuscle
< 0.01) in the muscle location as for the ρ of 25 mm, but also
depends significantly on the thyroid lobe side (pgland < 0.01),
showing an increase on the left side. It is also lower with in-
creasing STT (p < 0.01) and increases with larger TTD (p < 0.01).
Also, in this source-detector configuration BFI is increasing
with larger TTD (p < 0.01) and THC is smaller for larger STT (p
< 0.01).
Moreover, all hemodynamic variables are still significantly
depending on BMI (p < 0.01), similar to the data acquired from
the large source-detector separation.
As before, a full subject-wise representation for this data
subset of 11 subjects for µa, µ
′
s, THC, StO2 and BFI values can
be found in the Tables in A.4, A.5 and A.6.
5.3.2.7 Summary of dependencies for hemodynamic variables
For improved clarity, a summary of the statistical results
according to the LME models presented in Sections 5.3.2.2 -
5.3.2.6 is given in Tables 5.7 and 5.8. They recollect the depen-
dencies of the three hemodynamic variables total hemoglobin
concentration (THC), tissue oxygen saturation (StO2) and blood
flow index (BFI) on either organ, neck side and/or probe lo-
cation. Also included are influences by the three tissue di-
mensions as defined in 5.2: superficial tissue thickness (STT),
tissue thickness (TT) and total tissue depth (TTD). Dependen-
cies on demographic parameters (bodymass index (BMI), age
and gender) conclude these tables. A change of a hemody-
namic variable with the described parameter is indicated by
an arrow. In the “Organ - case”, for example, all three hemo-
dynamic variables are higher when retrieved from the thy-
roid probe locations. For the purpose of a complete overview,
cases of non-significance (p > 0.05) are listed as well.
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THC StO2 BFI
Organ thyroid ↑ thyroid ↑ thyroid ↑
Side - muscle left ↑ -
Location - - -
STT higher STT ↓ higher STT ↓ -
TT - - -
TTD - higher TTD ↑ higher TTD ↑
BMI higher BMI ↓ higher BMI ↓ higher BMI ↓
Age - - -
Gender - - -
Table 5.7: Results summary of statistical significance (p < 0.05) from
LME models for a source-detector separation of 13 mm
(see Section 5.3.2.6). The table lists of total hemoglobin
concentration (THC), tissue oxygen saturation (StO2) and
blood flow index (BFI) and influences by organ, neck side
and probe location as well as by tissue dimensions (su-
perficial tissue thickness (STT), tissue thickness (TT) and
total tissue depth (TTD)) and by demographic parame-
ters, such as body mass index (BMI), age and gender.
THC StO2 BFI
Organ thyroid ↑ thyroid ↑ thyroid ↑
Side - muscle left ↑ -
Location gland location 1 ↓ gland location 1 ↓ -
STT higher STT ↓ - -
TT - - -
TTD - - -
BMI higher BMI ↓ higher BMI ↓ higher BMI ↓
Age higher age ↓ - -
Gender females ↓ - -
Table 5.8: Results summary of statistical significance (p < 0.05) from
LME models for a source-detector separation of 25 mm
(see Sections 5.3.2.2 - 5.3.2.5). The table lists of total
hemoglobin concentration (THC), tissue oxygen satura-
tion (StO2) and blood flow index (BFI) and influences by
organ, neck side and probe location as well as by tis-
sue dimensions (superficial tissue thickness (STT), tissue
thickness (TT) and total tissue depth (TTD)) and by de-











5.3.3 Case studies with pathologies
In addition to the healthy population, nine case studies are
included in this study, representing subjects which were pre-
viously diagnosed with a pathology. In some cases the mea-
surement protocol was extended by adding probe locations
to the existing ones. For simplicity, in this section only two of
these cases are shown (CASE 4 and CASE 7). The cases were
chosen to illustrate the contrast obtained from the patho-
logic tissue. Furthermore, they represent a benign and a
malignant case. The remaining ones can be found in the
appendix (A.2). These cases turned out to be complex, non-
representative cases, so that they were excluded from the
analysis here. Is it noted, that the numbering is a result of
the order the volunteers were recruited.
For the cases presented here, Figures 5.5 and 5.6 show
the corresponding thyroid protocol schematics. The shaded
regions represent the locations of the thyroid nodules and
their approximate size in relation to the complete thyroid.
The measurements consisted of the same procedure as for
the healthy volunteers, as explained in Section 5.2, but with
addedmeasurement locations on the nodule side, i.e. “gland
center right” (CASE 4 and CASE 7) and “gland center left” (CASE4).
5.3.3.1 Pathology case 4 (CASE 4):
The fourth case was a male (38 years old; weight 71 kg;
height 1.64 m; BMI 26.4 kg/m2) with a thyroid nodule (maxi-
mum diameter > 65 mm) affecting the left lobe and extend-
ing into the isthmus. The nodule was heterogeneous with
necrotic areas. The FNAB examination showed atypical cells
suggestive of papillary thyroid cancer and a magnetic reso-
nance imaging (MRI) showed a destructured mass occupying
the left thyroid lobe and the isthmus, infiltrating all surround-
ing thyroid structures (trachea and esophagus) and the skin.
Due to the results, the tumor was considered unresectable
and radio- and chemotherapy with tyrosine kinase inhibitors
(“Sorafenib”) was suggested as a neoadjuvant therapy prior
to surgery. The radio- and chemotherapy showed an effect
and a total thyroidectomy was performed afterwards. Fur-
thermore, the third, fourth and sixth compartment were re-
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sected. Histopathology showed a papillary thyroid carcinoma
of 65mmwith invasion of the extrathyroidal fibroadipose tis-
sue. Twelve adenopathies were resected with three of them










a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure 5.5: Results of the 4th pathology case: The measurement
protocol a) consists of nine probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
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THC [µM] StO2 [%]
BFI
[cm2/s] × 10-9
Muscle (right) 82.6 ± 0.8 71.9 ± 1.2 7.3 ± 0.2
Gland location 1 (right) 138.5 ± 1.6 74.1 ± 0.5 12.9 ± 1.2
Gland location 2 (right) 134.7 ± 1.2 70.2 ± 0.5 12.9 ± 1.1
Isthmus 161.39 ± 2.4 73.6 ± 1.2 18.7 ± 2.0
Gland location 2 (left)* 201.3 ± 3.7 72.9 ± 2.2 33.1 ± 3.4
Gland location 1 (left)* 221.1 ± 11.4 71.6 ± 3.3 62.8 ± 6.4
Muscle (left) 92.7 ± 1.5 66.1 ± 3.3 17.8 ± 4.1
Gland center (right) 141.8 ± 2.4 71.8 ± 2.8 12.5 ± 0.5
Gland center (left)* 210.0 ± 6.1 71.6 ± 0.8 40.6 ± 3.01
Table 5.9: Results of CASE 4: Means and standard deviations from
for total hemoglobin concentration (THC), tissue oxygen
saturation (StO2) and blood flow index (BFI) are shown
here for all ninemeasurement locations according to the
study protocol for this patient as presented in Figure 5.5
a). * denotes the nodule locations.
The hybrid diffuse optics probe was applied on a total of
nine locations in this case as shown in Figure 5.5 a). The extra
locations were added in order to ensure that nodule is mea-
sured. The hybrid diffuse optics results are shown in Figures
5.5 b) - f) and Table 5.91. We see that in all three locations on
the left lobe the total hemoglobin concentration (THC) and
blood flow index (BFI) are higher than the right thyroid side
(p < 0.0001). We have defined a nodule index which was set
positive in all probe location on the left thyroid gland - as op-
posed to the nodule-free right thyroid gland where that index
was set to zero - and fitted a LME model with the nodule in-
dex as a fixed effect. The right thyroid lobe values average to
THC = 138.3 µM and BFI = 12.8 × 10-9 cm2/s, and, on the nod-
ule, in the left thyroid lobe they increase to THC = 210.8 µM
and BFI = 45.5 × 10-9 cm2/s. Additionally, the values show a
higher variability with three to nine times higher standard de-
viations, especially in the gland location 1 on the nodule side,
and are distinguishable from the contralateral lobe. The ob-
served standard deviations were: σTHC,left = 3.7 - 11.4 µM ver-
sus σTHC,right = 1.2 - 2.4 µM ; σStO2,left = 0.8 - 3.3 % versus
σStO2,right = 0.5 - 2.8 %; σBFI,left = (3.0 - 6.4) × 10
-9 cm2/s ver-
sus σBFI,right = (0.5 - 1.2) × 10
-9 cm2/s. Moreover, we observe a
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relatively high oxygen saturation (StO2) throughout the whole
thyroid (StO2 = 70.2 - 74.1 % compared to StO2, healthy = 66.6
- 68.4 %), while the reduced scattering coefficient (µ′s) in the
thyroid turns out lower than the healthy population (µ′s = 5.2 -
5.7 cm-1 compared to µ′s, healthy = 7.0 - 7.9 cm
-1). A tabular rep-
resentation of this case can be found in Table A.10 in Section
A.2
5.3.3.2 Pathology case 7 (CASE 7):
As CASE 7 we present results from a female (32 years old;
weight 68 kg; height 1.82 m; BMI 20.5 kg/m2) with a thyroid
nodule (40 mm) in the right lobe with foci of colloid degra-
dation and peripheral vascularisation suggestive of a hyper-
plastic nodule. An additional small nodule of a 3 mm di-
ameter in the right lobe was observed, with no laterocer-
vical adenopathies. Fine needle aspiration biopsy was per-
formed and suggestive of a follicular lesion. Furthermore,
the nodule showed microfollicular characteristics and was
classified according to the “Bethesda system for reporting
thyroid cytopathology” [63], which scales from one to six with
increasing malignancy risk as Bethesda 4. After the optical
measurements, a total thyroidectomy was performed and
histopathology showedmultinodular thyroid hyperplasia with
a hyperplastic dominant nodule (maximum diameter of 40
m) and regressive changes with adenomatoid nodules. No
follicular neoplasms were observed. Finally, the pathology
was classified as benign.
Figure 5.6 and Table 5.10 show the diffuse optics results2.
Similar to the previous cases, a nodule index was defined
and set to positive in “gland location 2” and “gland center”.
With the same LME model as for CASE 4 we have found a sig-
nificant difference from the null model (p < 0.01) with a THC
for a positive nodule index of 206.8 µM in contrast to 147.9
µM for non-nodule locations. The other parameters (StO2, BFI
and µ′s) are not significantly influenced by the two nodule lo-
cations. The µ′s values in three thyroid locations are lower
than the ones retrieved from the healthy population (µ′s = 4.0
- 6.5 cm-1 against µ′s, healthy = 7.0 - 7.9 cm
-1). A tabular repre-
sentation of this case can be found in Table A.13 in Section
A.2.
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CASE 7










a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure 5.6: Results of the 7th pathology case: The measurement
protocol a) consists of eight probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
5.4 D ISCUSS ION
After a general reflection of this study’s achievements, we
separate the discussion into subsections focusing on various
aspects in a detailed manner.
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THC [µM] StO2 [%]
BFI
[cm2/s] × 10-9
Muscle (right) 108.3 ± 0.8 61.0 ± 1.1 7.5 ± 0.6
Gland location 1 (right) 140.2 ± 2.9 66.2 ± 1.3 12.1 ± 1.3
Gland location 2 (right)* 191.8 ± 1.5 64.7 ± 2.2 11.2 ± 1.8
Isthmus 192.5 ± 4.4 66.0 ± 1.9 20.2 ± 0.9
Gland location 2 (left) 141.8 ± 0.1 72.5 ± 0.1 15.0 ± 1.8
Gland location 1 (left) 164.1 ± 2.5 69.2 ± 0.5 8.7 ± 0.5
Muscle (left) 117.1 ± 1.2 68.0 ± 1.6 8.5 ± 1.1
Gland center (right)* 226.5 ± 8.2 66.9 ± 0.5 37.6 ± 3.9
Table 5.10: Results of CASE 7: Means and standard deviations from
for total hemoglobin concentration (THC), tissue oxy-
gen saturation (StO2) and blood flow index (BFI) are
shown here for all eight measurement locations accord-
ing to the study protocol for this patient as presented in
Figure 5.6 a). * denotes the nodule locations.
5.4.1 Overview
The first result is that the proposed protocol including the
positioning of the subject, the neck and the diffuse optics
probe placement locations were sufficiently optimized. The
measurement protocol that was drawn-up (see Section 5.2)
allowed a good signal-to-noise-ratio and a good fitting qual-
ity for TRS and DCS, data sets as well as an appropriate and
convenient total measurement duration per subject (30 - 45
min). At the end, the optical and hemodynamic parameters
of the human thyroid and the sternocleidomastoid muscle
tissue from twenty-two healthy (ten females, twelve males)
and two subjects with a thyroid pathology were investigated.
The overall procedure demonstrates that it is possible to re-
late the diffuse optical signal to the hemodynamics in the tar-
get tissue.
Themeasurements appear to be robust in terms of repeata-
bility, since there was no perceivable difference between val-
ues from the same subject obtained at different times, nei-
ther over the time span of the measurement (∼ 30minutes),
nor for a time span of 11/2 months (data not shown). For the
latter, we rely on data from a subject, who has volunteered
twice within 11/2months and during which we have conducted
several probe placements per location. The variations were
within the obtained standard deviations. Furthermore, it is
i
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noted that male beard growth in the region did not pose any
specific influence on our signal, whereas turning the subject’s
head in order expose the thyroid - as verified by ultrasound -
showed a clear positive effect (see also Figure 5.1).
Varying the assumed water content ± 5 % around the 78 %
we used in the analysis did not show a noticeable influence
and since thyroid and neck muscle tissue are supposed to
have a similar water concentrations [328] we did not assume
different concentrations for each tissue. In the future, one
could expand the wavelength range to determine water and
lipid concentrations [277].
The normality tests on the optical and hemodynamic pa-
rameters (µa, µ
′
s, THC StO2 and BFI) resulted in a non-normality
for BFI in three locations (“gland location 2 (right and left)”
and “neck muscle (left)”). This was observed in previously
reported absolute BFI values [105] and may correctly reflect
the underlying physiology ormay be related to the technique.
Moreover, we would like to point out, that while the majority
of DCS results reported so far represent relative blood flow
changes with respect to a time or tissue reference and the
correct estimation of BFI depends on the optical tissue char-
acteristics [90, 209, 94, 149], we have used TRS data in the
DCS analysis leading to absolute, more accurate BFI values.
The probe locations were identified by an experienced ra-
diologist and for each location and subject an ultrasound im-
age was taken. Based on these images, we deduce, that the
probed region by the diffuse optics device extends below the
superficial tissues into the target tissues (muscle and thyroid)
and not into the further underlying regions.
The main target tissue was the thyroid gland and its homo-
geneity, which we have investigated by including two probe
locations on each lobe gland. We have also measured the
nearby muscles as a comparison. The overall set of locations
was exactly the same on both sides of the human neck.
The computed values for the total hemoglobin concentra-
tion (THC), tissue oxygen saturation (StO2) and the blood flow,
represented by the blood flow index (BFI), indicate high levels
of vascularisation and blood flow (Table 5.6), which is accor-
dance to previous measurements conducted by arterial spin
labeled perfusion magnetic resonance imaging [273].
i
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5.4.2 The extent of the probed regions
Using ultrasound guidance it is possible to identify differ-
ent anatomical structures in the neck region. High frequency
ultrasound, with frequencies between 7-13 Mhz, and the as-
sociated high spatial resolution permits to identify the thy-
roid gland, the trachea and the esophagus in the anterior
compartment of the neck, the common carotid artery and
the jugular vein in the lateral compartment of the neck, as
well as the muscular structures, both in the central and lat-
eral compartment of the neck. When using ultrasound guid-
ance it is therefore possible to mark the anatomical land-
marks of the thyroid and of the other anatomical structures
of the neck on the skin and to identify the position of diffuse
optics probe to correctly analyze different anatomical struc-
tures without their superposition, thus minimizing interfer-
ences in the optical analysis. The mentioned slight head tilt
and turn implemented in the protocol assisted this minimiza-
tion further. Representative ultrasound images of this proce-
dure and its effect are shown in Figure 5.1.
The data acquired from the larger source-detector separa-
tion, which presumably probes deeper regions of the tissue,
showed a significant (p < 0.0001) difference between the two
organs (muscle vs thyroid) for all parameters. This implies
that we are in fact probing the tissues underneath the super-
ficial layers.
To further investigate this point, we have studied the de-
pendence of THC, StO2 and BFI on the three variables defin-
ing the tissue dimensions: STT, TTD and TT (according to Fig-
ure 5.2). STT appears to have an influence on the calculated
THC in the thyroid lobes (p < 0.01). In a bootstrap analysis we
have found out that by exclusion of only one subject (ID: 19)
the statistical significant dependence of THC on superficial
tissue thickness disappears (p = 0.08). This strengthens our
assumptions that the majority of the detected photons carry
information on the tissue of interest. The fact that subject 19
is the one with the lowest BMI (18.3 kg/m2) in our study pop-
ulation taken together with the general influence of BMI (p <
0.01) on the data explains the found effect in the bootstrap-
ping analysis.
For further support to the claim that we are probing the
thyroid gland, we note that different dependencies on the tis-
sue dimensions were observed from the shorter ρ of 13mm,
i
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which has presumably probed shallower regions and was in-
corporated into our probe for a subset of eleven subjects (six
females, five males). The THC and StO2 values in this case
are dependent on the thickness of the superficial layers (p <
0.01), i.e. the superficial tissue thickness, thus indicating that
this shorter separation was in fact probing a more superficial
region. Additionally, there were no significant differences be-
tween gland location 1 and 2 in this configuration.
In summary, when looking at the dependence of the three
above-mentioned variables for the tissue dimensions, the re-
sults indicate that we reach the thyroid tissue and the signal
is dominated by that tissue. Nonetheless, we can not entirely
rule out possible contamination from other tissues in some
subjects, such as the jugular vein and /or the carotid artery.
We have done our best to develop a protocol to specifically
address this potential problem, including the neck extension
for thyroid exposure, as explained in Section 5.2 and Figure
5.1.
5.4.3 Lobe (Side) differences
Apart from a significant difference for oxygen saturation
(StO2) in the muscle location, we did not find any side influ-
ence on the values. In general, side differences in healthy
subjects would be surprising, which is why we suspect the
existence of the mentioned StO2 muscle side variation lies in
the systematic way we placed our probe on the different loca-
tions and/or is produced by a single subject. We now discuss
this further.
In the measurements, we have always started from the
muscle location on the right side moving point by point to
the left and then repeated the whole procedure. Since the
subject was asked to slightly turn the head according to each
probe location, the muscle in the last position was probably
less relaxed as the one in the starting position. This may ex-
plain the slightly higher values - indicating a higher active re-
gion - for the left neck muscle location and the significant
influence. The fact that the values from the muscle in the
short ρ, which is more sensitive to that region, also showed
side influences further supports that assumption.
Furthermore, a bootstrap analysis revealed that the signif-
icant difference between muscle sides in StO2 for a ρ of 25
mm (p = 0.01) becomes insignificant p = 0.06 by excluding sub-
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jects 12 and 18. This strong influence by only two subjects can
be attributed to the way of recording our data, as explained
above and a slight protocol modification can account for this
effect. Nevertheless, this finding does not change our main
hypothesis that we are able to probe the thyroid gland.
Asmentioned above, the thyroid values fromdifferent sides
were not significantly different (Section 5.3.2), which is ex-
pected. At the same time, our results indicated a depen-
dence on probe location for THC (p < 0.01) and StO2 (p = 0.02)
between gland location 1 and gland location 2. Although, we
tried to maximally expose the thyroid by a head tilt and turn,
we could see in the ultrasound images that we could not
achieve this by 100 %. Due to the dimensions of the thy-
roid and the two probe locations on the thyroid as defined
in our protocol, we may probe the thyroid better in one lo-
cation than the other, therefore leading to a change in the
computed values.
5.4.4 Influences of the subject demographics
Further significant influences on the data by the bodymass
index (BMI) (p < 0.0001), by age (pTHC, age< 0.01) and by gen-
der (pTHC, gender = 0.03) were found. Similar to other influ-
ences (Section 5.4.2) bootstrapping revealed a rather strong
influence by one (female) subject (ID: 7). Its exclusion leads
to a statistically non-significant gender relation (pTHC, gender =
0.07) and to a disappearance of the influence on THC by age
(pTHC, age > 0.05). Nonetheless, the BMI influence remains sig-
nificant, which seems reasonable. That diffuse optical mea-
surements are sensitive to BMI has been shown previously
in human breast tissue [294, 295, 91] and bone marrow [105].
Since diffuse optics is a non-invasive technique, one always
has to deal with superficial tissues such as skin and adipose
layers, which in turn make the optical measurements influ-
enceable by BMI. Furthermore, there are indications that the
BMI can actually influence the thyroid function [211, 58], which
can partially explain the significant BMI dependence in our
data. In the future, a multi source-detector probe can inves-
tigate this further.
It is noted that, while these bootstrapping analyses have
helped to resolve unexpected results, they also indicate that
future studies with a larger subject population are important
to further investigate any dependencies on subject demo-
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graphics, anatomy and physiology. This current study serves
as the basis for this and establishes the variability of the re-
sults, which is needed for power calculations.
5.4.5 Pathology cases
The case studies introduced in Section 5.3.3 show side dif-
ferences between the glands and clearly higher vascularisa-
tion as indicated by elevated THC and BFI values compared
to the healthy population. Assuming that the pathologic nod-
ules are in the thyroid gland below the superficial regions,
this further proves that we are sensitive to the thyroid’s mi-
crovasculature and that we are able to resolve differences
in the thyroid glands. The data from CASE 7 even suggests
differences within the same gland, which is noteworthy con-
sidering the typical thyroid dimensions and the spatial reso-
lution from diffuse optics. Furthermore, we see higher stan-
dard variations in the nodule signals in both pathologic cases,
which may be due to the abnormal, unstable hemodynamics
of the pathologic tissue volumes.
In CASE 4, we use THC (pTHC < 0.0001) and blood flow (pBFI <
0.0001) to differentiate the lobe with the 65mm nodule from
the nodule-free side, which according to the FNAB results
was suggestive of papillary thyroid carcinoma. This is in ac-
cordance to previous studies which have shown an increased
microvasculature in papillary thyroid carcinoma [267].
As for CASE 7 and its 40 mm nodule in the right lobe, we
have observed a significant (pTHC < 0.01) THC increase in the
lobe with the nodule. Furthermore, we note higher blood
flows in the nodule, in particular from the added location
(“gland center right”). The fact that we do not record higher
values in all probe locations from the infected lobe are due
to the smaller nodule dimensions compared to CASE 4.
The oxygen saturations (StO2) throughout the whole thy-
roid in CASE 4 are noticeably higher than in the healthy pop-
ulation and allow for no distinction between the presumably
healthy and the nodule side. This is similar to the reduced
scattering coefficients (µ′s) which are similar within both thy-
roid lobes and are relatively low compared to the healthy
population.
For CASE 7, StO2 differs between thyroid lobes and tends
to be lower on the nodule side, which might be explained by
an increased oxygen consumption due to the nodule. This
i
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different behaviour between the two cases, with a StO2 in-
crease in CASE 4 and a decrease in CASE 7, makes it difficult
to use this variable as a discriminator at this point. It seems
likely that µ′s could be helpful in the search for a contrast be-
tween tumor types, since the malignant case presents val-
ues on the lower end of the scale, while the benign case lies
somewhat in between the healthy population and the malig-
nant nodule. This is supported by previous results from a
study by Suh et. al. [301] conducted on twenty patients. They
have found that elastic scattering spectroscopy (ESS) can help
discriminate between benign and malignant thyroid nodules
due to its sensitivity to morphologic characteristics. Similar
to ESS, DOS is sensitive to index of refraction changes, i. e.
changes in nuclear size and density. These cellular arrange-
ments were confirmed to change among different thyroid
nodule types by Hung et al. [142] using two-photon excited
fluorescence (TPEF) together with second-harmonic genera-
tion (SHG). Altogether ,results from ESS and TPEF with SHG
support our findings and encourage the use of µ′s as a fur-
ther parameter to improve the thyroid screening process.
Apart from changes in the scattering characteristics, higher
vascularisation in nodules is expected [345, 93]. The thyroid,
in particular, as an already highly vascularised organ is show-
ing even higher degrees of vascularisation when a nodule
is developed, thus leading to increase hemoglobin concen-
trations and blood flows [81, 273]. This can be even more
present on the microvascular level [267]. Our findings are in
agreement with this on both the general as well as microvas-
cular level and are therefore a promising approach towards
an improvement of the thyroid screening procedure.
5.5 CONCLUS ION
The goal of this study was to establish a normal range for
optical parameters of the healthy thyroid and their possible
influences by physiological parameters, so that in the end
these measurements can be compared to values obtained
in the same way from pathologic thyroid tissues. We have
shown that it is feasible to do diffuse optical measurements
on the thyroid in-vivo and that the signal we are receiving is
giving information on the thyroid vascularisation. This is sup-
ported by the different tests on dependencies of tissue di-
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mensions and hemodynamic parameters (THC, StO2, BFI) as
well as the contrast between healthy and pathologic tissue.
As expected, the two thyroid lobes do not show any signif-
icant difference in healthy subjects, whereas the signal from
subjects with thyroid nodules clearly differed between sides.
The observed probe location dependence on demonstrates
that it is important to use various probe placements on the
gland. The fact that we did not record any changes over time
(30 min to 11/2 months) in the healthy thyroid tissue proves
the robustness and repeatability of such a protocol.
The signals from nodule locations result in elevated mi-
crovascular THC values, whichmakes this a promising param-
eter for improvement in thyroid screening. There are further
indications for higher BFI and altered µ′s from the pathologic
data encouraging the use of diffuse optics on thyroid tissue.
Finally, the observations prove that the diffuse optical sig-
nal is in fact strongly influenced by the thyroid tissue, that
we are able to characterize differences in the nature of this
tissue and therefore paving the way of an improvement in
sensitivity and specificity in thyroid screening by diffuse opti-
cal methods.
5.6 OUTLOOK
In a next step, diffuse optics will be employed on further
thyroid nodule cases and other pathologies in order to im-
prove thyroid screening methods and to compare healthy
and pathologic distributions.
Moreover, opening the field of thyroid cancer screening to
diffuse optics with promising results together with the nov-
elty of this project led to a European Horizon 2020 (H2020)
project called “LUCA” - Light and Ultrasound Co-analyzer for
Thyroid Nodules. Within LUCA, the combination of TRS, DCS
and US aims to provide doctors better information and more
specific results in the thyroid cancer screening process thus
having a strong socio-economic impact by saving unneces-
sary surgery costs and improve thyroid healthcare. The LUCA
- consortium is formed by eight different European multidis-
ciplinary partners ranging from the clinic to industry and re-
search facilities. In the first phase of the project, the focus
lies on the device integration and development of a new com-
bined diffuse optics-US probe. US is part of the standard thy-
i
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roid cancer screening process and will furthermore be used
to guide the diffuse optical measurement, similar to the work
presented in this Chapter. This Chapter has shown that it is
possible to retrieve a measurable contrast between healthy
and pathologic thyroid tissue. Therefore the use of the mi-
crovascular hemodynamic properties can help to improve con-
trast in screening. This will be further aided by information
on the optical properties (µa, µ
′
s), as indicated by the data pre-
sented here and in Section A.2. Additionally, the use com-
bined probe of US and diffuse optics could be extrapolated
to other cancer screening procedures.
i
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HYBR ID D I F FUSE OPT ICS AS A
MEASURE OF DEPTH OF
ANESTHES IA
This chapter sets out to reference non-invasive optical mea-
surements of cerebral oxygen metabolism to electrical (elec-
troencephalographic) measurements from brain healthy pa-
tients undergoing general anesthesia. To that end, the hybrid
device presented in Chapter 4 is used in the surgical environ-
ment. This serves as a first comparison of diffuse optically de-
rived cerebral metabolism against a typical clinical tool used
in this scenario. This procedure has the potential to estimate
brain oxygen metabolism also in traumatic brain injury pa-
tients, which could have important clinical implications in the
future.
This project is a collaboration with Dr. Ivette Chochrón da
Prat, Dr. Ángela Sánchez-Guerrero, Dr. Miriam de Nadal and
Dr. Juan Sahuquillo and colleagues from the Department
of Anesthesiology and the Neurotraumatology and Neuro-
surgery Research Unit (UNINN) at the Vall d’Hebron Univer-
sity Hospital and it’s Research Institute (VHIR) in Barcelona as
well as the Universidad Autònoma de Barcelona.
6.1 BACKGROUND
Anesthetic agents suppress the patient’s awareness by dis-
rupting the neuron activity and therefore preventing the for-
mation ofmemory in a dose-dependentmanner [239]. Propo-
fol is a non-barbiturate intravenous agent used commonly
for the induction and maintenance of anesthesia and for se-
dation in critical care [57, 206]. Propofol has many phar-
macologic advantages over other anesthetic agents such as
rapid effect, short action, and fewer side effects [57, 283, 319].
Due to its effect on the central nervous system (CNS), propo-
fol induces a decrease in cerebral metabolic rate of oxygen
(CMRO2) and therefore a dose-dependent depression of cere-
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pling between the two [314, 173, 35, 158, 234, 323].
The proprietary bispectral index (BIS) is a processed elec-
troencephalogram (EEG) measure that summarizes brain ac-
tivity and is used by anesthesiologists during general anes-
thesia as a measure of depth of anesthesia due to certain
anesthetics during the care of patients [283, 164]. The BIS
algorithm was developed based on adult EEG data and com-
bines several readings of time, frequency and high order spec-
tral sub-components into the BIS index [43, 161]. This index is
a single dimensionless parameter that scales from 0 (isoelec-
tric EEG) to 100 (awake) with increasing brain activity [43, 161,
54, 286]. Awake, unsedated individuals typically have BIS val-
ues > 97 and the BIS is progressively reduced by drug-induced
sedation [161, 293]. During general anesthesia BIS values be-
tween 45 and 60 have been recommended for anesthetic
maintenance [157]. BIS provides a real-time feedback of con-
sciousness during surgical procedures [283, 78, 268, 221, 161,
148, 172, 337] and is widely used to evaluate the depth of
anesthesia and in particular to obtain real-time pharmacody-
namic information during propofol-induced anesthesia [283,
69, 259, 101, 43, 117, 269, 125, 275, 120, 204, 186]. Moreover, it is
often considered as a surrogate indicator for CMRO2 during
propofol-induced general anesthesia [259, 101, 43, 6, 192, 117,
272, 8].
General anesthesia diminishes neuronal activity. In conse-
quence, CMRO2 is decreased, which has been observed by
positron emission tomography (PET) [158, 9, 8]. A combina-
tion of time-resolved and diffuse correlation spectroscopy
(TRS and DCS, respectively), also called hybrid diffuse optics,
can measure microvascular blood dynamics via the tissue
oxygen saturation (StO2) and a blood flow index (BFI) non-
invasively. This together with the knowledge of the arterial
oxygen saturation (SaO2) from a standard pulseoximeter al-
lows the calculation of the oxygen extraction fraction (OEF)
and the above-mentioned CMRO2 [90, 45, 209, 262, 94, 29],
as we have seen also in Section 3.2.4. While TRS can derive
the tissue’s absorption and reduced scattering coefficients
(µa and µ
′
s), DCS uses information from the intensity autocor-
relation decay times to estimate the tissue blood flow (see
also Chapter 2). In DCS, the more accurate the knowledge of
µa and µ
′
s is, the better we can estimate the tissue blood flow
i
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and its changes (see Chapter 9). This is where hybrid diffuse
optics provides a huge advantage by combining knowledge
about the tissue’s static and dynamic optical properties [209,
94, 29, 30, 28]. Both diffuse optical techniques have been em-
ployed in the investigation of the human brain in-vivo, its au-
toregulatory mechanisms and hemodynamic properties [105,
60, 45, 209, 97, 333, 341, 92, 91], as also shown in Chapters 7
and 8.
Previous studies have shown that there is a need for regis-
tration of the patient’s awareness during surgical procedures
and that it is therefore crucial to monitor continuously the
effect of anaesthetics on the patient’s brain during surgical
procedures [136, 16, 1, 276, 5]. Techniques making use of
photon diffusion in human tissue have the potential to aid in
this matter and are therefore a promising approach [113, 136,
71, 184, 316, 152, 106, 191]. In the study presented here, the
hybridization of newer diffuse optical techniques (TRS and
DCS) sets out to show its capability of addressing the patient’s
awareness via non-invasive assessment of CMRO2.
Moreover, neurocritical patients therapy requires advanced,
multi-modality neuro-monitoring and the need to locally and
on-line measure microvascular cerebral hemodynamics and
metabolism, which is not possible with the current modali-
ties. The optical modalities presented in Chapter 4 can be
used as a promising non-invasive and reliable neuromonitor-
ing tool for continuous monitoring of cerebral hemodynam-
ics in neurocritical care patients.
Here, the interest lies in non-invasively measuring the influ-
ences on the brain hemodynamics during controlled propofol-
induced anesthesia of patients without brain diseases by us-
ing diffuse optical methods. These values will be compared
to BIS.
6.2 PAT IENTS AND METHODS
A prospective study was conducted in patients above eigh-
teen years of age, who underwent general surgical proce-
dures under standard general anesthesia at Vall d’Hebron
University Hospital (VHUH), between December 2014 and Jan-
uary 2016. Patients were enrolled in the study based on the
following inclusion criteria: 1) absence of previous stroke, cere-
bral tumor, chronic hydrocephalus, neurodegenerative sick-
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ness, or evidence of carotid stenosis; 2) no contraindications
for total intravenous anesthesia (TIVA) with propofol; 3) pa-
tients needed to undergo a general surgery, excluding laparas-
copies with extreme patient positions, i. e. Trendelenburg po-
sition; 4) class I (healthy) or II (mild systemic disease) in the
physical status classification system defined by the Ameri-
can Society of Anesthesiologists (ASA) [266] and 5) written
informed consent signed by the patient or next-of-kin. The
study was approved by the VHUH Institutional Ethics Com-
mittee (protocol AC/U(AT)203/2012[3531]) and the study was
conducted in accordance with the Declaration of Helsinki.
6.2.1 Diffuse optical device
The hybrid diffuse optical device used the combination of
TRS and DCS as presented in Chapter 4. Near-infrared light
was sent into the tissue through a set of fibers incorporated
into a combined DCS/TRS-BIS probe with a source-detector
separation (ρ) of 25 mm for both optical modalities (please
refer to Section 4.2 for details). Diffuse optical data was mea-
sured bilaterally on the frontal lobes during extracraneal sur-
gical procedures. The BIS signal was retrieved from the left
brain hemisphere. The combinedDCS/TRS-BIS probe is shown
in Figure 6.1. The probe was designed around the BIS sensor
while providing a compact housing for the source and detec-
tor fiber head of both modalities. It was 3-D printed in Tan-
goBlack shore 27 material and incorporated in a head strap
which wrapped around the patient’s head. It also covered
and protected the entire combined probe against any kind
of contamination by the surgical environment.
The data was taken with the hybrid device explained in
Chapter 4. It consists of two single longitudinal mode lasers -
one for each brain hemisphere - operating at a wavelength of
785 nm for DCSmeasurements and with pulsed light sources
at three different wavelengths (690, 785 and 830 nm) for TRS
measurements. A multimode fiber with a core diameter of
200 µm (NA = 0.22) served as the DCS source fiber and TRS
light is sent to the tissue through a graded-index fiber with
a core diameter of 62.5 µm (NA = 0.275). At the DCS detec-
tion site, set of four single mode fibers (core diameter of
5.6 µm) - each one connected to a single-photon counting
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Figure 6.1: Bottom view of the 3-D printed combined BIS-TRS/DCS
probe. The first three electrodes of the BIS sensor are
placed on the subject’s left forehead followed by the
black fiber pad which fits around the BIS sensor. The
fourth electrode is attached next to the patient’s left eye.
Source (top) and detector (bottom) fiber tips are placed
in between the first and second electrode, surrounded
by TangoBlack shore 27material.
avalanche photodiode - collected the scattered photons. A
eighty-five fold graded-index fiber bundle - same fiber prop-
erties as the source fiber - collected the TRS light and guided
the photons into two hybrid photo multiplier detectors, one
for each brain hemisphere. For further details, please refer
to Sections 2.4, 2.5, 2.6 and 4.2.
6.2.2 Clinical data and patient medication
In addition to the recordings provided by the hybrid dif-
fuse optical setup, information on the arterial oxygen satu-
ration (SaO2), heart rate (HR), end-tidal CO2 (EtCO2) and mean
arterial pressure (MAP) - measured by an arm cuff - was ex-
tracted from an anesthesia monitor (Datex-Ohmeda Aisys™,
GE Healthcare, Little Chalfont, United Kingdom) by the open-
source VitalSigns capture (VScapture) program [159]. The BIS
data was acquired by an unilateral BIS sensor (BIS Vista™,
Medtronic plc, IRL) and saved by the Windows™ hypertermi-
nal throughout the entire procedure.
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General anesthesia was performed under total intravenous
anesthesia with propofol at a concentration of 1 % (Propo-
fol Fresenius®, Fresenius Kabi Deutschland GmbH, Bad Hom-
burg, Germany) using the Schnidermodel [270] based on age,
height, weight and gender of the patient [206, 126] imple-
mented in a TIVA system (Alaris Asena® PK, Becton, Dickin-
son and Company, Franklin Lakes, NJ, USA). After tracheal in-
tubation pulmonary volume-controlled ventilation was main-
tained with a fraction of inspired oxygen (FiO2) of 0.5, a tidal
volume of 6-7 mg/kg, a respiration rate (RR) between 12 to
16 breaths per minute and a positive end-expiratory pres-
sure (PEEP) of 4-6 mmHg. The entire anesthesia procedure
was carried out by experienced anesthesiologists of the Uni-
versity Hospital Vall d’Hebron.
It should be noted that the patients received further medi-
cations, known to influence the cerebral hemodynamics, such
as fentanyl [38, 222, 210]. The data presented here does not
consider such effects and is focused on the global agreement
between rCBF and relative bispectral index (rBIS) in the left
brain hemisphere. The reason for the left hemisphere is given
by the fact that a unilateral BIS sensor was used and placed
on the left forehead.
6.2.3 Data evaluation
As explained in Section 2.6, the data is first evaluated by fit-
ting the respective semi-infinite medium solutions (see Sec-
tions 2.4 and 2.5) to the measurement. The fitting is done by
using the downhill-simplex or Nelder-Mead method in MAT-
LAB™’s implemented “fminsearch” function [179, 226]. Fur-
ther data analysis is then carried out in R [255]. A wavelet
analysis is performed [177] and the figures and tables pre-
sented here are generated using packages within R [224, 329,
330, 331]. In all models and statistical tests, “p-values” of
less than 0.05 were considered statistically significant to re-
ject the null hypothesis.
The oxy- and deoxyhemoglobin (HbO2 and Hb) contents
were calculated using the absorption information (µa) from
TRSmeasurements at different wavelengths (see Section 2.1).
Three main tissue constituents (HbO2, Hb and H2O) were con-
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sidered and tabulated extinction coefficients from [253] and
[132] were used. The tissue oxygen saturation (StO2) was cal-
culated assuming a water concentration of 77 % and a negli-
gible lipid contribution.
As explained in Section 3.2.4, StO2 can be expressed as a
superposition of arterial, capillary and venous oxygen satura-
tions (SaO2, ScO2 and SvO2), which gives rise to blood volume
percentage in venous compartment (γ) [70]. Assuming that
this quantity does not change (γ1 = γ2), the measures of StO2
were converted into relative OEF (rOEF) and CMRO2 (rCMRO2)
changes using the relation from Equation 3.8 [90, 33, 209, 94,
70].
The patient’s average value was taken as the reference and
defined as zero. The relative changes of the variable of inter-
est throughout the entire surgical procedure was then cal-
culated with respect of the individual subject reference and







Substituting the variable X in Equation 6.1 by BIS yields rBIS
(= Y) and for X = OEF results in Y = rOEF. In the calculation of
rCBF (= Y), the variable X is set to αDb, which is often referred
to as the blood flow index (BFI) (see Equation 2.26).
Data collected during patient movements in the surgery
was excluded from the dataset. Prior to a wavelet denoising,
the data was grouped in 5 s bins for each patient in order to
match the BIS sample size.
The rCBF and rCMRO2 values from each subject were com-
pared to rBIS for the entire study population using a two-
sided Pearson product-moment correlation test with confi-
dence intervals of 95%. Data was evaluated in three different
steps: I, II and III. While in step I all data points were included,
step II only considers relative changes in the optically derived
parameters (rCMRO2 and rCBF), which are outside the one σ
variation around the mean: |rCBF|> σrCBF and |rCMRO2|>
σrCMRO2 . In step III, this condition was also applied on the
rBIS data. The steps are summarised as follows:
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Step I: Consider the complete rCMRO2, rCBF and rBIS data
set.
Step II: Consider all rBIS data but only significant changes
in optical measurements, i. e. changes greater than the
standard deviation.
Step III: Consider only changes in rCMRO2, rCBF and rBIS,
that are larger than the standard deviation.
Furthermore, the individual intercepts and slopes for each
analysis step were computed. Results are presented for the
entire study population and for each subject individually. The
relative BIS values were calculated for an equal comparison
to the derived rCMRO2 and rCBF.
6.3 RESULTS
6.3.1 Study population
Seventeen patients (seven females and ten males) were in-
cluded in the study population out of twenty recruited ones
in total. The average age, height, weight and body mass in-
dex (BMI) is presented in Table 6.1 for the entire study popu-
lation, as well as separated by gender.
Age [yrs] Weight [kg] Height* [cm] BMI [kg/m2]
All 54.5 ± 12.3 81.5 ± 14.1 165.1 ± 11.6 29.8 ± 4.0
Females 52.9 ± 15.3 80 ± 12.9 159.4 ± 9.1 31.5 ± 4.4
Males 55.7 ± 10.5 82.4 ± 15.5 169.0 ± 11.9 28.6 ± 3.3
Table 6.1: Demographic parameters: Mean ± their standard devi-
ation. * denotes a statistically significant difference be-
tween females and males (t-test, p < 0.05).
The data from three recruited patients had to be excluded
due to the following issues: BIS data capture failed (two cases),
the fiber probe was removed during the surgery (one case).
All subjects were patients without a brain disease and un-
derwent the following surgical procedures: (para-) thyroidec-
tomy (n = 4), hemithyroidectomy (n = 1), cholecystectomy (n
= 5), cholecystomy (n = 1), morbid obesity (n = 1), cystectomy
(n = 1), an exploratory laparascopy (n = 1), hemicolectomy (n












Using the wavelet transform and shrinking the wavelet co-
efficients in order to denoise our data, the combined stan-
dard deviations in the rCBF/rCMRO2 and rBIS recordings were
reduced from initially around 40 % to about 20 % over stable
periods of anesthesia. rBIS, rCBF and rCMRO2 were calculated
using Equation 6.1. A representative time evolution of (r)BIS,
rCBF and rCMRO2 from the left brain hemisphere in one sub-



































































































Figure 6.2: Representative time evolution of the a) bispectral in-
dex (BIS) and b) rBIS [%]. c) shows the relative cerebral
metabolic rate of oxygen extraction change (rCMRO2)
[%] and d) the relative cerebral blood flow change (rCBF)
[%] during anesthesia induction (t0 = 175 s) by propofol
(1%).
These parameters are plotted around the initiation of gen-
eral anesthesia by TIVA of propofol (1%). The induction took
place at t0 = 175 s. It is noted, that the graphs presented in
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A clear decrease in BIS (plotted in Figure 6.2 a)) from almost
100 to about 25 represents a characteristic BIS drop due to
propofol-induced general anesthesia.
rBIS decreases from around 100 % to about -40 % and the
rCBF from around 70 % to approximately -50 % between t =
175 s and t = 375 s. In this anesthesia induction phase the
two variables correlate significantly with a Rpearson of 0.95 (95
% conf. interval = 0.93 - 0.96) and p-value of less than 0.001.
6.3.3 Step I: Global agreement between BIS (electrical) and op-tical data
Expanding the value range over the entire surgical proce-
dure and analyzing all included subjects leads to a statisti-
cally significant (p < 0.001) correlation coefficient of Rpearson
= 0.32 (95 % conf. interval = 0.30 - 0.33) between rBIS and
rCMRO2 and Rpearson = 0.33 (95 % conf. interval = 0.31 - 0.34)
between rBIS and rCBF. The slopes and their standard errors
set to mrCMRO2 = 0.29 ± 0.01 and mrCBF = 0.30 ± 0.01.
6.3.4 Step II: Consideration of only significant changes in opti-cal measurements
Since we are looking at the changes of rCBF and rCMRO2
with respect to each subject’s averaged value defined as 0
% and our one σ variation around this reference is σrCBF =
22.8 % and σrCMRO2 = 22.0 %, the second step only consid-
ers values that fulfill the following conditions: |rCBF|> σrCBF
and |rCMRO2|> σrCMRO2 . Applying this criterion results in
significant (p < 0.001) correlations with an increased correla-
tion coefficient RpearsonrBIS:rCMRO2 = 0.46 (95% conf. interval
= 0.43 - 0.48) and RpearsonrBIS:rCBF = 0.47 (95 % conf. interval
= 0.44 - 0.49).
After evaluation step II1, the individual subject correlations
between rBIS and rCMRO2 are statistically significant (p < 0.01 -
0.001) in twelve out of the seventeen patients measured in to-
tal. Statistically significant correlation coefficients range from
Rpearson = 0.14 (ID 5; p < 0.01) to Rpearson = 0.96 (ID 6; p < 0.001).
Here, the non-significant cases are IDs 3, 4, 11, 13 and 14.
1 A subject-wise representation of correlation coefficients, intercepts and
slopes for step II is given in Tables B.1 and B.2.
i
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For rCBF, ID 13 shows a statistically significant correlation
(Rpearson = -0.28; p < 0.05) in addition to the same twelve cases
as for rCMRO2 (p < 0.001). The correlation coefficients for rCBF
and BIS range in this case from Rpearson = -0.28 (ID 13; p < 0.05)
over Rpearson = 0.16 (ID 5; p < 0.001) to Rpearson = 0.98 (ID 8; p <
0.01).
6.3.5 Step III: Consideration of only significant changes in allparameters
Applying the same condition as in step II (see Sections 6.2.3
and 6.3.4) on the rBIS values (step III), correlation coefficients
increase to Rpearson, rCMRO2 = 0.67 (95 % conf. interval = 0.64 -
0.70) and Rpearson, rCBF = 0.67 (95% conf. interval = 0.64 - 0.70).
After evaluation step III2, the individual subject correlations
between rCMRO2 and rBIS are statistically significant (p < 0.01 -
0.001) in twelve out of the seventeen patients measured in to-
tal. Their correlation coefficients cover a range from Rpearson =
0.29 (ID 10; p < 0.01) to Rpearson = 0.97 (ID 6; p < 0.001). The non-
significant cases are IDs 3, 9, 11 and 13, while ID 8 has no data
left after applying the above-mentioned exclusion criteria to
perform a correlation test.
In the case of rCBF, the same twelve cases as for rCMRO2
show a statistically significant correlation (p < 0.01 - 0.001).
Their correlation coefficients range from Rpearson = 0.28 (ID 10;
p < 0.01) to Rpearson = 0.98 (ID 6; p < 0.001). As for rCMRO2, ID
8 has no data left after the third evaluation step to perform
a correlation test. This is due to the fact that data could only
be taken while the patient was already anesthesized and no
significant changes were recorded during this period.
6.3.6 Summary of all analysis steps
Table 6.2 summarizes the retrieved Pearson correlation co-
efficients, intercepts and slopes from the linear regression
analysis3. They are shown with their respective standard er-
rors and for the three steps as presented in Section 6.2.3. The
slopes of the calculated rCMRO2 and rCBF against the rBIS val-
2 A subject-wise representation of correlation coefficients, intercepts and
slopes for step III is given in Tables B.3 and B.4.
3 Data for individual subjects is presented in Tables B.1, B.2, B.3 and B.4.
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ues are 0.53 ± 0.02 and 0.54 ± 0.02 respectively. These in-
crease to 0.59 ± 0.02 and 0.60 ± 0.02 in step III of the analysis.
In consequence, the intercepts decrease from step II to step
III (mCMRO2, II = -1.74 ± 0.48 to mCMRO2, III = -6.93 ± 0.90 and
mCBF, II = -0.18 ± 0.50 to mCBF, III = -5.09 ± 0.93).
rCMRO2
step R intercept slope N InD [%]
I 0.32*** -0.04 ± 0.20 0.29 ± 0.01 11913 100
II 0.46*** -1.74 ± 0.48 0.53 ± 0.02 4307 36.15
III 0.67*** -6.93 ± 0.90 0.59 ± 0.02 1408 11.82
rCBF
I 0.33*** 0.50 ± 0.20 0.30 ± 0.01 11913 100
II 0.47*** -0.18 ± 0.5 0.54 ± 0.02 4183 35.11
III 0.67*** -5.09 ± 0.93 0.60 ± 0.02 1379 11.58
Table 6.2: Pearson correlation coefficients (*** = p < 0.001), inter-
cepts and slopes with their respective standard errors
from rCMRO2 and rCBF versus rBIS. Step I represents
the bare correlation and linear regression fit analysis
results. Step II considers only values outside the ± σ
region of rCBF, rCMRO2 (|rCBF|> σrCBF; |rCMRO2|>
σrCMRO2 ). In step III, additionally, only values of |rBIS|>
σrBIS are included. N = total number of used data points;
InD = percentage of included data.
Figure 6.3 shows the corresponding three data sets and
their linear regression fits for a) rCMRO2 and b) rCBF. The
changes associated with a rBIS value of 100 - 150% are due to
the patient waking up from the surgery, while the main cloud
of data points around 0 % correspond to the phases where
the patient was maintained under general anesthesia. These
periods lasted between 40min and 5 h.
6.4 D ISCUSS ION
In this study, a hybrid diffuse optical device was used to
estimate cerebral metabolism [90, 45, 209, 262, 94, 29] dur-
ing propofol-induced anesthesia. Propofol induced a change
in the state of consciousness reflected in the BIS and CMRO2
readings. The correlation between rCBF and rBIS is in agree-
ment with previous observations [314, 173, 158, 112] and, in
combination with TRS data, enabled us to link this to the
i
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Figure 6.3: Correlation plots: rCMRO2 against rBIS (a) and rCBF
against rBIS (b). Data sets considering all values or only
the ones outside the mean ± σ region are plotted in dif-
ferent colors. In blue all values are considered, in red
only the ones outside the mean ± σ of rCBF or rCMRO2
respectively, while in black we consider only the values
which lie also outside the rBIS ± σrBIS.
rCMRO2. The diffuse optical measurements presented here
provide information on the microcirculation, while measures
of the widely used transcraneal Doppler (TCD) only result in
information at the macrovascular level [133, 2]. Moreover,
data obtained with TRS and DCS does not require insonation
windows like TCD [199, 180, 24], thus providing an advantage
over this widely used technique.
i
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Seventeen patients were reported within the defined inclu-
sion criteria over a range of eleven different types of surg-
eries. In many of the noted cases, various movements of the
patient due to the standard procedure for specific surgeries,
led to exclusion of those periods in the data. This resulted in
only a few patients in which the anesthesia induction phase
and the characteristic BIS and rCMRO2 drops during that pe-
riod could be recorded. An illustrative case was shown in Fig-
ure 6.3. The changes are significantly correlated between BIS
and rCMRO2 (Rpearson = 0.95; p < 0.001). Possible pharmacody-
namic interactions between propofol and fentanyl affecting
the level of consciousness were seen in the BIS values [222,
210] so that such interactions should not affect the global cor-
relation between optical and BIS data.
Data was denoised using wavelets and shrinking the coeffi-
cients in the spectrum, reducing the standard deviation from
σ ∼ 40% to σ ∼ 20%. Different degrees of changes (step I-III)
were used for the correlation investigation. In all steps signif-
icant correlations were found (p < 0.001). Surgery durations
ranged between 1 h and 6 h, thus producing long periods of
time where data was taken without any induced changes in
the cerebral activity. This led us to exclude those regions in
the correlation analysis. For significant changes in rCMRO2,
rCBF and rBIS (step III) strong significant correlations were
retrieved (Rpearson, rCMRO2 = 0.67 and Rpearson, rCBF = 0.67; p <
0.001). In step II, episodes of significant changes in only the
optically derived values also correlate significantly with rBIS
(Rpearson, rCMRO2 = 0.46 and Rpearson, rCBF = 0.47; p < 0.001). The
data suggests that we are sensitive to changes above the one
σ variations around the mean, which is not surprising given
the fact that a huge cloud of data points is formed around
the reference value as a result of setting it to each subject’s
average value (Equation 6.1).
In steps II and III, an overall slope ranging from 0.53 ± 0.02
(mrCMRO2:rBIS, II) to 0.59 ± 0.02 (mrCMRO2:rBIS, III) was fitted.
The slopes between rCBF and rBIS (0.54 ± 0.02 - 0.60 ± 0.02) do
not differ significantly, which supports the assumption that
propofol maintains physiological coupling.
The data is consistent over several different types of surg-
eries and it correlates well for relative changes in both optical
data sets. Additional data from a clean anesthesia induction
i
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and emergence from anesthesia could provide further sup-
port, since large BIS and CMRO2 are expected in these events.
It is however important to state that the data was collected
during standard surgical procedures. The surgeries were con-
ducted regarding the patient’s health, which is of primary im-
portance. Therefore, movements, medications, patient posi-
tioning and the over all surgery process are necessary and in
the recording of diffuse optical data we needed to adapt to
these circumstances.
6.4.1 Clinical relevance
In the study of normal brain physiology as well as in the in-
vestigation of neuroprotective drug effects or methods, that
target rCBF and rCMRO2, such as induced hypothermia, it is
essential to estimate these parameters accurately. The knowl-
edge of the relationship between rCBF and rCMRO2 is a key
in defining the viability of the brain following an acute insult
and in understanding brain ischemia pathophysiology and
ischemic-induced cascades. Most of the invasive methods
used in neurocritical care, such as microdialysis, tissue oxy-
gen pressure (PtO2) probes or jugular bulb oximetry, present
only rough estimates of cerebral metabolism and blood flow,
the consumption of oxygen or of the repercussions affect-
ing brain metabolism due to a lack in oxygen supply, i. e. hy-
poxia. Using PtO2 probes (Licox® or Paratrend/Neurotrend™)
one can estimate the local brain tissue oxygenation in a con-
tinuously and by jugular bulb oximetry one obtains contin-
uous information on global jugular venous oxygen satura-
tion (SjvO2) and - under constant SaO2 and PO2 - information
on the relation of CBF to CMRO2 [127, 131, 36, 317]. Micro-
dialysis allows one to monitor cerebral metabolism, to com-
pare it to the systemic level by measures of glucose, lactate
and pyrovate and it indicates episodes of hypoxia of hyper-
metabolism. Nonetheless, these techniques require invasive
probes and can not simultaneously provide information on
CBF and CMRO2.
Positron emission tomography (PET) using radiotracers such
as 15O-labeled H2O remains the gold standard to assess oxy-
gen levels in brain [217]. PET has been the tool used in most
studies to differentiate among the three types of brain tis-
sue that are affected by ischemic stroke: the irreversibly dam-
aged core, the potentially salvageable penumbra and the area
i
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of oligaemia [217]. While PET remains the best tool available,
a significant disadvantage is, that measurements can only be
performed at specific time-points. This is also true for (ar-
terial spin labeled perfusion) magnetic resonance imaging.
Continuous monitoring would be tremendous advantage in
clinical practice considering highly variable and dynamic neu-
rocritical patients. The study presented here demonstrates
that the above-mentioned parameters can be estimated con-
tinuously by hybrid diffuse optical methods in a non-invasive
manner and with an acceptable reliability. This technique of-
fers the clinicians as well as the scientific community a unique
and powerful tool to improve the understanding of the patho-
physiology of the acute injured brain. This tool has the poten-
tial to aid the clinicians in the design of therapeutic strategies
targeted to the hemodynamic profile of the at risk brain.
6.4.2 Cases without a significant correlation
The correlations vary among subjects (see Tables B.1, B.2,
B.3 and B.4). Table 6.3 shows a list of the non-significant
cases, their types of surgeries and the amount of data used
for the correlation analysis.
ID surgery type
NrCMRO2 NrCBF
step II step III step II step III
3 cholecystectomy 14 8 14 8
41 cholecystectomy 211 31 218 35
92 exploratory laparascopy 63 19 63 19
11 hemithyroidectomy 8 7 9 8
133 cholecystectomy 51 49 51 49
144 cholecystectomy 184 43 186 43
Table 6.3: Surgery and data information of the non-significant cor-
relation cases. The grey areas refer to excluded cases
after applying a threshold for N (see text). N = total num-
ber of used data points.
For rCMRO2 and rCBF the listed subjects show non-existence
of significant correlations with rBIS for either analysis step II
or III or both.
1 Case 4 is only significant in the third evaluation step.
2 Case 9 is only significant in the second evaluation step.
3 Case 13 is significant only for rCBF in the second evaluation step.
4 Case 14 is only significant in the third evaluation step.
i
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It is noteworthy, that in total five cholecystectomies were
performed throughout the entire study and four of these
surgeries appear in the cases listed in Table 6.3. These were
laparascopic surgeries and therefore similar to the procedure
in ID 9 and known to be able to provoke hyperemia in conse-
quence of elevated arterial partial pressure of carbon dioxide
(PaCO2) [324, 185, 144, 76, 118] caused by pneumoperitoneum
(abdominal insufflation with CO2). The effect of elevated ar-
terial partial pressure of carbon dioxide (hypercapnia) has
been discussed in Chapter 3 and is studied in Chapter 7 and
8 and could give one explanation for the absence of a signif-
icant correlation. Furthermore it was found earlier that cere-
bral oxygen metabolism can also change under hypercapnic
conditions [335, 34], yet not in consequence to the above-
mentioned pneumoperitoneum [324]. Moreover, the data
presented here was taken from intubated and controlled pa-
tients connected to a respiratory anesthesiamonitor to avoid
such alterations. By maintaining normocapnic conditions in
this manner the hyperemia effect is reduced and therefore
we expect a constant cerebral oxygenmetabolism is conserved
[178].
In cases without a significant correlation only a few data
points for the correlation calculation are available as a re-
sult of applying the criterion for steps II and III (see Table
6.3). Based on this, the data was examined using only those
cases with some minimum number of data points. This num-
ber is set to 60 in step II and 40 in step III, considering that
in step III the amount of usable data points is further re-
duced. Applying this criterion leads to non-consideration of
the grey marked subjects in Table 6.3. In step II, this results in
a slightly increased Rpearson of 0.48 (95 % conf. interval = 0.45
- 0.50) for rCMRO2 and 0.49 (95 % conf. interval = 0.46 - 0.51)
for rCBF. Additionally, in step III, further increased correlation
coefficients are calculated: 0.69 (95 % conf. interval = 0.66 -
0.72) for rCMRO2 and 0.70 (95 % conf. interval = 0.67 - 0.72)
for rCBF.
There are cases in the study population, which are not likely
to show significant correlations between rCMRO2/rCBF and
rBIS. This may be due to a data sets for specific cases, which
do not include sufficient points to ensure that the correlation
analysis is not compromised by noise. It is the short surgery
duration with many patient - and therefore probe - move-
ments that leads to the reduced size of these data sets. Appli-
i
i






122 HYBR ID D I F FUSE OPT ICS AS A MEASURE OF DEPTH OF ANESTHES IA
cation of the evaluation steps explained in Section 6.2.3 then
leads to further data exclusion. These criteria were defined
in order to remove periods of stable anesthesia and cerebral
activity and therefore noise correlation. Nonetheless, they
lead to very few data points in some patients making correla-
tion analysis unreliable. This problem could be addressed in
the future using improved probe attachments.
6.4.3 Confounding factors in optical data
In the estimation of CMRO2 based on optical data we have
to keep in mind that the detected light, has passed through
skin, skull and the cerebral spinal fluid (CSF) before it reaches
the frontal cortex. The resulting partial volume effects can
lead to underestimation of rOEF and rCBF [219, 140, 29, 116,
92, 299, 300, 298, 32]. Since rCMRO2 is derived from these
quantities (see Equation 3.8), the possible underestimation
translates to the calculated metabolism.
A homogeneous medium was assumed in the analysis of
DCS and TRS data. However, this assumption is not entirely
correct as the head consists of separate tissue layers with
different optical properties. The fraction of moving scatter-
ers (α) in each tissue layer may vary. The blood flow index
(BFI) is defined as the product of α times Db (see Equation
2.26), which means that variations in α will directly affect re-
ported BFI (see Chapter 2). Similarly, the oxygen extraction
fraction (OEF), calculated from TRSmeasurements can be un-
derestimated by not taking a multi-layered medium into con-
sideration. Both parameters, BFI and OEF are needed for the
calculation of CMRO2 (Equation 3.8) and possible underesti-
mations could bury some changes.
Apart from partial volume effects, an error might be intro-
duced due to a change in the contribution of arterial, venous
and capillary oxygen saturations (SaO2, SvO2 and ScO2, respec-
tively) to the measured tissue oxygen saturation (StO2) by the
hybrid device [219]. rCMRO2 was calculated using Equation
3.8 and considering that the blood volume percentage in ve-
nous compartment (γ) did not change. Since the data was
averaged over the entire surgery, γ could have changed, lead-
ing to an error according to Equation 3.9.
i
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6.5 CONCLUS ION
Hybrid diffuse optical data during general surgeries with
patients under general anesthesia with target-controlled in-
fusion of propofol was obtained. Cerebral metabolism and
blood flow (CMRO2 and CBF) calculated by a combination of
TRS and DCS correlate with BIS readings, which provide infor-
mation on the state of consciousness via EEGmeasurements
of the brain and are widely used in the clinic. This provides
the first comparison of non-invasively derived CMRO2 and
CBF by hybrid diffuse optics with the established BIS readings
and demonstrates the potential of diffuse optical techniques.
Diffuse optical techniques enable the continuous monitor-
ing of patient consciousness during surgical procedures con-
ducted under general anesthesia. The findings presented
here relate EEG measures to optically derived CMRO2 and
CBFmeasurements and allow the investigation of the physio-
logical coupling. The results presented here further support
previous studies showing that propofol-induced anesthesia
maintains physiological coupling between CMRO2 and CBF.
6.6 OUTLOOK
A logical next step would be to use the optical hybrid de-
vice in monitoring of neurocritical patients. This would allow
studying the hybrid device’s applicability in the classification
of the pathophysiology in patients who suffer acute brain
damage and could provide a promising non-invasive assess-
ment of cerebral hemodynamics and oxygenmetabolism and
could be used to guide the therapeutic management of these
patients. This may prove to be a powerful tool for optimiza-
tion and monitoring of specific patient treatments, thus im-
proving treatment effectiveness and outcome. In addition,
this tool would provide a unique opportunity to compare the
temporal profile of many sought-after variables not measur-
able to date by any single method and correlate them with



















RESP IRAT IONAL AND POSTURAL
EF FECTS ON CEREBRAL
HEMODYNAM ICS
In this chapter, we use the information presented in Chap-
ters 2 and 3 to investigate changes in microvascular cerebral
blood flow as a consequence of different arterial partial pres-
sures of carbon dioxide and oxygen brought on by changes in
inhaled gas contents in two different subject body positions.
These positions and alterations in partial pressures are used
and can occur in surgery under general anesthesia and may
lead to complications. Here, the DCS modality presented in
Chapter 4 is used in the clinical environment for the investiga-
tion of partial pressure and position influences on the brain’s
microvasculature in awake volunteers without brain disease.
This study is a result of a collaboration with Dr. Neus Fabre-
gas, Dr. Ricard Valero, Dr Enrique Carrero, Dr. Javier Tercero
and colleagues from the Anesthesiology Department at Hos-
pital Clínic in Barcelona.
7.1 BACKGROUND
The positioning of the patient may affect cerebral perfu-
sion pressure (CPP) and intracraneal pressure (ICP) via mean
arterial pressure (MAP) and indirectly alter cerebral blood flow
(CBF) (see Chapter 9). The alterations in the inclination of the
patient’s bed in the hospital are referred to as head-of-bed
(HOB) manoeuvres. Applications of HOB manoeuvres range
from improving brain health in traumatic brain injury (TBI)
and (ischemic) stroke patients to evaluation and investigation
of cerebral autoregulation (CAR) [23, 109, 171, 12, 170, 11, 97,
332, 274] and cerebrovascular resistance (CVR) health (see
Chapter 3). By raising the head above the heart level, the ar-
terial pressure is reduced and the venous drainage increased,
thus leading to a CBF decrease. In ischemic stroke (IS) pa-
tients one main goal is to maximize the cerebral perfusion,
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noeuvres are furthermore a common tool in the clinic to aid
the surgery.
In the clinical practice, the different positions and bed an-
gles range from head rotation, hyperextension, hyper- or lat-
eral flexion to position adjustments of the whole body, such
as supine (“dorsal decubitus”), lateral, (three-quarter) prone
and sitting (or “beach chair”) position [265]. The sitting po-
sition still remains controversial [121, 102, 119], but is widely
used [265, 102, 251, 86, 202] in several interventions, such as
shoulder surgery [291, 82], posterior fossa and cervical spine
surgery since it provides optimum access to midline lesions
[251]. It furthermore provides better cerebral venous decom-
pression and favors gravity drainage of blood and cerebral
spinal fluid (CSF), thus lowering ICP [121, 102, 251, 25] and is
therefore a useful tool in neurosurgery.
There are, however, higher incidence rates of complications
associatedwith general anesthesia in the sitting position, that
can alter arterial partial pressure of carbon dioxide (PaCO2)
and partial pressure of oxygen (PO2) and may indirectly af-
fect the brain [238, 225, 22, 281, 107, 213, 265, 137, 251, 86, 187,
236, 190, 338, 203, 139]. Furthermore, cerebral ischemia has
also been observed in relation to shoulder surgeries in sitting
position [237, 249].
From Chapter 3 we know that changes in the inhaled gas
contents alter CBF. Hyperoxia (HO), hypercapnia (HRC) and
hyperventilation (HV) and how these manoeuvres affect CBF
and indirectly challenge CAR were discussed [193, 52, 242,
278, 196, 154, 305, 336, 257, 96, 200, 322, 7, 309, 72, 48, 51,
296, 176, 88, 77, 61, 141, 289, 197, 297, 3, 24].
By altering the respiratory gas contents, such as inhaled
CO2 (InspCO2) and inhaled O2 (InspO2) or simply by changing
the respiration rate (RR), PaCO2 and PO2 change thus causing
vasoconstriction (HO, HV) or vasodilatation (HRC).
The interplay between the effects caused by HOB angle
change and the manipulation of PaCO2 and PO2 on the cere-
bral hemodynamics remains a field of interest as HO, HRC
and HVmay occur during surgical procedures in different po-
sitions. In fact, complications such as venous air embolism
(VAE) [238, 225, 22, 281, 107, 213, 86, 338, 203], paradoxical
air embolism, upper airway obstruction or pneumocephalus
i
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[137, 190] are associated with HO, HRC, HV [252, 291, 225, 107,
213, 251]. In anesthesized and intubated patients pulmonary
volume-controlled ventilation is used to account for periods
of HO or HRC. Nonetheless, these need to be identified first
and this is usually based on the analysis of the exhaled gas
mixture and its O2 and CO2 contents [55, 249]. The externally
controlled patient ventilation can futhermore lead to hyper-
ventilation (HV).
There are indications that near-infrared techniques may
help identify the complications mentioned above or could
provide an early warning sign [252, 225]. It is the existence of
complications and their increased incidence rates in the sit-
ting position that is worrisome. Although no increased mor-
tality rate has been reported [265], there is a need for a clear
understanding of influences of the sitting position on cere-
bral hemodynamics [82] and how these are affected in com-
bination with CBF alterations due to induced vasodilatation
and constriction.
Commercial devices, whichmake use of near-infrared spec-
troscopy (NIRS) as discussed in Section 2.1, have been uti-
lized to monitor cerebral regional oxygen saturation (SrO2) in
shoulder surgeries in the sitting position [155, 174, 182, 220,
80, 111]. The need for close non-invasive monitoring of cere-
bral hemodynamics in this scenario has been emphasized
earlier [214, 174]. The evolution of CBF has been examined
using transcraneal Doppler (TCD) observing no significant in-
fluence on CBF by the “beach chair” positioning [291].
These studies either use commercial NIRS devices, such
as the INVOS™ (Medtronic plc, IRL) or FORE-SIGHT™ monitor
(CASMedical Systems Inc., Branford, CT, USA), which both use
continuous wave near-infrared illumination for the measure-
ment of SO2 [219], or employ TCD, which only provides infor-
mation on the blood dynamics at themacrovascular level, for
cerebral blood flow velocity (CBFV) measurements.
A more advanced technique providing information on CBF
at the microvascular level is diffuse correlation spectroscopy
(DCS). A number of DCS measurements have reported the
above-mentioned relative CBF (rCBF) changes in response to
HOB procedures [90, 109, 171, 170, 98, 44, 97], but not in com-










128 RESP IRAT IONAL AND POSTURAL EF F ECTS ON CEREBRAL HEMODYNAM ICS
Recording macrovascular CBFV by TCD, which is associated
with CBF [327, 175, 73, 42, 24, 2] and microvascular CBF esti-
mated by DCS at the same time during the mentioned chal-
lenges is an approach to investigate CAR and more closely to
look at the regional hemodynamic implications of HO, HRC
and HV together with the subject’s positioning. By combin-
ing the investigation of CBF and CVR responses to the above-
mentioned respiratory challenges and their response from
the subject position we can look for possible differences in
the brain’s behaviour due to an already changed CBF and
therefore an alteration in the ability to regulate blood flow
by vasoconstriction or dilatation. The study presented here
aims to investigate microvascular cerebral blood flow (mCBF)
together withmacrovascular CBFV information and additional
physiological parameters, such as heart rate (HR), mean ar-
terial pressure (MAP), peripheral arterial oxygen saturation
(SpO2) and SrO2 upon position changes together with their re-
sponses to different respiratory challenges, such as hyper-
oxia (HO), hypercapnia (HRC) and hyperventilation (HV). To
that extent, the respiratory challenges were conducted in two
different positions (supine and 50° sitting (or “beach chair”)
position).
7.2 METHODS
Nineteen volunteers were recruited for this study. The in-
clusion criteria were absence of pathologies and no use of
any nervous system activator in the eight hours prior to the
measurement. Additionally, smokers were excluded. The
mentioned criteria and exclusion of two cases for protocol
elaboration purposes and a technical issue in additional two
cases led to the inclusion of fifteen healthy volunteers out
of the nineteen recruited ones. Each subject signed an in-
formed consent, which was approved by the ethical commit-
tee of Hospital Clínic in Barcelona (CEIC - Comité Ético de In-
vestigación Clínica del Hospital Clínic de Barcelona), as well as
all procedures and devices of this study. The measurements












The general health condition of the included volunteers
and global physiological parameters, such as HR, BPdia, BPsys,
and MAP were recorded by a Nexfin® device (BMEYE, Ams-
terdam, The Netherlands), which provided further measures,
such as cardiac output (CO), cardiac index (CI), stroke volume
(SV), stroke index (SI) and systemic vascular resistance (SVR).
In addition to SpO2 - provided by a standard pulseoximeter -
the SrO2 in leg and arm of the subjects was also monitored.
This data was taken with an INVOS™ device (Medtronic plc,
IRL), which employs infrared-light from a light emitting diode
(LED) at wavelengths of 730 and 810 nm to measure the pro-
portion betweenHbO2 and THC. The respiratory values (EtCO2,
InspCO2, InspO2 and exhaled O2 (ExpO2)) were recorded us-
ing an anesthesia monitor (Julian®, Dräger Medical GmbH,
Lübeck, Germany).
The CBFV (systolic and mean) measures were taken with a
TCD device (Intraview™, Rimed, Tel Aviv, Israel) for recordings
of hemodynamic changes in the macrovasculature. Based
on measured CBFVsys and CBFVmean information, the diastolic
cerebral blood flow velocity (CBFVdia) was calculated using the
relation:
CBFVdia =




Figures 7.1 and 7.2 illustrate the different procedures each
volunteer experienced in different two positions (50° sitting
and supine). Three challenges were used: hyperoxia (HO),
hypercapnia (HRC) and hyperventilation (HV). The initial po-
sition and challenge order was randomized. After one com-
plete set of challenges the subject’s position was changed.
The challenges were defined as follows (see also Figure 7.1):
Challenge I: Hyperoxia (HO)
5min pre-baseline, 3min challenge, 5min post-baseline
ExpO2 > 70 %
Challenge II: Hypercapnia (HRC)
5min pre-baseline, 2min challenge, 8min post-baseline
i
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CO2 concentration ∼ 6.8 - 8 %
O2 concentration ∼ 30 %
EtCO2 ↑ 20mmHg
Challenge III: Hyperventilation (HV)
5min pre-baseline, 1min challenge, 5min post-baseline
Metronome rate ∼ 40min-1
EtCO2 ↓ 15mmHg
For the HO challenge the subjects were asked inhale pure
O2. Once their exhaled O2 (ExpO2) rose beyond 70% the pa-
tient was considered to be hyperoxic and the mask was kept
in place for another three minutes. In total, each subject un-
derwent two hyperoxias, one in a 50° sitting position and one
in supine position, while the order of these positions was ran-
dom between subjects. In a similar manner, each subject
performed a HRC maneuver in two positions for two min-
utes each after they started inhaling an increased content
of CO2 (6.8 - 8 %; see also Figure 7.1 and 7.3) and their EtCO2
increased by at least 20 mmHg. In the illustration in Figure
7.3, we see the white bag, which has a gas mixture of 6.8 - 8
% CO2, in the back. This gas mixture reaches the volunteer
through a plastic tube and a mouthpiece. As above, there
was one HRC in a 50° sitting position whereas for a second
one the subject was placed in supine position. The order of
these positions was randomized for each subject.
In the same randomized way, each subject underwent aHV
challenge in both mentioned positions. Here a metronome
was held in front of the volunteer and the challenge lasted
for one minute after the EtCO2 dropped at least 15 mmHg.
All challenges had a preceding baseline of five min and were
concluded by a recovery period which lasted another five
min, except for the HRC case, where the recovery time was
set to eight min.
In addition to the challenge protocols (see Figure 7.2), each
subject’s position was changed in a defined manner prior to
the challenge protocol (supine : 50° : supine : 30° : legs at
45°; see Figure 7.2). After the complete set of challenges, the
entire procedure was concluded with an additional baseline
in supine position followed by the subject standing up, both
for a duration of five minutes (see Figure 7.2).
i
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Figure 7.1: Challenge protocols: Hyperoxia required an exhaled O2
(ExpO2) content of > 70 % and lasted for 3 min. Hy-
percapnia required an increase of end-tidal CO2 (EtCO2)
by at least 20 mmHg and hyperventilation an EtCO2 de-











Study start Study end
Figure 7.2: Start sequence: The different positions were kept for
a duration of five minutes except for the 30° and legs
at 45° positions, which lasted three minutes; End se-
quence: The procedure consisted of a supine baseline
for fiveminutes followed by the subject standing for five
minutes.
7.2.3 Diffuse optical device
A custom-built research DCS system (one part of the hy-
brid device presented in Chapter 4) monitored the microvas-
culatury CBF changes via fiber probes placed on the subject’s
frontal lobes. The source-detector separation (ρ) was 25mm
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source
detector
gas mixture bag  












ρ = 25 mm
Figure 7.3: Diffuse optics headprobe for respiratory challenges: Im-
age was taken during theHRC procedure. CO2 bag with
a gas mixture of 6.8 - 8 % CO2 content is seen in the
back.
Figure 7.3 shows the headstrap with the incorporated 90°
fiber tips schematically together with the holder for the TCD
probes. As presented in Chapter 4, the laser were operating
at a wavelength of light (λ) of 785 nm and light was sent to
the tissue through a multimode fiber with a core diameter of
200 µm (NA = 0.22). A a set of four single mode fibers (core di-
ameter of 5.6 µm; NA = 0.13), each one connected to a single-
photon counting avalanche photodiode (Excelitas, Québec,
Canada) collected the light and the signal was processed in
real-time by a digital correlator (Correlator.com, New Jersey,
USA), which calculated the normalized intensity autocorrela-
tion function (g2) from intensity fluctuations in the recorded
light.
7.2.4 Data analysis
Non-valid challenges were not considered. For example, if
a subject could not withstand the 120 second duration of a
hypercapnia the data was discarded. For the detailed defini-
tions of challenge durations and further parameters please
refer to Section 7.1.
Based on the calculated the intensity autocorrelations for
different delay times g2(τ) information on the tissue dynam-
i
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ics, i. e. relative cerebral blood flow (rCBF), was computed.
The semi-infinite homogeneous medium solution of the cor-
relation diffusion equation as described in Section 2.3.3 was
used in the fitting procedure.
Derivation of the normalized electrical field autocorrelation
function (g1) from g2 after the determination of the mode pa-
rameter (β) is done via the Siegert relation g2 = (1 + β g1)1/2 [183]
(see also Section 2.6). Using the “fminsearch” function (based
on the Nelder-Meadmethod) withinMATLAB (TheMathWorks
Inc., Natick, MA, USA) [179, 226] and setting <∆r2(τ)> to 6 Db
τ, we have fitted the semi - infinite medium solution of the
diffusion approximation [94] to our g1 derived from the mea-
surement, as described in Section 2.3.3. The result was con-
verted to ameasure of relative cerebral blood flow (rCBF) with
respect to a baseline (see Section 7.2).
All reported values reflect the respective mean plus minus
the standard errors - unless stated otherwise - and the entire
statistical analysis was carried out in the statistical software
package R [255]. As the primary method for statistical sig-
nificant influences linear mixed effects (LME) models (“nLME”
[244] package in R) were used. Fitted LME models which
did not differ significantly from the null model were rejected.
The recorded variables were tested for statistical significance
among their relative and absolute changes with respect to
each challenge’s baseline by a Mann-Whitney-Wilcoxon test.
The DCS measures of cerebral blood flow on the microvas-
cular level were checked for correlations with the TCD mea-
sures, which are related to CBF on the macrovascular level
(Spearman rank correlation test). In all models and statistical
tests, “p-values” of less than 0.05were considered statistically
significant, enabling rejection of the null hypothesis.
7.3 RESULTS
Fifteen patients (five females and 10 males) were included
in the study population. Their average age, height, weight
and body mass index (BMI) is presented in Table 7.1 for the
study population as a whole and is separated by gender.
Bilaterally collected CBF data - acquired by DCS - was anal-
ysed and averaged over both hemispheres for each subject,
i
i






134 RESP IRAT IONAL AND POSTURAL EF F ECTS ON CEREBRAL HEMODYNAM ICS
Age* [yrs] Weight* [kg] Height* [cm] BMI* [kg/m2]
All 32.5 ± 6.3 72.2 ± 11.3 173.7 ± 8.6 23.8 ± 2.3
Females 28.4 ± 2.3 61.2 ± 9.3 166.6 ± 7.5 21.9 ± 1.8
Males 34.6 ± 6.7 77.7 ± 7.6 177.3 ± 6.8 24.7 ± 2.0
Table 7.1: Demographic parameters: The demographic parameters
of the population given as mean ± their standard devi-
ation. * denotes a statistically significant difference be-
tween females and males (t-test, p < 0.05).
since no statistical significant differences between brain hemi-
spheres was observed (LMEmodel with hemisphere as a fac-
tor; p > 0.05).
7.3.1 Study start and study end procedure
The procedure was the same for all subjects. The supine
position is used as a baseline and all values for the following
positions reflect the changes with respect to this initial base-
line. The results are shown in Figure 7.4, where the baseline
is represented by the black dashed lines.
Plotted in Figure 7.4 are the relative microvascular cere-
bral blood flow rCBF and macrovascular cerebral blood flow
velocity (rCBFVmean, CBFVdia and rCBFVsys) changes with one
boxplot per position and variable. The four boxes to the left
of the grey dashed line correspond to the posture changes
at the beginning of the study (supine : 50° : supine : 30°
: legs at 45°), while the box on the right shows the results
of the “study end” procedure (supine : standing; see Figure
7.2). Additional parameters, ∆HR, ∆MAP, ∆SpO2, ∆SV, ∆CO
and ∆SrO2 are shown in Figure C.2.
Changes with positions show that rCBF and rCBFV have sim-
ilar tendencies. The rCBF changes in the 50°, supine, legs at
45° as well as the right after standing up differ significantly (p
< 0.001) from the baseline (initial supine position; see Figure
7.2). The same holds for all CBFV changes when the volun-
teers stood up (p <0.05), as well as for the CBFVsys in the 50°
position (p < 0.001).
i
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Figure 7.4: Posture changes in the beginning and the end - sepa-
rated by a dashed grey line - of each case. The changes
correspond to the protocols presented in Figure 7.2
and the abbreviations read as follows: rCBF = relative
microvascular cerebral blood flow change; rCBFVmean,
rCBFVdia and rCBFVsys = mean, systolic and diastolic
blood flow velocity changes. Statistically significant
changes (p < 0.05) are marked by *. The dashed lines
refer to the baseline taken from each initial supine posi-
tion values for the beginning and the end of each case.
7.3.2 Respiratory challenges
The validity criterion explained in Section 7.2.4 reduced the
data sets for the HRC challenge to eleven in the 50° sitting
position and twelve for the supine position, while HV and HO
data sets are complete.
Representative responses to the respiratory challenges are
shown in Figure 7.5.
Each challenge in each position shows statistically signifi-
cant (p < 0.05) changes in rCBF (Table 7.2), with respect to the
5 min baseline prior to the challenge. This is true for both
cases:
Case I: no position distinction
Case II: separating supine and 50° position
Microvascular responses to the HO and HRC challenges
show the same tendency in both positions, i. e. CBF either
i
i
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Hyperoxia
























































































































































































Figure 7.5: Respiratory challenge responses in two positions: The
top graphs show the hyperoxia (HO) challenge, the mid-
dle graph the hypercapnia (HRC) challenge and the bot-
tom one refers to the hyperventilation (HV). The left
graphs correspond to the results from the supine, the
ones on the right side to the 50° sitting position. Blue
shows the rCBF evolution over time with their standard
deviations in light blue and green lines represent the
ExpO2 (for the HO challenge) or EtCO2 (in the HRC and
HV case).
decreases (HO) or increases (HRC).
A LME mean model and a LME position model was em-
ployed in each challenge and fitted to the valid microvascular
rCBF data (see Section 7.2.4). These models fitted a microvas-
cular CBF response during HO showed of ∼ 9 % decrease
(rCBFsupine = -9.26 ± 2.53; rCBF50° = -9.11 ± 3.49; rCBFglobal = -
9.18 ± 1.80). In the HRC challenge, the rCBF increases range
from 48.71 ± 9.98% (rCBFsupine) to 63.70 ± 12.24% (rCBF50°) de-
pending on the position. Without position separation we ob-
tain a rCBF increase of rCBFglobal = 55.85 ± 8.03%. In response
i
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rCBFHO [%] -9.26 ± 2.53 -9.11 ± 3.49 -9.18 ± 1.80
rCBFHRC [%] 48.71 ± 9.98 63.70 ± 12.24 55.85 ± 8.03
rCBFHV [%] -4.29 ± 4.23 5.40 ± 5.78 0.56 ± 3.39
Table 7.2: Mean relative cerebral blood flow (rCBF) response, their
standard errors and statistical significances for each chal-
lenge. The changes are statistically significant (p < 0.05)
and calculated with respect to each challenge’s baseline.
to HV we obtain small rCBF changes when not separating be-
tween positions (rCBFglobal = 0.56 ± 3.39), but a rCBF decrease
in the supine position (rCBFsupine = -4.29 ± 4.23) and increas-
ing rCBF in the 50° position (rCBF
50°
= 5.40 ± 5.78). No LME po-


























sup 50 sup 50
Position
*
Figure 7.6: Responses to the hyperoxia challenge in two positions:
Microvascular rCBF and macrovascular CBFV (mean, di-
astolic and systolic) change in response to inhalation of
100% O2. The baseline is marked by the black dashed
line. rCBFVmean is statistically significantly (p < 0.05) dif-
ferent between positions (marked by *).
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Hypercapnia




















sup 50 sup 50
Position
Figure 7.7: Challenge responses to hypercapnia in two positions:
Microvascular rCBF and macrovascular CBFV (mean,
diastolic and systolic) change during increased EtCO2
(∆EtCO2 = +20mmHg) in response to inhalation of a gas
mixture with an increasedCO2 content (∼ 6.8 - 8%). The
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Figure 7.8: Challenge responses to hyperventilation in two posi-
tions: Microvascular rCBF and macrovascular CBFV
(mean, diastolic and systolic) change during increased
RR and therefore decreased EtCO2 (∆EtCO2 = -15











7.3.2.1 Macro- and microvascular hemodynamics
Based on a Spearman correlation test1 between microvas-
cular rCBF - estimated by DCS - and macrovascular CBFV -
retrieved from TCD - we find, no significant correlations be-
tween microvascular CBF and macrovascular CBFVmean and
CBFVdia measures, neither in the supine nor the 50° posi-
tion. Moreover, the macrovascular CBFVsys change was not
significantly correlated with the microvascular CBF response
during HO and HV nor was HRC in the 50° sitting position.
In contrast, CBF in the microvasculature is significantly corre-
lated with the macrovascular CBFVsys in supine position dur-
ing HRC (Rspearman = -0.65; p = 0.01).
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7.3.2.2 Challenges in detail
HYPEROX IA Here we look in more detail at the response
of other parameters during HO. In Section 7.3.2 and 7.9, we
saw the changes of CBF in the microvasculature and CBFV
(mean, diastolic and systolic) in the macrovasculature. In this
section, we add the ∆ExpO2, ∆HR, ∆MAP, ∆SpO2, ∆SV, ∆CO
and ∆SrO2 measures from the arm and look at their absolute
changes during theHOmaneuver. These parameters in both
positions are shown in Figure 7.9. Values cited in the text rep-
resent median ± inter-quartile range (IQR).
Hyperoxia
rCBF [%] rCBFVmean [%] ΔExpO2 [%]
ΔHR [bpm] ΔMAP [mmHg] ΔSpO2 [%]














































































Figure 7.9: Hyperoxia data per position: Relative microvascular
cerebral blood flow (rCBF) and macrovascular cerebral
blood flow velocity (rCBFVsys and rCBFVmean) changes
and absolute changes of heart rate (HR), mean arte-
rial pressure (MAP), peripheral arterial oxygen satura-
tion (SpO2), exhaled O2 (ExpO2), stroke volume (SV) and
cardiac output (CO). Statistically significant changes
(Mann-Whitney-Wilcoxon test, p < 0.05) in each position
are marked by *. The baseline is marked by the black
dashed line. rCBFVmean is statistically significantly (LME
position model, p < 0.05) different between positions
(marked by * in red).
We see that ExpO2 increased significantly (p < 0.001) with
a ∆ExpO2, supine = 64.2 (7.2) % and ∆ExpO2, 50° = 64.7 (8.0) %
i
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so that the following total ExpO2 were achieved: ExpO2, supine
= 80.2 (5.5) % and ExpO2, 50° = 78.5 (8.0) %. The rCBF and
rCBFVmean values set to rCBFsupine = -9.1 (13.5) %, rCBF, 50° = -8.0
(14.7) % and rCBFVmean, supine = -7.6 (16.7) % and rCBFVmean, 50°
= -2.9 (22.5) %, respectively. While CBF changed in both po-
sitions significantly (p < 0.01), the TCD-recorded CBFVmean de-
creased significantly only the supine position (p < 0.01). De-
creases in HR and CO were significant in the 50° position (p <
0.01), as wereMAP increases in the supine position (p < 0.001).
The oxygen saturations acquired by a standard pulseoxime-
ter placed on one finger and the INVOS® device with one
sensor one the subject’s arm (see Section 7.2.1) increased by
∆SpO2, supine = 2.0 (1.7) %, ∆SpO2, 50° = 2.0 (1.0) %, ∆SrO2, supine
= 1.2 (0.9) % and ∆SrO2, 50° = 0.9 (1.2) %, respectively. The SpO2
changes were statistically significantly different from the base-
line in both positions (p < 0.001), whereas only the SrO2, which
was recorded by the INVOS® device, changed significantly
only in the supine position (p < 0.01).
According to the LME position model as used in Section
7.3.2 the CBFVmean response to the HO challenge has a statis-
tically significant dependence on the positioning of the vol-
unteer (p = 0.03, rCBFVmean, supine = -12.2 ± 3.7 % compared to
rCBFV
mean, 50°
= -3.4 ± 3.4%; fitted value ± standard error). All
other changes showed no significant position dependencies.
As a result of a Spearman correlation test of rCBFwith other
variables2, such as the relative cerebral blood flow velocity
changes (rCBFVmean, rCBFVdia and rCBFVdia) and the absolute
changes of HR, MAP, SpO2, ExpO2, SV and CO, we find that
the rCBF changes correlate significantly in the supine position
with ∆HR (Spearman’s rank correlation coefficient (Rspearman) =
0.64, p = 0.01), SV (Rspearman = 0.67, p < 0.01) and CO (Rspearman
= 0.68, p < 0.01), while none of the other above-mentioned
parameters revealed statistically significant correlations with
rCBF.
HYPERCAPN IA The obtained relative and absolute changes
of recorded and relevant parameters during this challenge
are shown in Figure 7.10. Please note that only data from
subjects that underwent the entire 2 minute challenge, was
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Figure 7.10: Hypercapnia data per position: Relative microvascular
cerebral blood flow (rCBF) and macrovascular cerebral
blood flow velocity changes (rCBFVsys and rCBFVmean)
and absolute changes of heart rate (HR), mean arterial
pressure (MAP), peripheral arterial oxygen saturation
(SpO2), end-tidal CO2 (EtCO2), stroke volume (SV) and
cardiac output (CO). Statistically significant changes
(Mann-Whitney-Wilcoxon test, p < 0.05) in each posi-
tion are marked by *. The baseline is marked by the
black dashed line.
In this challenge, EtCO2 increased significantly (p < 0.01) with
∆EtCO2, supine = 30.9 (12.1) mmHg and ∆EtCO2, 50° = 27.1 (6.1)
mmHg. The relative CBF showed significant (p < 0.001) in-
creases (rCBFsupine = 49.9 (32.9) %, rCBF50° = 78.0 (65.6) %).
The relative CBFVmean in supine (rCBFVmean = 42.0 (55.7) %) and
50° sitting position (rCBFVmean = 60.2 (37.7) %) increased sig-
nificantly (p < 0.01) as well. Furthermore, a significant (p <
0.001) increase of MAP with ∆MAPsupine = 12.2 (10.5) mmHg
and ∆MAP
50°
= 17.5 (13.3) mmHg was recorded, as well as
decreases in SV with ∆SVsupine = -5.6 (4.2) ml and ∆SV50° = -
4.7 (3.7) ml. The latter decrease was statically significant (p
= 0.03). HR and CO did not show significant changes (p >
0.05) in none of the positions. The oxygen saturations ac-
i
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quired by a standard pulseoximeter placed on one finger in-
creased significantly (p < 0.01) with ∆SpO2, supine = 1.9 (1.5) %
and ∆SpO2, 50° = 1.6 (0.8) %, while the ones acquired by the
INVOS® device with one sensor on the subject’s arm (see
Section 7.2.1) decreased with ∆SrO2, supine = -0.9 (1.6) % and
∆SrO2, 50° = -0.1 (1.3) %. According to aMann-Whitney-Wilcoxon
test, the change in the supine position was statistically signif-
icant (p = 0.02)
As in Section 7.3.2, we employed a LME position model on
these variables and found no significant position dependen-
cies. We also performed a Spearman rank correlation test3.
As mentioned above, there is a significant correlation in our
data between the rCBF change and the CBFVsys change in
the supine position (Rspearman = -0.65, p = 0.03). In the 50°
position, there is a significant correlation between rCBF and
∆MAP (Rspearman = 0.75, p = 0.01).
HYPERVENT I LAT ION Figure 7.11 shows the relative and ab-
solute changes of relevant parameters during the oneminute
long challenge described in Section 7.2.
In this challenge EtCO2 increased significantly (p < 0.001)
with ∆EtCO2, supine = 16.6 (2.4) mmHg and ∆EtCO2, 50° = 16.2
(3.7) mmHg. The relative CBF shows positive and negative
changes (rCBFsupine = -4.0 (7.0) % and rCBF50° = 0.5 (25.5) %).
Macrovascular relative CBFVmean decreases significantly (p <
0.01) in both positions with rCBFVmean, supine = -40.9 (12.1) %
and rCBFVmean, 50° = -32.9 (21.8) %. A significant (p < 0.001) HR
increase with ∆HRsupine = 17.9 (13.6) bpm and ∆HR50° = 17.5
(9.7) bpm was observed. Furthermore, a significant (p = 0.03)
decrease of MAP in the supine position with ∆MAPsupine = -
2.2 (12.1) mmHg and a decrease of ∆MAP
50°
= -4.4 (9.4) mmHg
in the 50° position. Also, significant (p < 0.001) increases in
CO with 1.5 (1.3) l/min (supine) and 1.8 (0.8) l/min (50°) were
observed. The oxygen saturations acquired using a standard
pulseoximeter placed on one finger increased signifcantly (p
< 0.001) with ∆SpO2, supine = 1.7 (1.4) % and ∆SpO2, 50° = 1.9 (1.1)
%, as well as those acquired with one sensor on the subject’s
arm (INVOS®, see Section 7.2.1), which also increased signifi-
cantly (p < 0.01) with ∆SrO2, supine = 1.2 (1.2) % and ∆SrO2, 50° =
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Figure 7.11: Hyperventilation data per position: Relative microvas-
cular cerebral blood flow (rCBF) and macrovascular
cerebral blood flow velocity changes (rCBFVsys and
rCBFVmean) and absolute changes of heart rate (HR),
mean arterial pressure (MAP), peripheral arterial oxy-
gen saturation (SpO2), end-tidal CO2 (EtCO2), stroke vol-
ume (SV) and cardiac output (CO). Statistically signifi-
cant changes (Mann-Whitney-Wilcoxon test, p < 0.05) in
each position are marked by *. The baseline is marked
by the black dashed line.
4.7 (2.8) %.
After fitting a LME model with the position factor, we ob-
tain no significant position dependencies.
A Spearman rank correlation test was also conducted4. In
HV, changes of microvascular CBF in the supine position cor-
relate significantly with ∆MAP (Rspearman = 0.67, p < 0.01) and
∆EtCO2 (Rspearman = 0.57, p = 0.03). In the 50° position, we
found correlations of rCBF with rCBFVmean (Rspearman = 0.57, p =
0.04).
4 for tabulated results of the correlation test for the HV challenge please
refer to Tables C.5 and C.6
i
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7.4 D ISCUSS ION
Opticallymeasured cerebral blood flow (CBF) responses due
to hyperoxia (HO) and hypercapnia (HRC) compare to simi-
lar measurements collected using (functional) magnetic res-
onance imaging (MRI) [336, 47, 176, 326, 46, 96, 160], arterial
spin labeled perfusionmagnetic resonance imaging (ASL-MRI)
[342] and positron emission tomography (PET) [151, 263]. Here
a number of aspects of the data presented above are exam-
ined more closely. We start with the bare position changes
in the beginning and end of the study. These served as qual-
ity check on the brain’s response. The protocol and how the
desired conditions could be achieved andmaintained are dis-
cussed and we also focus on the micro- and macrovascular
levels and the respiratory challenges in detail. Finally, the
postural effect on the manoeuver response are discussed.
7.4.1 Study start and end procedures
The responses to the initial position changes (see Section
7.3.1) were observed as expected, thus providing a valid check
for the CBF changes observed in the respiratory challenges
(Section 7.3.2). A decrease of rCBF in healthy subjects with
increasing the HOB angle has been previously observed and
reported [171, 170].
7.4.2 Challenge validity
All challenges in both positions met the criteria defined in
Section 7.2. This is expected as the presented values are a re-
sult of an average of the challenge taken over its respective
duration once the specific challenge criterion (increase or de-
creased EtCO2 or ExpO2) has been met. The fact that all aver-
age values are in accordance with the defined criteria shows
that the desired conditions could bemaintained over the nec-
essary durations. This serves as an additional positive valid-
ity check. Moreover, four (50° position) and three (supine po-
sition) data sets from subjects undergoing theHRC challenge
had to be excluded due to the subject not withstanding the
manoeuvre for the desired period of 2min. This is a notable
number considering the total of fifteen volunteers and has
to be kept in mind when looking at the HRC data.
i
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7.4.3 Micro- and macrovascular levels
Mirco- and macrovasculature correlate only in the supine
position during HRC (Rspearman = -0.65). In this case, CBF mea-
sured at the microvascular level and CBFV recordings from
the macrovessels show increases of comparable nature. Ac-
cordingly, a possible correlation between rCBF and CBFVsys
might be expected from the boxes plotted in Figure 7.10 but
the negative correlation in this case seems surprising. The
other respiratory challenges did not show any significant cor-
relations between the two vascular levels. The fact that no
significant positive correlation was found, could reveal that
the blood vessel’s in the brain may respond differently de-
pending on the vasculatory level.
7.4.4 Hypercapnia
Due to the strongHRCwith a CO2 concentration of 6.8 - 8%
the rCBF changes are much larger than in the HO or HV case
(rCBFsupine = 45.49 ± 8.99% compared to rCBF50° 65.03 ± 12.86
%). A similar tendency is seen at the macrovascular level
(rCBFVmean, supine = 42.0 (55.7) % compared to rCBFVmean, 50° =
60.2 (37.7) %), yet this difference is not significant. This could
be related to the large IQR and may at least indicate a dif-
ference in response to hypercapnic conditions depending on
the two investigated positions. In general, a CBF increase is
expected since HRC increases the arterial partial pressure of
carbon dioxide which leads the vessels to dilate (see Chap-
ter 3) [181, 166, 165]. The increases in EtCO2 levels show that
the desired hypercapnic conditions could be maintained well
during the HRC duration.
Readings from pulse oximetry can be influenced by alter-
ations in the arterial partial pressure of carbon dioxide, lead-
ing to an impairment between peripheral arterial and the ac-
tual arterial oxygen saturation, especially during hypercap-
nia [218]. On the other hand, the Bohr effect, as discussed
in Chapter 3, influences the oxygen-hemoglobin dissociation
due to a lower pH value in hypercapnic conditions. Further-
more, the SpO2 increase seems surprising compared to the
small, non-significant changes around the baseline of SrO2 in
the 50° position or even the statistically significant SrO2 de-
crease in the supine position. The latter significance is likely
i
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to be produced by an outlier, resulting in a median close to
the lower quartile and thus a significant SrO2 change in the
supine position. The INVOS™ device used for the recording
of SrO2 employs the same principles of absorption in near-
infrared spectroscopy as presented in Chapter 2 and is us-
ing continuous wave light (see also Section 1.2). It is there-
fore important to keep in mind, that, while both parameters
(SpO2 and SrO2) express oxygen saturation, SpO2 provides in-
formation about the arterial oxygen saturation and SrO2 is a
measurement of the regional tissue oxygenation. The latter
is therefore the result of a mixture of arterial, capillary and
venous oxygen saturation, similar to the tissue oxygen sat-
uration retrieved from the hybrid device presented in Chap-
ter 45. The differences between the recorded SpO2 and SrO2
therefore point towards a possible change in the transfer
constants k1, k2 and k3, e. g. changes in the blood volume
percentages in the different compartments (arterial, capillary
and venous).
The increased blood pressure and heart rate (HR) readings
during hypercapnia are expected [96, 166]. The latter - in
combination with the stroke volume changes - explains the
non-significant changes in the cardiac output. Nonetheless,
the fact that theHR changes are non-significant and no signif-
icant cardiac output increases were seen on average is not ex-
pected. During hypercapnia the body tries to compensate for
the increased CO2 content in the inhaled air by incrementing
the heart’s activity, e. g. increased cardiac output [168]. The
fact that the heart rate and cardiac output changes are non-
significant is not surprising since these readings - together
with the stroke volume - were all recorded with the same
Nexfin® device.
To address this further the presentedHR readings are com-
pared with the ones obtained from ECG data in Figure 7.12.
Although these readings show slight differences, e. g. a me-
dian HR decrease in the 50° position, these changes are not
statistically significant with respect to the baseline and the
IQRs are overlapping between both devices. In total, the HR
averages support each other.
5 Please refer also to Section 3.2.4 and [70] for further details.
i
i





























0.3 (7.2) −2.2 (6.6)3.0 (11.3) 1.9 (5.2)
Figure 7.12: Heart rate changes during hypercapnia in two subject
positions taken with the Nexfin® device and from ECG
recordings. The baseline is marked by the black dashed
line.
7.4.5 Hyperventilation
The rCBF values in both positions increase in response to
HV. The challenges in both positions were valid for all sub-
jects, maintaining the EtCO2 below the desired individual drop
of 15 mmHg throughout the challenge. This supports the
validity of the acquired data from the physiological point of
view. The data does not point towards a significant position
influence in this manoeuver. Nonetheless, it is noteworthy,
that the supine value (rCBFsupine = 8.01 ± 6.75%) is only half of
the recorded rCBF at 50° (rCBF
50°
15.20 ± 8.56%). There might
still be a position dependence in HV, but due to its observed
adverse effect on the rCBF and the rather strong variation in
readings, this could be unobservable in this population.
The increased HR during HV, observable in both positions,
leads to an increased CO, while maintaining the SV around
the baseline values. The HR increase might furthermore indi-
cate a possible exercising condition for the volunteer related
to the active hyperventilation they were asked to carry out.
Changes in the HR as recorded by ECG do not show sta-
tistically significant changes with respect to the baseline, as
such these readings do not support the exercising hypothe-
sis. Nonetheless, on an individual subject basis HR increases
are seen as well, which might still show a subject-dependent
response to the active hyperventilation.
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1.5 (13.1) −0.1 (7.7)17.9 (13.6) 17.5 (9.7)
Figure 7.13: Heart rate changes during hyperventilation in two sub-
ject positions taken with the Nexfin® device and from
ECG recordings. The baseline is marked by the black
dashed line.
The observable slight increases in both oxygen saturation
values (SpO2 and SrO2, arm) are intelligible by a shift in the
oxygen-hemoglobin dissociation curve to the left, as it was
described in Chapter 3. The blood’s pH increases due to the
lower PaCO2 leading to the mentioned shift. In consequence,
higher oxygen saturation levels can be reached.
We do not expect to see an increase in CBF in response to
HV, as the reduced arterial partial pressure of carbon diox-
ide (PaCO2), which is intended by this challenge, leads to vaso-
constriction [305, 257, 48, 343, 256, 130, 181]. A condition un-
der which PaCO2 is reduced is also referred to as hypocapnia
- as opposed to HRC - and is provoked by HV. Differences be-
tween active and passiveHVwere observed previously, show-
ing stronger CBF decreases when the volunteer performed a
passive HV [165]. The data acquired according to the mea-
surement protocol for HV of this study is either the result of
a hypocapnia and an additional effect, such as imposed exer-
cise, which causes CBF to increase in some cases or subject to
motion or activation artefacts induced by head movements
or increased concentration of the volunteer to correctly ex-
ecute the manoeuver. Such effects on the hypocapnic CBF
might explain the above-mentioned differences between ac-
tively and passively conducted HV and have been discussed
previously [150, 176]. For these aspects please refer to Chap-
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It shall be noted, that there are indications of CBF increases
being related to a non-intact coupling between PaCO2 in the
body and in the brain [108]. Previous data obtained with a
combined NIRS/US device for non-invasive monitoring of the
capillary oxygen saturation and CBF (CerOx®, Ornim Medical
Ltd, Israel) also revealed an increasing CBF during HV [193].
7.4.6 Hyperoxia
The CBF changes in the microvasculature during HO are
similar between positions (rCBFsupine = -9.98 ± 2.17 % com-
pared to rCBF
50°
= -9.24 ± 2.79) and do not indicate any po-
sition dependence. The statistically significant difference for
CBFVmean between the supine and 50° position in response to
HO is likely to be caused by the subjects with a CBFVmean in-
crease in the 50° sitting position. This is surprising, but might
be related to the operator dependence of TCD, i. e. the cor-
rect placement of the probe at the insonation window and
the angle the ultrasound waves enter the tissue. In conse-
quence, this might also explain the non-existence of signifi-
cant correlations between micro- and macrovasculature, i. e.
rCBF and relative CBFV. In general, a CBF decreasing effect
in HO caused by a direct vasoconstricting effect of the partial
pressure of oxygen and an indirect one caused by the altered
arterial partial pressure of carbon dioxide [176] due to an in-
creased InspO2 is expected and was discussed in Sections 3.1
and 3.2.3.
High O2 levels could be reached as confirmed by the sig-
nificant changes in ExpO2. Non-significant SV changes are
expected due to the non-exercising nature compared to the
other two respiratory manoeuvres. In fact, the heart rate in
50° even decreases significantly during hyperoxia, illustrating
the relaxing effect of this manoeuvre. The peripheral arte-
rial oxygen saturation (SpO2) increases significantly in both
positions as does the regional oxygen saturation (SrO2) in the
supine position, which is directly related to the increased PO2
as seen in the oxygen-hemoglobin dissociation curve (3.2).
Moreover, SrO2 in the 50° position increased in response to
hyperoxia, although this was not statistically significant.
i
i






7.5 CONCLUS ION 151
7.4.7 Effect of subject positioning
Notable differences between positions in response to the
respiratory challenges were seen, however these differences
were not statistically significant. It is likely that the sitting po-
sition is not a confounding factor in these awake volunteers,
however, this can not be concluded definitively. This is note-
worthy since the complications associated with general anes-
thesia in the sitting position, which have been reported can
cause the alteration in the partial pressure of oxygen and CO2.
This suggests that the reported increased incidence rates of
venous air embolism (VAE), upper airway obstruction or para-
doxical air embolism associated with general anesthesia in
the sitting position [238, 22, 281, 137, 86, 338, 190, 203] can
not be explained by the bare usage of the respiratory ma-
noeuvres presented here. A possible explanation could be
combination of these manoeuvres with general anesthesia.
7.5 CONCLUS ION
Although the fittedmean responses toHRC andHV appear
to be different in each position, no significant influences of
position on the CBF response toHO, HRC andHVwere found.
This would mean, that the bare effect of change in arterial
partial pressure of carbon dioxide and/or oxygen is stronger
than any influence induced by position.
This chapter has shown that an optical device is able to
measure CBF changes due to position changes and manoeu-
vers, that these compare to previous findings and that sub-
ject positioning in unanesthesized subjects does not seem
to have an effect, although we know that head-of-bed posi-
tion affects CBF. The results from the HV challenges showing
some CBF increases require further investigation (see Chap-
ter 8). However, it is worth noting that other studies have
found positive rCBF changes during hyperventilation [193, 108].
It is possible that conducting the same study with subjects
under general anesthesia and pulmonary volume-controlled
ventilation would reveal a significant position dependence on
CBF. Information on brain metabolism would provide further
insight on the underlying physiology and in Chapter 6, we
have shown that brain metabolism (CMRO2) during general
anesthesia can be estimated by the presented hybrid device.
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HYPERVENT I LAT ION
In Chapter 7we used diffuse correlation spectroscopy (DCS)
to measure cerebral blood flow (CBF) and saw different rCBF
responses to the hyperventilation (HV) challenge. There are
some subjects, which respond in the expected way with a de-
crease in relative cerebral blood flow (rCBF), and other sub-
jects whose response is just the opposite, a rCBF increase. It
appears that there are two subgroups in our subject popu-
lation, “positive” and “negative” responders. In this chapter
this phenomena will be further investigated by comparing
the rCBF results to the cerebral blood flow velocity (CBFV) ob-
tained using transcraneal Doppler (TCD) and presenting data
from sixteen additional subjects who underwent a hyperven-
tilation (HV) challenge.
8.0.1 Background: Why does cerebral blood flow increase dur-ing hyperventilation?
There are different rCBF responses to HV observed in Sec-
tion 7.3.2.2. We saw rCBF decreases as well as increases dur-
ing HV (see also Figure 7.11). In Figure 8.1 representative evo-
lutions of rCBF are shown in blue. The rCBF changes, which
are representatively shown in Figure 7.11 (ID # 4 from the pop-
ulation presented in Chapter 7) are unexpected, since HV is
used with the intention of reducing arterial partial pressure
of carbon dioxide (PaCO2), thus leading to a vasoconstriction
and therefore a reduction in cerebral blood flow (CBF) (see
3.8). This is why the HV challenge is often considered as the
counterpart to hypercapnia (HRC) and therefore referred to
as hypocapnia (HOC).
For further investigation of this phenomenon, the HV chal-
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supine position
ID # 4 ID # 9






































































































































Figure 8.1: Hyperventilation response groups: The rCBF changes
in blue with their standard deviations represented by
the shaded areas together with the absolute EtCO2 (top
graph) and mean CBFV (bottom) evolution over time.
Graphs on the left show a subject with rCBF increases
during the HV and the ones on the right refer to a sub-
ject which shows rCBF decreases in response to HV.
were measured using the hybrid TRS/DCS device, presented
in Chapter 4.
8.1 PROTOCOL
In total, thirty-one subjects are included in the presented
dataset. Based on the exclusion criteria (non-smokers, ab-
sence of pathologies, no nervous system activator in themea-
surement preceding eight hours), fifteen volunteers (referred
to as cohort 1) signed an informed consent andwere recruited
under the protocol approved by the ethical committee of Hos-
pital Clínic in Barcelona (CEIC - Comité Ético de Investigación
Clínica del Hospital Clínic de Barcelona). These volunteers
are the same ones as presented in Chapter 7. The additional
sixteen subjects (cohort 2) were measured at ICFO. These
signed an informed consent which was approved by the eth-
ical committee of Hospital Clínic in Barcelona (CEIC - Comité
Ético de Investigación Clínica del Hospital Clínic de Barcelona).
The measurements were conducted according to the princi-
ples of the Declaration of Helsinki.
In addition to the thirty-one subjects, additional subjects were
i
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recruited under the same protocol as cohort 2 to qualitatively
address questions, which arose from our data. These results
are presented in the discussion (Section 8.3.1).
8.1.1 Clinical data
The measured parameters - apart from the blood flow in-
dex (BFI) - were heart rate (HR), diastolic, systolic and mean
arterial blood pressure (BPdia, BPsys, and MAP, respectively).
These were recorded by a Nexfin device (BMEYE®, Amster-
dam, The Netherlands) for cohort 1 and a FINAPRES monitor
(FINAPRES®, Amsterdam, The Netherlands) for cohort 2. A
standard pulseoximeter provided measurements of the pe-
ripheral arterial oxygen saturation (SpO2). The EtCO2 record-
ings were provided by a respiratory monitor (Julian®, Dräger
Medical, Lübeck, Germany or Capnostream 20®, Medtronic,
Dublin, Ireland; cohort 1 and 2 respectively). Similar to theHV
results presented in Chapter 7, the data for the first cohort
of volunteers (n = 15) contains further parameters which are
listed in Section 7.2.1.7.2. In this cohort, themacrovasculatory
CBFV (diastolic, systolic andmean) measures were taken by a
TCD device (Intraview®, Rimed, Tel Aviv, Israel) and calculated
using the relation 7.1.
8.1.2 Diffuse optical device
The DCS monitor recorded the BF in the microvasculature
on frontal lobes of subjects in cohort 1 and 2. On the lat-
ter, TRS acquired absorption and scattering data (µa and µ′s),
which was used to calculate THC and StO2. The fiber tips were
incorporated in a black head strap (see Figure 7.3) at a source-
detector separation of 25mm.
8.1.3 Hyperventilation protocol
As mentioned in Section 7.2, the HV challenge was defined
to consist of a pre- and post-baseline and HV was supposed
to be carried out at respiration rate (RR) of 20min-1 for 1min
(see Fig 8.2).
There was a slight difference between protocols for cohorts
1 and 2 in regards to the duration of the post-baseline:
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Figure 8.2: Protocol for hyperventilation (HV)
Cohort I: 5 min pre-baseline, 1min challenge, 5 min post-
baseline
Metronome rate ∼ 40min-1
EtCO2 ↓ 15mmHg
Cohort II: 5 min pre-baseline, 1min challenge, 3 min post-
baseline
Metronome rate ∼ 40min-1
EtCO2 ↓ 15mmHg
Since the measurements of the second cohort of volun-
teers were carried out in supine position, only the results
from the HV challenge in that position presented in Chapter
7 (cohort 1) are included in the analysis here.
8.1.4 Data analysis
From the calculated intensity autocorrelations for differ-
ent delay times g2(τ) we determined the mode parameter
(β) and calculated the normalized electrical field autocorre-
lation function (g1) using the Siegert relation g2 = (1 + β g1)1/2
[183] (see also Section 2.6). The semi-infinite homogeneous
medium solution of the correlation diffusion equation as de-
scribed in Section 2.3.3 and [94] was fitted to the calculated
g1 in order retrieve the particle Brownian diffusion coefficient
(Db) from each curve. Data from different detectors placed at
the same forefront was averaged and the αDb is reported as
a BFI. The according semi-infinite medium solution for the re-
flectance [240] was convoluted with the instrument response
function (IRF) and fitted to the recorded distribution time of
flight (DTOF) curve in order to retrieve the µa and µ′s values.
For details please refer to Chapter 2.
Assuming a water content of 77 % and a negligible lipid
content, the derived µa and µ
′
s values were turned into THC
and StO2 using the extinction coefficients for Hb, HbO2 and
i
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water from [253, 132].
The values during the initial baseline (see Figure 8.2) were
taken as a reference used for the calculation of relative and
absolute changes. The entire study population, including both
cohorts is separated into two groups based on their rCBF re-
sponse and Mann-Whitney-Wilcoxon tests on the difference
between these groups were performed within R [255]. All re-
ported values reflect the respectivemedian and inter-quartile
range (IQR), unless stated otherwise. In all statistical tests,
“p-values” of less than 0.05 were considered statistically sig-
nificant to reject the null hypothesis.
8.2 RESULTS
Thirty-one subjects (eleven females and twentymales) were
included in the study population. These consist of the fifteen
subjects from the measurements presented in Chapter 7 (co-
hort 1) and sixteen additional volunteers (cohort 2). The en-
tire population’s average age, height, weight and body mass
index (BMI) is presented in Table 8.1.
Age [yrs] Weight* [kg] Height* [cm] BMI* [kg/m2]
All 34.2 ± 8.3 72.3 ± 12.2 173.1 ± 8.7 24.0 ± 2.9
Females 31.2 ± 8.5 60.5 ± 8.3 164.4 ± 5.5 22.4 ± 2.4
Males 35.9 ± 7.9 78.8 ± 8.6 178.0 ± 5.9 24.9 ± 2.8
Table 8.1: Demographic parameters: The demographic parameters
of the population given as mean ± their standard devi-
ation. * denotes a statistically significant difference be-
tween females and males (t-test, p < 0.05).
Since no significant differences between brain hemispheres
were observed (p > 0.05), only the results of the left hemi-
sphere are presented here for clarity. Based on the rCBF re-
sponses, the data is separated into the two possible groups
(“rCBF increasers” and “rCBF decreasers”) and plotted accord-
ingly for parameters recorded in the two cohorts. This divi-
sion into two groups is based only on the positive and nega-
tive rCBF changes during the challenge in each position. The
(grouped) boxplot representations are presented in the same
way as in Chapter 7 and can be seen in Figure 8.3 for rCBF,
rCBFVmean, total hemoglobin concentration (rTHC) and tissue
i
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oxygen saturation (∆StO2). It must be noted, that CBFV was
onlymeasured in cohort 1, while in cohort 2 also themicrovas-














































































































































































































































































































group 1 group 2
Figure 8.3: Shown are the relative microvascular cerebral blood
flow (CBF), total hemoglobin concentration (THC) and
absolute tissue oxygen saturation (StO2) changes to-
gether with the relative mean macrovascular cerebral
blood flow velocity (CBFVmean) change. Data is sepa-
rated by challenge response. Group 1 represents the
subjects with a rCBF decrease, while group 2 refers to
subjects with a rCBF increase during HV. Statistically
significant changes (Mann-Whitney-Wilcoxon test, p <
0.05) are marked by *. The baseline is marked by the
black dashed line.
The subjects with rCBF decreases have a median (IQR) of
-12.13 (2.53) % in cohort 1 and -6.63 (8.21) % in cohort 2, while
the second group shows rCBF increases of 9.01 (8.87) % and
6.52 (6.24) % for respective cohorts. The CBFVmean changes
recorded in the first cohort in both groups are negative with
-42.15 (4.12) % for group 1 and -37.21 (19.67) % for group 2.
From the TRS data analysis extracted StO2 and THC changes
in the second cohort set to ∆StO2 = 7.41 (10.43) % (group 1),
∆StO2 = -0.23 (11.38) % (group 2), rTHC = -1.00 (5.59) % and
rTHC = -1.45 (11.58) %. Apart from the rCBF values, there is no
significant difference between groups according to a Mann-
i
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The ∆HR, ∆MAP, ∆SpO2 and ∆CO values during theHV chal-
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Cohort 1: mCBF decrease Cohort 1: mCBF increase







































































group 1 group 2 group 1 group 2
Figure 8.4: Absolute changes of heart rate (HR), mean arterial pres-
sure (MAP), peripheral arterial oxygen saturation (SpO2)
and cardiac output (CO) separated by subject positions
and challenge response. Group 1 represents the sub-
jects with a rCBF increase, while group 2 contains sub-
jects with rCBF decrease during HV. Statistically signif-
icant changes (Mann-Whitney-Wilcoxon test, p < 0.05)
are marked by *. The baseline is marked by the black
dashed line.
As before, the data is separated by cohorts and based on
rCBF response. The boxes to the left of each cohort refer to
subjects with a rCBF increase during HV (group 1), while the
boxes to the left of each cohort contain subjects with rCBF
decrease (group 2). Apart from MAP, all changes are posi-
tive with an increase in HR of 19.06 (16.64) bpm in group 1
and 17.64 (9.47) bpm in group 2 for the first cohort of volun-
teers. In the second cohort, HR increases of 30.42 (15.0) bpm
in group 1 and of 24.24 (8.59) bpm in group 2 were recorded.
The MAP changes in the first cohort are negative with -3.11
(9.14) mmHg and -1.44 (5.21) mmHg for groups 1 and 2 re-
spectively, while in the second cohort MAP increases by 2.53
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(11.04) mmHg in group 1 and by 2.34 (7.81) mmHg in group 2.
The ∆SpO2 values in cohort 1 range from 2.69 (2.70) % (group
1) to 1.94 (1.49) % (group 2) and in the second cohort from
2.31 (1.20) % (group 1) to 2.00 (2.58) %. Groups 1 and 2 also
show increases in CO in both cohorts. These values are 2.69
(2.70) l/min (group 1, cohort 1), 1.94 (1.49) l/min (group 1, co-
hort 1), 2.31 (1.20) l/min (group 1, cohort 2) and 2.00 (2.58) l/min
(group 2, cohort 2). A Mann-Whitney-Wilcoxon test was used
and showed no significant difference between groups in any
of the variables presented here.
8.3 D ISCUSS ION
Adding further microvascular CBF data recorded from hy-
perventilating subjects to the existing data set presented in
chapter 7 allowed also to check the reproducibility of our pre-
vious results and served to increase the total study popula-
tion. An additional sixteen subjects were included and re-
sponses to HV were measured. Further information could
be collected by adding the TRSmodality and thus estimating
hemoglobin concentrations in the brain during the challenge.
Unfortunately, CBFV data could not be recorded in the sec-
ond cohort of volunteers due to the lack of a TCD device. The
drop in PaCO2 was induced by having each volunteer increase
their RR to a specific metronome frequency. The goal was to
decrease EtCO2 by 15mmHg and to continue in this condition
for 1min.
The results from chapter 7 were able to be reproduced as
the presence of two distinct groups in response to HV were
also observed in the second cohort of healthy volunteers.
The rCBF decreases range from -12.13 (2.53) % in cohort 1 to
-6.63 (8.21) % in cohort 2. Group number 2 shows rCBF in-
creases of 9.01 (8.87) % (cohort 1) and 6.52 (6.24) % (cohort 2),
which are comparable between cohorts (no statistically sig-
nificant difference was found).
None of the other physiological parameters (macrovascu-
lar CBFV, HR, MAP, SpO2 or CO) suggested the existence of
distinct subject groups. Furthermore, tendencies in these
parameters are similar, i. e. HRs, SpO2s and COs all increase
during active HV and are comparable to reported changes
in the literature [193]. The observed HR increase might also
i
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include a possible exercising effect, which could have been in-
troduced by the active hyperventilation. The recorded CO in-
crease gives further support to this point. The CBFV in group
1 (CBFVmean = -42.15 (4.12) %) shows a slightly larger decrease
as compared to group 2 (CBFVmean = -37.21 (19.67) %), but this
difference was not found to be statistically significant (p >
0.05). Nonetheless, this might point towards the existence of
two groups in active HV and additional CBFVmeasurements
could provide further information.
In general, a decrease in CBF is expected due to the HOC
effect ofHV. The reduction of PaCO2 induced by an increased
RR leads a lower blood pH, which in turn causes the oxygen-
hemoglobin dissociation curve to shift to the left, thus in-
creasing the oxygen affinity. Furthermore, the blood vessels
constrict which causes a decrease in CBF [305, 7, 48, 343, 256,
130, 181]. This was discussed in Chapter 3 and HV is used in

























Figure 8.5: Inhaled air reaches the lungs and the alveoli. Gas ex-
change between them and the blood happens through
diffusion along a gradient in partial pressures. The
PaCO2 in the blood depends on the PaCO2 in the alve-
olus. Partial pressure differences between different lo-
cations in the body could lead to different PaCO2s be-
tween the lung and brain blood vasculature.
However, there are reports of CBF increases in response
to increased RR. Lund et al. [193] used a CerOx® monitor
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(Ornim Medical Ltd, Israel), which combines NIRS and US for
non-invasive monitoring of ScO2 and CBF, and observed a 9%
(median) increase in the CBF index. In a study of cerebrovas-
cular response during rowing Faull et al. [108] state that the
observed CBF increases in response to the higher RR could
be explained by a mismatch between the measured EtCO2
and the actual PaCO2 in the brain. While the EtCO2 drops dur-
ing short frequent breaths, PaCO2 might not be affected and
therefore may lead to an unexpected response to HV.
In the measurements presented in this and the preceding
chapter, we rely on the EtCO2 readings in order to initiate the
1 min duration once the volunteer has reached the desired
EtCO2 level, e. g. after a 15mmHg drop in EtCO2 has occurred,
thus assuming that the volunteer is purely hypocapnic. In
fact, we are measuring EtCO2, which only can give a rough es-
timation of the blood’s PaCO2. This point is schematically illus-
trated in Figure 8.5. It gives an idea of the relation between
EtCO2 and PaCO2 in the blood. The EtCO2 reading is the maxi-
mum peak of the exhalation curve. Depending on the depth
of the respiration, this might not entirely reflect the lung gas
mixture. If there is a difference between PaCO2 in the blood
and the lung alveoli this will present an additional confound-
ing factor. Furthermore, we measure the cerebral response,
which is a result of changes in PaCO2 in the brain and could
be different from the changes in PaCO2 in the blood near the
lungs [108]. Nonetheless, it seems that in our measurements
the microvasculature reacts differently from the macrovascu-
lature.
Two confounding factors that could be influencing our data
are motion artefacts and the patient concentration needed
to adjust breathing to the metronome rhythm. We qualita-
tively address these points in the next section.
8.3.1 Clicking task and motion artefacts
The datamay suggest, that the adjustment of RR to the rate
of the metronome causes the blood vessels to dilate at the
microvascular level in the brain in some subjects to react dif-
ferently than at the macrovascular level. The effect of an im-
posed (motor) exercise could counteract the vasoconstricting
effect and therefore lead to a CBF increase [150, 176]. In order
to test this, we conducted further measurements on an addi-
tional five subjects (ID # 32 - 36). These measurements were
i
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conducted under the same protocols and the subjects signed
the same informed consent as the second cohort presented
in Section 8.1. The volunteers were asked to concentrate on a
rhythmic sound similar to the one from the metronome. The
rhythmwas set to 40 tones per minute with ± 0.5 second vari-
ations to avoid habituation of the subject to the signal. With
each sound the volunteer was asked to click a keyboard but-
ton in order to mimic to the action chain (listen : act). DCS
was used to record CBF changes during this procedure.















ID # 32 ID # 34 ID # 35 ID # 36















ID # 32 ID # 34 ID # 35 ID # 36
Figure 8.6: rCBF response to a simple clicking task. Top graph:
left brain hemisphere, bottom graph: right brain hemi-
sphere. The grey region represents the baseline (first 30
s).
The exercise started after a 30 s baseline and lasted 3min.
In Figure 8.6 the data is shown for four subjects. The volun-
teer ID # 33 was excluded due to not completing the task
according to the protocol. We observe slight increases be-
tween 10 - 20 % after approximately 80 s of exercise, after
an initial decrease (5 - 20 %). This suggests that there was
no corruption of our signal due to concentration-induced mi-
crovascular CBF changes as a result of the subject acting on
the marked rhythm by metronome.
As an additional check for motion artefacts, which may in-
troduce rCBF increases, we asked the additional volunteers
who performed the clicking task to nod their head for 1 min
after an initial baseline. The timing was chosen in order to
i
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replicate the HV duration as presented in Section 8.1. The
head nod did not show any changes, effectively eliminating
motion artefacts as the possible cause of the adverse rCBF
results during HV.
8.3.2 Altered hyperventilation
A milder HV was conducted on a further six subjects (ID #
37 - 42) with the same RR as in the standard HV (20 min-1),
as well as with twice the RR (40 min-1) in two of them (ID #
41 - 42). Here, the volunteers were asked to simply adjust
their RR to the metronome and not to focus on reaching a
specific EtCO2 drop. This aims to remove a possible effect
associated with the patient’s effort by focusing on achieving
the defined EtCO2 drop and therefore the forced usage of the
entire lung volume. For that reason, we did not control the
EtCO2, but only focused on having the subject adjust RR to the
metronome. Only DCS data was acquired in these subjects.
The rCBF responses of ID # 41 and 42 - the subjects with the
doubled RR - are presented in Figure 8.7.
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ID # 41 ID # 42
Figure 8.7: rCBF response from two subjects to HV at twice the RR
as presented in Section 8.1.3. Top graph: left brain hemi-
sphere, bottom graph: right brain hemisphere. The grey
region represents the baseline (first 30 s).
While the first HV in these volunteers at the RR as pre-
sented in Section 8.1.3 without the use of the EtCO2 criterion
did not show any notable changes in CBF, in the two sub-
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jects (ID # 41 and 42), who were also asked to hyperventilate
at a further increased RR (twice the rate as before), CBF de-
creases could be observed. It should be noted, that these
measurements only provide a qualitative check to address
the questions of whether the task and/or exercise of adjust-
ing your RR to a sound you hear and to reach a specific EtCO2
threshold (∆EtCO2 = -15mmHg) could provoke a CBF increase,
whose effect is stronger than the HV effect.
8.4 CONCLUS ION
The additional CBFmeasurements recorded here also sup-
port the existence of two groups. Other physiological pa-
rameters did not show two groups. Further measurements,
recording CBF with a DCS device during milder HV, as well as
the clicking task in order to simulate a possible activation of
the frontal lobe regions, do not suggest that either one or
the other acts as a confounding factor. Data from an active
HV with a doubled RR points towards an influence of the HV
level, i. e. if the subjects are asked to reach the defined EtCO2
level (∆EtCO2 = -15mmHg from the baseline), this invokes an
exercising effect which is stronger than the one intended by
the HV. This effect might be stronger in some (less-trained)
volunteers, thus causing the recorded microvascular CBF in-
crease in response to activeHV. It is nonetheless noteworthy
that in the first cohort we saw significant CBFV decreases in
all subjects, while the microvascular rCBF only showed this in
some (group 1). None of the other clinical parameters indi-
cate a possible systemic effect. The fact that we were able
to reproduce the microvascular changes in CBF recorded by
DCS in a second cohort strongly supports the validity of the
measurements. The work presented here gives further sup-
port to the existence of two groups in terms of microvascular
CBF changes. However, varying the level of activeHV (smaller
and bigger EtCO2 drops) and varying the RR while simultane-
ously recording macrovascular CBFV data may be interesting



















IS IT A MA JOR M ISTAKE TO
CALCULATE CEREBRAL BLOOD
FLOW IN RESPONSE TO
HEAD -OF -BED W ITHOUT A
HYBR ID DEV ICE ?
This chapter focuses on one possible advantage, that can
come out an hybridization of the two diffuse optical modali-
ties TRS and DCS in in-vivo measurements. The assumption
here is, that through a better estimation of optical properties
by TRS the DCS analysis can more accurately estimate the in-
formation on blood flow. The work presented here is made
possible by Hospital Clínic in Barcelona and the correspon-
dent ethical committee in collaboration with ICFO.
9.1 INTRODUCT ION
It is known that relative cerebral blood flow (rCBF) derived
from diffuse correlation spectroscopy (DCS) measurements
changes by so-called head-of-bed (HOB) manoeuvres [90, 109,
171, 170, 98, 44, 97]. These manoeuvres consist of an alter-
ation of the subject’s bed inclination. In healthy patients a
lowering of the HOB angle leads to an increase in microvas-
cular cerebral blood flow (CBF) [98]. HOB angle changes are
used to evaluate cerebrovascular resistance (CVR) and brain
health in traumatic brain injury (TBI) and stroke patients [23,
109, 171, 12, 170, 11, 97, 332, 274].
From DCSmeasurements a so-called blood flow index (BFI)
is reported. It is a result of calculating the normalized elec-
trical field autocorrelation function (g1) from the normalized
intensity autocorrelation function (g2) (see Equation 2.23) and
fitting a Brownian diffusion model (<∆r2(τ)> = 6 Db τ) to the
calculated normalized electrical field autocorrelation function
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Sections 2.4, 2.6 and 4.1.3. The electrical field autocorrelation
decay factor (K) in Equation 2.17 is defined as:
K(τ) =
√
3 µa µ′s + k20 α µ′
2
s 〈∆r2(τ)〉︸ ︷︷ ︸
6 Db τ
(9.1)
For the mean-square displacement <∆r2 (τ)>, it was found
empirically to be best expressed by <∆r2 (τ)> = 6 Db τ [321,
90, 262, 94, 89, 56, 27]. BFI is then defined as BFI = αDb, with
α representing the fraction of moving scatterers and Db the
particle Brownian diffusion coefficient. In HOB manoeuvres
these are often reported as relative values with respect to a
baseline [90, 109, 171, 170, 98, 44, 94, 97]. From Equation 9.1
we see that the model we fit to our DCS data is dependent
on the absorption coefficient (µa) and reduced scattering co-
efficient (µ′s). Their values need to be specified in order to
evaluate the data acquired with a DCS system (see Sections
2.3.3 and 2.7.2). A common guess for them is µa = 0.1 cm
-1 and
µ′s = 10 cm
-1.
The advantage of combining DCS with time-resolved spec-
troscopy (TRS) into a hybrid device - as presented in Chapter 4
- is the simultaneous acquisition of µa, µ
′
s and Db, which allows
a more accurate estimation of the BFIwith the TRS-derived µa
and µ′s values [149].
One could think of various ways for using µa and µ
′
s for
the DCS evaluation. These range from a general guess over
population or subject averaged values to either averaged val-
ues over certain episodes of the measurement or even the
usage of TRS-derived optical properties for each individual
data point taken per subject. It is furthermore an open ques-
tion, whether the actual relative CBF change due to a HOB
sequence depends on the knowledge of the correct µa and
µ′s. In this chapter, we aim at answering this question by com-
paring five different evaluation methods against each other.
The comparison is done on the BFI basis as well with the rCBF
values in consequence of a HOB angle change in healthy vol-
unteers.
9.2 PROTOCOL
This study, all including procedures and devices were em-
ployed according to the protocol ICFO_HCP/2012/1 and each
i
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subject signed an informed consent, both approved by the
ethical committee of Hospital Clínic in Barcelona (CEIC - Comité
Ético de Investigación Clínica del Hospital Clínic de Barcelona).
Moreover, all measurements were carried out in compliance
with the principles specified in the Declaration of Helsinki.
The exclusion criteria were absence of pathologies, smoking
and no diagnosed blood pressure alteration. In consequence,
sixteen volunteers were recruited and included in this study.
Two hybrid TRS/DCS sensors with a fixed source-detector sep-
aration (ρ) of 25 mm were placed on the subject’s forehead,
one on the left hemisphere and one the right one. Each
sensor consists of two source-detector pairs, one for each
modality. The TRS setup uses picosecond pulsed laser light
at three different wavelengths (λ1 = 690 nm; λ2 = 785 nm;λ3
= 830nm) and its evaluation yields the absorption (µa) and re-
duced scattering (µ′s) coefficients (for details see Sections 2.5
and 4.2).
While DCS data was recorded for 1800 ms on one hemi-
sphere, each TRS wavelength acquired data for 600 ms on
the opposite one. This led to total acquisition time of 3600
ms for all full data set of TRS and DCS data from both hemi-
spheres.
A standard pulseoximeter and a capnograph (Capnostream
20®, Medtronic, Dublin, Ireland) were used to monitor the
following parameters: peripheral arterial oxygen saturation
(SpO2), heart rate (HR), RR, EtCO2 and integrated pulmonary
index (IPI), which gives a simple indication about the subject’s
respiratory status in real time. These values were taken for
monitoring the volunteer’s general health condition through-
out the procedure, so that any general potential physiologi-
cal influence on our data could be ruled out. For the same
purpose, the subject’s blood pressure (BPdia, BPsys and MAP)
was recorded as well (FINAPRES®, Amsterdam, The Nether-
lands).
The following simple HOB angle change was chosen: 30°:
0° (or “supine”) (see Fig. 9.1).
Each position was kept for five minutes. The interest lies in
the resulting BFI values for each position, their relation to one
another and behaviour between different evaluation types.
i
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5 min 5 min
+ 30° supine
Figure 9.1: HOB protocol sequence: 30°: 0° (supine).
To that end, theDCS data was evaluated in five different ways.
These are:
Method I: fix µa at 0.1 cm-1 and µ′s at 10 cm-1
Method II: population (n = 10) average of µa and µ′s
Method III: subject average of µa and µ′s (entire sequence)
Method IV: subject position average of µa and µ′s
Method V: subject individual µa and µ′s per acquisition (“one-
to-one”)
The first method is a results of the standard guess for µa
and µ′s used in the diffuse optics community. Starting with
method IIwe use the TRS information in the DCS analysis and
move to subject individualised values for µa and µ
′
s (method
III-V). As the method number increases, we move closer to
the real-time µa and µ
′
s for each subject.
The entire statistical analysis was carried out in R [255]. In
order to compare the five analysis methods and their influ-
ence on the computed CBF changes LME (“nLME” [244] pack-
age in R) models for the subject’s HOB angle and different
evaluationmethods were defined. For the calculation of rCBF,
the first HOB (30°) position was set as a baseline (rCBF = 0 %).
Fitted values from the LME models are reported as means
plus minus their standard errors and models which did not
differ significantly from the null model were rejected. Other
reported values are median values and their respective inter-
quartile ranges (IQRs). In all models and statistical tests, “p-
values” of less than 0.05 were considered statistically signifi-
cant to reject the null hypothesis.
i
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A total of sixteen subjects (six females, ten males), whose
blood pressures did not change significantly throughout the
procedure, were evaluated in five different ways. These differ
from each other in the way µa and µ
′
s are fed into theDCS anal-
ysis, as explained in Section 9.2. Table 9.1 shows the study
population demographics.
Age [yrs] Weight* [kg] Height* [cm] BMI [kg/m2]
All 35,8 ± 9.7 72.4 ± 13,4 172.6 ± 9.1 24.2 ± 3.4
Females 33.5 ± 11.3 60.0 ± 8.2 162.5 ± 2.5 22.7 ± 3.0
Males 37.2 ± 9.0 79.9 ± 9.9 178.6 ± 5.2 25.1 ± 3.5
Table 9.1: Demographic parameters: The demographic parameters
of the population given as mean ± their standard devi-
ation. * denotes a statistically significant difference be-
tween females and males (t-test, p < 0.05).
DCS recorded data did not show significant differences be-
tween brain hemispheres, so that for clarity only the results
of the left hemisphere are presented here. All statistically
significant results are comparable to the right hemisphere,
whose results are presented in Section D.
9.3.1 Blood flow indices upon different usage of optical proper-ties
The BFI values calculated using the methods explained in
Section 9.2 are presented in Figure 9.2. Their median (IQR)
values are shown in Table 9.2.
According to Table 9.2, BFI values in the left brain hemi-
sphere obtained with µa and µ
′
s values of 0.1 cm
-1 and 10 cm-1
(method I) set to median (IQR) values of BFI
30°, I
= 7.19 (2.51)
× 10-9 cm2/s and BFIsupine, I = 9.54 (3.19) × 10
-9 cm2/s and the
ones for the study averaged µa and µ
′
s values (method II) to
BFI
30°, II
= 6.89 (2.41) × 10-9 cm2/s and BFIsupine, II = 9.13 (3.08) ×
10-9 cm2/s.
For method III, where we used the individualised µa and
µ′s values from each subject, the BFI median (IQR) values re-
sult in BFI
30°, III
= 6.28 (2.62) × 10-9 cm2/s and BFIsupine, III =
7.43 (2.74) × 10-9 cm2/s. In methods IV and V we obtain me-
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Figure 9.2: Comparing evaluation methods I-V against each other



















Table 9.2: Medians (and IQR) for the absolute BFI values taken
from the left brain hemisphere separated by methods
and positions. Data was taken in two positions accord-
ing to measurement protocol.
dian (IQR) values of BFI
30°, IV
= 6.19 (3.01) × 10-9 cm2/s and
BFIsupine, IV = 7.43 (2.74) × 10
-9 cm2/s and BFI
30°, V
= 6.23 (2.82)
× 10-9 cm2/s and BFIsupine, V = 7.38 (2.78) × 10
-9 cm2/s.
A LME model on method influence1 revealed a significant
difference between the first two methods (I and II) and meth-
1 The fitted intercepts and their slopes are presented in Table D.5.
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ods III-V (p ≤ 0.05). The according p-values are presented in
Table 9.3. For better visibility, statistically significant differ-
ences between methods are marked by a grey background.
30° position
method I II III IV
II p > 0.05 -
III p < 0.001 p < 0.001 -
IV p < 0.001 p < 0.001 p > 0.05 -
V p < 0.001 p < 0.001 p > 0.05 p > 0.05
supine position
II p > 0.05 -
III p < 0.001 p < 0.001 -
IV p < 0.001 p < 0.001 p > 0.05 -
V p < 0.001 p < 0.001 p > 0.05 p > 0.05
Table 9.3: Results (p-values) from a LME model with the method
factor for the absolute BFI values. Statistically signifi-
cance is marked by a grey background.
The top part of Table 9.3 shows the resulting p-values for
the comparison of BFI values from the 30° position between
methods. The bottom part refers to the same test, but con-
ducting it on the BFI values taken while the volunteers was in
the supine position.
All values between positions differ significantly (p < 0.001)
independently of the used analysis method. The BFIs calcu-
lated based on methods I and II differ significantly (p < 0.05)
from the ones evaluated with method III, IV and V. Between
the latter three, no significant difference was found.
9.3.2 Influence of optical properties on estimated relative cere-bral blood flow
After evaluating BFI according to the five methods as pre-
sented in Section 9.2, for each volunteer the 30° position av-
erage was taken as a baseline and the CBF change with the
HOB angle calculated for each method individually. The re-
sulting rCBF values are shown in Figure 9.3. The graph com-
pares all five methods (I:“fixed”; II: “study average”; III: “sub-
ject average”; IV:“subject position average” and V: “one-to-
i
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fixed study average subject average
subject position average one−to−one
Figure 9.3: Comparing evaluation methods 1-4 against each other
by looking at the CBF changes with respect to the 30°
position (starting position). The dashed line represents
zero CBF change and “left” and “right” label the respec-
tive brain hemispheres.








Table 9.4: Medians (and IQR) for the relative CBF changes with re-
spect to initial 30° position separated by methods.
Table 9.4 shows the rCBF values in terms of a median and
its respective IQR after the change from 30° to supine posi-
tion for each analysis method and hemisphere. These values
set for method I to rCBFleft, I = 28.14 (26.72) % and the ones for
the study averaged µa and µ
′
s values (method II) to rCBFleft, II =
28.67 (27.35) %.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the rCBFmedian (IQR) val-
ues result in rCBFleft, III = 28.47 (27.03) %. In methods IV and V
we obtain median (IQR) values of rCBFleft, IV = 30.91 (20.94) %
i
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and rCBFleft, V = 28.23 (27.63) %.
Similar to the analysis of the BFI values (Section 9.3.1), we
employ a LMEmodel to investigate differences between rCBF
values among different analysismethods2. Here we only com-
pare rCBF in the supine position between the above-presented
different analysis methods. The p-values of this investigation
are shown in Table 9.5. As before, statistically significant dif-
ferences betweenmethods aremarked by a grey background
for better visibility.
method I II III IV
II p > 0.05 -
III p > 0.05 p > 0.05 -
IV p = 0.01 p < 0.05 p < 0.05 -
V p > 0.05 p > 0.05 p > 0.05 p < 0.05
Table 9.5: Results (p-values) from a LME model with the method
factor for the relative CBF values with respect to the ini-
tial 30° position. Statistically significance is marked by a
grey background.
According to Table 9.5, the rCBF calculated based onmethod
I-III does not differ significantly. Method IV differs significantly
(p≤ 0.05) from all other ones in the resulting rCBF for a change
from 30° to supine position. Values obtained from method V
are comparable to method I-III.
9.4 D ISCUSS ION
The blood flow index (BFI) changes not only with position
but also dependent on the analysis method used. The first
point has its origin in the orthostatic challenge by changing
the head-of-bed (HOB) angle and was reported previously in
DCSmeasurements [90, 109, 171, 170, 98, 44, 97]. Since BFI de-
pends on the optical properties µa and µ
′
s (see Equation 9.1)
and it is not feasible to evaluate all three parameters at the
same time from a single measurement [83], we used TRS to
gain information on µa and µ
′
s. Based on the different meth-
ods used in analysing DCS data in this Chapter, we obtain
BFI values ranging from 6.19 - 7.19 × 10-9 cm2/s in the initial
30° sitting position. In supine these range from 7.38 × 10-9
2 The fitted intercepts and their slopes are presented in Tables D.7 and D.8
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cm2/s to 9.54 × 10-9 cm2/s. Since these values are dependent
on the optical properties, they also vary between study pop-
ulations. This is reflected in the statistically significant differ-
ences found between analysis methods I and II on one side
and methods III, IV and V on the other side. Since the later
three use subject-specific µa and µ
′
s values they lead to differ-
ences in the BFI compared to methods I and II, where either
a general guess of µa and µ
′
s or their population average was
taken.
The majority of DCS work reports relative blood flow mea-
sures in terms of rCBF [90, 109, 171, 170, 98, 44, 97]. The data
presented here shows rCBF increases of around 28 - 30 %
with a HOB angle change from 30° position to supine. Previ-
ous work reports changes between 18 % and 25 % [109, 171,
98, 97], with significantly higher responses in male subjects
(rCBF = 27.1 %) [98].
This chapter aimed at giving an answer to the specific ques-
tion whether the previously reported changes in CBF under-
or overestimated the actualmicrovascular rCBF response. The
LME models employed to investigate this, found method IV
to be significantly different from the other ones. It is the
method with the usage of µa and µ
′
s position averages per
subject and therefore taking into account absolute changes
in µa and µ
′
s, when moving to the supine position. As men-
tioned before, µa and µ
′
s influence BFI. In healthy volunteers
only µa is imagined to change due to changes in the blood
volume, not µ′s. Along this line, method V should even reflect
physiology more correctly, but it is likely that it propagates
variations in the optical properties to strongly, thus burying
a possibly effect in this crosstalk. Method IV looks therefore
like the cleanest and the one closest to physiology. It shall be
noted that several studies [195, 278, 46, 98, 346, 97, 282, 92,
300, 115] using DOS estimate µa changes using the differen-
tial pathlength method, which assumes that the variations in
optical properties are small compared to the baseline value
[13, 79]. Assuming furthermore a homogeneous distribution
across the medium the temporal changes in the optical den-
sity can then be related to changes in chromophore concen-
trations and therefore to variations inHb andHbO2. Nonethe-
less, this method can lead to underestimations similarly to
the confounding factors discussed in Section 6.4.3.
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9.5 CONCLUS ION
A combination time-resolved spectroscopy (TRS) and dif-
fuse correlation spectroscopy (DCS) does not only allow an es-
timation of cerebral metabolism (CMRO2), but also improves
the DCS-derived blood flow index (BFI). The work in this chap-
ter has shown that hybridization of TRS and DCS is advanta-
geous in the estimation of the derived blood flow index (BFI)
during a simple head-of-bed (HOB) procedure. Previous work
did not rely on a TRS-derived absolute absorption (µa) and re-
duced scattering coefficient (µ′s). Since BFI is dependent on
the optical properties µa and µ
′
s, the absolute, subject spe-
cific values should be used in the analysis of DCS data, thus
retrieving a BFI which closer reflects physiology. This is ex-
pressed by the statistically significant difference of BFI values
resulting frommethod III, IV and V, which used individual sub-
ject optical properties, compared to the first two.
In HOB procedures, it appears to be sufficient to use an av-
erage of subject specific µa and µ
′
s independent of HOB angle
in order to estimate BFI.
Relative CBF changes are also significantly influenced by
the absolute µa and µ
′
s calculation. Using these values for spe-
cific measurement periods leads to a significantly improved
rCBF estimation, as expressed by the significant difference of
the fourth method. The highest degree of integrating both
techniques (DCS and TRS), is the evaluation of BFI with si-
multaneously acquired µa and µ
′
s values, as done in analysis
method V in this chapter. Improving the SNR in the TRSmea-
surements could reduced a possibly introduced cross-talk in
the fifth method and therefore reveal also a significant differ-
ence for that method.
Although CBF measures presented in this Chapter lie on
the upper range of previously reported values [109, 171, 98,






































After a general introduction, I discussed the oxygen deliv-
ery in the human body, how hemoglobin takes in oxygen and
deploys it in the destination region due to different partial
pressures of oxygen (PO2) between the blood and the sur-
rounding tissue. The compartment model was introduced
as well as the dependence of oxygen saturation on PO2 and
how their relation is affected by CO2 via a change in pH. The
role of blood flow in oxygen supply to the brain, the differ-
ences between the macrovasculature (Circle of Willis) and mi-
crovasculature were discussed. I furthermore introduced the
concept of cerebral autoregulation, which is the interplay of
mean arterial pressure, cerebral perfusion pressure and in-
tracraneal pressure, and their relation to cerebrovascular re-
sistance and cerebral blood flow (CBF). How changes on the
arterial partial pressure of carbon dioxide affect these param-
eters were also introduced and therefore lay the groundwork
for the respiratory challenges in Chapters 7 and 8.
How hybrid diffuse optics, whose concepts have been dis-
cussed in Chapter 3, can be used to estimate the cerebral
metabolism was explained. In Chapter 6, this was shown
using a constructed hybrid setup. This instrument was ex-
plained and characterised in Chapter 4 and the physical ba-
sics for this device were introduced in Chapter 2.
The mentioned hybrid setup was also used in further mea-
surements with probes placed on the human forehead brain,
similar to the study presented in Chapter 6, in order to inves-
tigate the responses of CBF to changes in the inhaled gas con-
tents (Chapter 7). For this purpose the volunteer’s end-tidal
CO2 was either in- or decreased by a specific amount. These
effects where achieved by challenges called hypercapnia or
hyperventilation and either in- or decreased CBF. A third one
consisted of an increasing the amount of exhaled O2 and
thus decreasing CBF. All three challenges were conducted
in two positions (supine and 50°) in order investigate possi-
ble microvascular position dependencies in order to help un-
derstand increased incidence rates of complications during











Since the response to hyperventilation showed unexpected
positive changes in CBF, which only few people reported ear-
lier [193, 108], this challenge was repeated in additional sub-
jects and the results could be reproduced (see Chapter 8).
Based on their relative rCBF change, the subjects were sepa-
rated into two groups (“CBF decreasers” and “CBF increasers”)
in order look for possible group correlation in other clinical
parameters, such as heart rate, mean arterial pressure, car-
diac output, etc.. Additionalmeasurements with clicking tasks
and head nods could rule out motion artefacts and strong
concentration influences, suggesting that the answer lies in
the way the hyperventilation was performed. By increasing
the breathing rate, the expected negative CBF change could
be observed in two further recruited subjects, for which the
protocol was changed by doubling the respiration rate. Us-
ing the same hybrid device, measurements were conducted
on the human neck with the goal of improving thyroid can-
cer screening (Chapter 5). As a first step, values of the ab-
sorption and reduced scattering coefficient at three wave-
lengths according to the presented device, as well as the to-
tal hemoglobin concentration, tissue oxygen saturation and
the blood flow index in a healthy population were reported.
Moreover, data frompathological cases was taken. This study
led to a European Horizon 2020 (H2020) project called Light
and Ultrasound Co-analyzer for Thyroid Nodules (“LUCA”; for
further information see http://www.luca-project.eu).
i
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Two relatively new techniques, time-resolved spectroscopy
(TRS) and diffuse correlation spectroscopy (DCS), employing
low intensity light in the near-infrared and diffuse optical con-
cepts were combined in a single hybrid instrument. The sys-
tem provides reproducible measurements of tissue optical
properties and allows both techniques to be used simultane-
ously. It provides non-invasive information about (cerebral)
hemodynamics and metabolism. The advantages of the hy-
bridization of TRS and DCS were shown throughout the stud-
ies presented in Chapters 5 - 9.
In Chapter 5, I showed, for the first time, that it is feasi-
ble to do diffuse optical measurements on the thyroid in-
vivo. The hybrid device was used with the ultimate goal of
testing the feasibility of improving thyroid cancer screening.
Several challenges, from the adequate probe design to elimi-
nation of possible confounding factors such as repeatability,
shielding of the signal by muscle tissue, correct probe place-
ment and the elaboration of a feasible measurement proto-
col were tackled. Moreover, it was crucial to decide on the
adequate subject recruitment, a sensible integration with ul-
trasound (US) measurements and their use in the analysis.
With the US information and the noted tissue dimensions,
I was able to conclude that the hemodynamic parameters
(THC, StO2, BFI) derived from diffuse optical measurements
reflect thyroid vascularisation. Pathologic contrast was ob-
served with elevated microvascular THC values, making it a
promising parameter for improvement in thyroid screening.
Further indications of elevated BFI and altered µ′s in patho-
logic areas - reflecting the proliferation of cells - encourage
the use of diffuse optics on thyroid tissue. Further results
from pathological cases are promising. This project opened
the door for diffuse optics in thyroid cancer screening and
led to a European Horizon 2020 (H2020) project called “LUCA” -
Light and Ultrasound Co-analyzer for Thyroid Nodules. LUCA
will continue this work by developing a new combined dif-
fuse optics TRS/DCS-US probe and is a collaboration between











Biomèdiques August Pi I Sunyer) and research entities (ICFO,
Politecnico de Milano, University of Birmingham and EIBIR
- European Institute for Biomedical Research), as well as in-
dustry partners (ECM - Echo Control Medical, Vermon SA and
Hemophotonics SL).
The data I presented in Chapter 6 showed that optically
derived brain metabolism (CMRO2) during general anesthe-
sia correlated significantly with the widely used bispectral
index (BIS) readings, which provides information about the
state of consciousness via EEG readings of the brain, and
are widely used and accepted in the clinic. The presented
data set is one of the few DCS - and even fewer in combina-
tion with TRS - to have been acquired during surgeries under
general anesthesia. This non-invasively collected optical data
from patients under propofol-induced general anesthesia re-
lates to EEGmeasures. This brings diffuse optical techniques
closer to applications in the clinic. It furthermore shows that
the hybridization of TRS and DCS is powerful tool that has the
potential to continuously monitor patient consciousness dur-
ing general anesthesia surgeries as well as cerebral hemody-
namics in neurocritical care patients, thus improving neuro-
monitoring. Furthermore, additional support was given to
the point that propofol-induced anesthesia maintains phys-
iological coupling between CMRO2 and CBF. Moreover, the
acquisition of this data required the design of fiber probes
around existing sensors in the clinic, such as the BIS sensor,
as well as a close integration and adaptation to the clinical
environment of the constructed TRS/DCS hybrid device.
As another potential impact of DCS - and in the future TRS
- in the area of general anesthesia, I used diffuse optically de-
rived microvascular cerebral blood flow (mCBF) for the inves-
tigation of possible position dependencies of brain hemody-
namics in response to respiratory challenges in the study pre-
sented in Chapter 7. These challenges were hyperoxia (HO),
hypercapnia (HRC) and hyperventilation (HV) and can occur
during surgical procedures under general anesthesia. No sig-
nificant subject position influences were identified, thus sug-
gesting that the reported increased incidence rates of compli-
cations, such as venous air embolism (VAE), upper airway ob-
struction or paradoxical air embolism, which can lead to the
above-mentioned conditions (HO, HRC and HV), associated
i
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with general anesthesia in the sitting position, are not related
to the respiratory manoeuvres alone, but to a combination
with general anesthesia. Additional information about brain
metabolism can further help in understanding this problem.
This is where the hybrid device presented in Chapter 4 and
used in the studies in Chapters 5 and 6 has proven itself to
be capable of such measurements in the clinic. This empha-
sizes again its potential in answering questions on the cere-
bral hemodynamical behaviour in the clinal environment and
the area of general anesthesia.
Furthermore, the hybrid system was utilized to investigate
various data analysismethods and physiological confounders
of certain challenges as shown in Chapters 8 and 9. I found
support to the hypothesis that active hyperventilation can im-
pose an exercise, which is stronger that actual hyperventila-
tion influences on other cerebral hemodynamics. Moreover,
I showed that the use of TRS-derived values - averaged for
specific measurement periods - led to significantly improved
rCBF estimation. Improvements in the SNR from TRS mea-
surements are likely to more closely reflect physiology.
The work presented in this thesis has advanced the field of
diffuse optics by validating it against clinical monitors, thus
bringing these techniques closer to the application in the con-
tinuous patient (neuro-) monitoring, as well incorporating dif-
fuse optics in existing clinical processes such as cancer screen-
ing with the potential to significantly improve specificity and
sensitivity. Moreover, the combination of TRS and DCS for
their simultaneous data acquisition as well as the advantages
of such a hybridization were presented. This allows improved
information gain on cerebral hemodynamics by better reflect-
ing physiology and estimating brain health.
i
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THYRO ID CHARACTER ISAT ION BY
D I F FUSE OPT ICS
In Chapter 5 the combination of time-resolved spectroscopy
(TRS) and diffuse correlation spectroscopy (DCS) was used
to characterize the human thyroid tissue with a final goal
of optimizing current thyroid cancer screening procedures.
This work led to a European Horizon 2020 project called Light
and Ultrasound Co-analyzer for Thyroid Nodules (http://www.
luca-project.eu) and in this first part of the appendix, indi-
vidual subject data as well as further case studies with patholo-
gies are shown in addition to the data presented in Chapter
5.
A.1 OPT ICAL AND HEMODYNAM IC VALUES PER SUB J ECT
Here the absorption coefficient (µa), reduced scattering co-
efficient (µ′s), total hemoglobin concentration (THC), tissue oxy-
gen saturation (StO2) and blood flow index (BFI) values for
each subject are added. The measurement protocol was ex-
plained in detail in Chapter 5. A schematic showing the probe
















Figure A.1: US-guided probe placements on the human neck: Seven
different probe locations were defined in the measure-
ments protocol. Probe size and placement are shown in










190 THYRO ID CHARACTER ISAT ION BY D I F FUSE OPT ICS
Tables A.1, A.2 and A.3 show the data for a source-detector
separation (ρ) of 25mm and Tables A.4, A.5 and A.6 do so for
the subset with ρ of 13mm 1.
1 The numbers shown are mean values with their respective standard de-
viations. Although IDs 11 (gland location 2, 25mm), 12 (gland location 1, 25
mm) and 16 (gland location 1, 13mm) show a non-decreasing µ′s behaviour
with a wavelength increase, the ranges of their respective standard devi-
ations still allow an actual value decrease with increasing wavelength. In














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A.2 PATHOLOGY CASES 197
A.2 PATHOLOGY CASES
In Section 5.3.3, data from two thyroid pathologies was
presented, but nine cases were included in the study. Here
the data from the other seven cases is presented. Figures
A.2 - A.9 show the corresponding thyroid protocol schematics
with the shaded regions representing the thyroid nodule lo-
cation(s) and their approximate size(s) in relation to the com-
plete thyroid. The measurements consisted of the same pro-
cedure as for the healthy volunteers, explained in Section 5.2
but with added measurement locations on the nodule side.
These locations are:
I: “gland center right” (CASE 2, 3, 4, 6 and CASE 7)
II: “gland center left” (CASE 3, 4 and CASE 8)
III: “isthmus b” (CASE 6)
IV: “adenopathy” (CASE 2)
i
i
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A.2.1 Pathology case 1 (CASE 1):
This case is a 58 year old woman (weight 75 kg, height 1.60
m, BMI 29.3 kg/m2) presenting a left thyroid nodule, which
was characterized as solid, iso-hypoechoic and well defined
with peripheral vascularization and a size of 22 x 18 x 33mm.
The fine-needle aspiration biopsy (FNAB) showed atypical cells
suggestive of papillary thyroid carcinoma. The patient under-
went a total thyroidectomy. Histopathology showed a follic-
ular lesion of 34 mm, which was well differentiated with un-
certain malignant potential. Due to the results, the lesion
was considered as malignant and was treated with radioio-
dine ablation.
The results in pseudo-color scale are presented in Fig. A.2
including the measurement protocol in Fig. A.2 b). The tab-
ulated values are shown in Table A.7. CASE 1 shows gener-
ally lower total hemoglobin concentrations and blood flow
indices for all locations. The oxygen saturation in the thyroid
is comparable to the healthy population, while the muscles
show lower saturations.
The nodule was located on the left thyroid side in the “gland
location 2” (marked with * in Table A.7), where the blood flow
index (BFI) is lower than the in rest of the thyroid locations,
yet higher than the muscle. Moreover, the reduced scatter-
ing coefficient (µ′s) reveal here lower scattering characteristics
than the healthy tissue. In the left “gland location 2” we see
up to 21 % lower reduced scattering coefficient (µ′s) values
than on the healthy right side, which is a difference three
times bigger than in the “gland location 1”. Also the BFI value
in the starred nodule location is rather low compared to the
healthy and active thyroid tissue and therefore closer to the
muscle tissue.
In CASE 1 the rather large nodule size of 33mm suggests al-
ready that photons emitted from at least one probe position
on the left thyroid gland should reach the pathologic tissue.
In fact, the location probing the nodule is the gland location
2. The reduced scattering coefficient (µ′s) for all three wave-
lengths show clear differences between sides (Tab. A.7) with
a 21 % lower value for the nodule location in this case. Since
the thyroid is already an very active organ, cancerous tissue,
while also possessing a high activity, can actually reveal infe-
rior hemodynamic values than its surrounding healthy tissue.
i
i
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CASE 1





a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.2: Results of the 1st pathology case: Themeasurement pro-
tocol a) consists of seven probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
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A.2.2 Pathology case 2 (CASE 2):
The second case was a 24 year old woman (weight 52 kg;
height 1.53 cm; BMI 22.2 kg/m2) who presented a right thyroid
nodule with a maximum diameter of 8mm and an adenopa-
thy of 20 mm next to the right thyroid gland. The nodule
was characterized as solid, hypoechoic, with irregular bor-
ders and microcalcifications. The adenopathy was charac-
terized as a nodular heterogeneous solid lesion including a
abundant central vascularisation andmicrocalcifications. The
FNAB of the thyroid nodule was non diagnostic due to a in-
sufficient sample, while the FNAB result of the adenopathy
showed atypical cells compatible with a metastasis of a papil-
lary thyroid carcinoma. A total thyroidectomywas performed,
with central node dissection and modified right lateral neck
and right supraclavicular dissections. The histopathology re-
vealed a right papillary thyroid microcarcinoma (7 mm) and
one adenopathy in the lateral section of 19 mm consistent
with the ultrasound diagnosis. Due to the results, the nodule
as well as the adenopathy was considered as malignant the
patient was treated with radioiodine ablation.
The results in pseudo-color representation are shown in
Fig. A.3. In this case the nodule was located within the right
thyroid gland and the measurement protocol was extended
with two additional probe placement (“thyroid gland center”
and “adenopathy”). Note that the nodule was rather small
with a maximum diameter of 8mm.
We can see here, that the patient showed generally higher
oxygen saturations throughout the whole thyroid and espe-
cially in the right gland 2 position a noticeable lower (~ 24
% compared to the non-starred locations) total hemoglobin
concentration (THC), which is heremore similar to the respec-
tive muscle probe location. Also a lower THC value from the
added location (“gland center right”) than from the other non-
pathologic ones was recorded. The µ′s values from starred
probe locations - gland location 2 and gland center on the
right side - are higher. The BFI has an up to 56% higher value
in the right gland location 2 compared to the other side and
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CASE 2











a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.3: Results of the 2nd pathology case: The measurement
protocol a) consists of nine probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
Similar to the first case, µ′s side variations in CASE 2 iden-
tify the “pathologic positions” as the right gland 2 probe loca-
tion and gland center position, which is further supported by
the low total hemoglobin concentration (THC) and high (up
to 56 % higher) BFI values. This increase in the BFI might be
i
i
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explained with previous observations of increased microvas-
culature in papillary thyroid carcinomas and the sensitivity
of TRS/DCS to this vasculature part. Nonetheless, we note
that this case presented a microcarcinoma with a maximum
diameter of 8 mm, which is small compared to the total thy-
roid size. Similar to the 1st case, the reduced scattering coef-
ficient (µ′s) serves as a further discriminator between patho-
logic and non-pathologic tissues - especially their differences
between corresponding locations on opposite sites.
i
i
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A.2.3 Pathology case 3 (CASE 3):
A 23 years old man (weight 74 kg; height 1.81 m; BMI 22.6
kg/m2) who presented two right cystic nodules, one with a
size of 27 x 17 mm and solid content and the other one with
a maximum diameter of 14mm was included as the 3rd case.
The patient also presented a left thyroid nodule with a maxi-
mum diameter of 14mm. The FNAB examination of the solid
content from the bigger right thyroid nodule showed atypi-
cal follicular cells. A total thyroidectomy was performed and
histopathology showed a extensive regressive cystic lesion
with a size of 20 mm and the presence of atypical cells. The
cells were suspicious for papillary thyroid carcinoma but the
sample was insufficient for a diagnosis. The lesion was CK19
positive and BRAF negative. Due to the results, the lesion
was considered as malignant and was treated with radioio-
dine ablation.
The thyroid scheme with the nodules as black shadowed
regions can be seen in Figure A.4 b) and the results from the
measurement on CASE 3 are presented in pseudo-color scale
in Fig. A.4 b) to f).
Since the patient had three different thyroid nodules, two
of which located on the right side and one on the left side, we
added two probe locations (“thyroid gland center right” and
“thyroid gland center left”) in this case. Note that, on the right
side the gland carried one cystic nodule with a maximum di-
ameter of 27mm in addition to 14mm nodule.
On the right side we see the center position (marked by *
in Tab. A.9) clearly sticking out in the total hemoglobin con-
centration (THC) with the highest value in general for this
case, while at the same time presenting the lowest oxygen
saturation on this thyroid side. Apart from the center posi-
tion, information about the nodule was also retrieved in the
gland location 1 (marked with * in Tab. A.9) showing a similar
trend. This position presents also the highest reduced scat-
tering coefficient (µ′s) for this case. The blood flow indices (BFI)
recorded at the nodule locations are on the higher end of the
BFI range for this subject. All starred locations show consis-
tently lower oxygen saturations than the rest of the thyroid
tissue and blood flow indices for these locations are at the
lower end of thyroid range for this subject.
i
i
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CASE 3















a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.4: Results of the 3rd pathology case: The measurement
protocol a) consists of nine probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
The 3rd case furthermore presented clear differences in
the added probe locations as well as in the right gland lo-
cation 1 (marked by * in Tab. A.9). Although, it is difficult to
assign the values on the right side to a specific nodule out of
the two located here, the high total hemoglobin concentra-
i
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tions, lower oxygen saturations and changed scattering char-
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A.2.4 Pathology case 4 (CASE 4):
This case was presented in Chapter 5 and its condition and
protocol is just briefly repeated here, so that the tabulated
results, which contain more details than in Section 5.3.3.1 can
be better understood.
The fourth case was a male (38 years old; weight 71 kg;
height 1.64 m; BMI 26.4 kg/m2) with a thyroid nodule (maxi-
mum diameter > 65 mm) affecting the left lobe and extend-
ing into the isthmus. The nodule was heterogeneous with
necrotic areas. The FNAB examination showed atypical cells
suggestive of papillary thyroid cancer and MRI showed a de-
structured mass occupying the left thyroid lobe and the isth-
mus, infiltrating all surrounding thyroid structures (trachea
and esophagus) and the skin. Due to the results, the tumor
was considered unresectable and a radio- and a chemother-
apy with tyrosine kinase inhibitors (“Sorafenib”) was suggested
as a neoadjuvant therapy prior to a possible surgery. The
radio- and chemotherapy showed an effect and a total thy-
roidectomy was performed afterwards. Moreover, the third,
fourth and sixth compartment were resected. The histopathol-
ogy showed a papillary thyroid carcinoma of 65 mm with
invasion of the extrathyroidal fibroadipose tissue. Twelve
adenopathies were resected. Out of these twelve, three were
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A.2.5 Pathology case 5 (CASE 5):
CASE 5, a 33 years old woman (weight 49 kg; height 1.59
m; BMI 19.4 kg/m2) was diagnosed of a multinodular goiter
with two left solid thyroid nodules of 40 and 20 mm. FNAB
examination was performed in the biggest nodule, showing
a follicular lesion with uncertain significance. The right thy-
roid lobule showed no atypical behaviour. First a hemithy-
roidectomy of the left thyroid lobe was performed and the
corresponding histopathology showed a follicular carcinoma
of 50mm. In continuation the right thyroid lobe was resected
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CASE 5









a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.6: Results of the 5th pathology case: The measurement
protocol a) consists of seven probe locations. The re-
sults are shown for the b) absorption (µa) and c) re-
duced scattering coefficients (µ′s) for 785 nm as well as
the d) total hemoglobin concentration (THC), e) tissue
oxygen saturation (StO2) and f) blood flow index (BFI).
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A.2.6 Pathology case 6 (CASE 6):
The sixth case was a 48 years old woman (weight 50 kg;
height 1.60m; BMI 19.5 kg/m2) presenting a multinodular goi-
ter with several macronodules in both lobes, the biggest one
of 44mm in the right lobe. FNAB examinationwas performed
and was suggestive of multinodular goiter with follicular cells
and colloid, with no atypical cells. The isthmus also presented
a nodule of 9 mm and in the left lobe a nodule of 14 mm
was also observed. Total thyroidectomy was performed and
histopathology showed a thyroid hyperplasia with regressive
changes a no evidence of malignancy.
i
i
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CASE 6












a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.7: Results of the 6th pathology case: The measurement
protocol a) consists of nine probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
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A.2.7 Pathology case 7 (CASE 7):
This case was presented in Chapter 5 and its condition and
protocol is just briefly repeated here, so that the tabulated
reults, which contain more details than in Section 5.3.3.2 can
be better understood.
As CASE 7 results from a female (32 years old; weight 68
kg; height 1.82 m; BMI 20.5 kg/m2) with a thyroid nodule (40
mm) in the right lobe are presented. The nodule showed foci
of colloid degradation and peripheral vascularisation sugges-
tive of a hyperplastic nodule. An additional small nodule of
a 3 mm diameter in the right lobe was observed, with no
laterocervical adenopathies. Fine needle aspiration biopsy
was performed and suggestive of a follicular lesion. Further-
more, the nodule showed microfollicular characteristics and
was classified according to the “Bethesda system for report-
ing thyroid cytopathology” [63] which scales from one to six
with increasing malignancy risk as Bethesda 4. After the op-
tical measurements, a total thyroidectomy was performed
and histopathology showed multinodular thyroid hyperpla-
sia with a hyperplastic dominant nodule (maximumdiameter
of 40 m) and regressive changes with adenomatoid nodules.
No follicular neoplasms were observed. Finally, the pathol-
ogy was classified as benign.
CASE 7
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A.2.8 Pathology case 8 (CASE 8):
CASE 8 is a 67 years old man (weight 98 kg; height 1.66 m;
BMI 35.6 kg/m2) presented a left thyroid nodule with a diam-
eter of 23 mm and subclinical hypothyroidism. FNAB exami-
nation was performed and was suggestive of follicular carci-
noma. The right thyroid lobe was very destructured. A total
thyroidectomy was performed and histopathology showed
adenomatoid thyroid hyperplasia with oncocystic changes and
no evidence of malignancy.
i
i
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CASE 8







a) Protocol b) µa [cm
-1]
c) µ′s [cm
-1] d) THC [µM]
e) StO2 [%] f) BFI [cm2/s] ×10-8
Figure A.9: Results of the 8th pathology case: The measurement
protocol a) consists of eight probe locations. The results
are shown for the b) absorption (µa) and c) reduced scat-
tering coefficients (µ′s) for 785 nm as well as the d) total
hemoglobin concentration (THC), e) tissue oxygen sat-
uration (StO2) and f) blood flow index (BFI). Note, that
these color plots do not include the muscle locations.
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METABOL ISM AND BRA IN EEG
CORRELAT IONS
In Chapter 6 a combination of TRS and DCS was used to es-
timate cerebral metabolism and blood flow (CMRO2 and CBF)
in patients under general anesthesia with target-controlled
infusion of propofol. These optically derived parameters were
shown to correlate with BIS readings, which are widely used
in the clinic and are relate to the state of consciousness via
EEG measurements of the brain. In the correlation analy-
sis the data was examined in three steps (for further details
please refer to Section 6.2.3):
Step I: Consider the complete rCMRO2, rCBF and rBIS data
set.
Step II: Consider all rBIS data but only significant changes
in optical measurements, i. e. changes greater than the
standard deviation.
Step III: Consider only changes in rCMRO2, rCBF and rBIS,
that are larger than the standard deviation.
Here the subject individual Pearson’s product-moment cor-
relation coefficients from Steps II and III are presented, which
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ID Rpearson intercept slope N InD [%]
1 0.47*** 37.05 ± 2.32 0.72 ± 0.13 108 19.89
2 0.32*** -16.24 ± 1.79 0.63 ± 0.13 204 29.39
3 0.29 34.76 ± 5.20 0.23 ± 0.21 14 40.00
4 -0.12 17.01 ± 2.42 -0.24 ± 0.14 211 29.84
5 0.14** 8.48 ± 2.09 0.14 ± 0.05 425 41.50
6 0.96*** -6.87 ± 2.26 1.61 ± 0.05 78 23.64
7 0.46*** -6.45 ± 0.91 1.14 ± 0.07 1026 35.64
8 0.88*** 17.40 ± 0.95 0.40 ± 0.04 32 59.26
9 0.64*** 25.36 ± 3.92 0.52 ± 0.08 63 19.87
10 0.32*** -18.89 ± 3.21 0.67 ± 0.16 145 68.40
11 0.16 -34.97 ± 17.00 0.38 ± 0.95 8 24.24
12 0.62*** 2.24 ± 3.14 0.98 ± 0.10 156 28.84
13 -0.18 127.85 ± 17.96 -0.20 ± 0.15 51 16.14
14 0.06 9.20 ± 1.61 0.03 ± 0.03 184 33.03
15 0.48*** 10.58 ± 1.46 0.30 ± 0.03 267 29.15
16 0.66*** 10.53 ± 0.45 0.20 ± 0.01 418 35.70
17 0.48*** -16.76 ± 0.48 0.49 ± 0.03 917 57.89
Table B.1: Pearson correlation coefficients, intercepts and slopes
of rCMRO2 versus rBIS considering values outside the
mean ± σregion (step II: |rCMRO2|> ±σrCMRO2 ). Results
are shown individually per subject. N = total number of
used data points; InD = percentage of included data. The
levels of significance are defined as follows: *** for p <
0.001; ** for p < 0.01; * for p < 0.05.
i
i
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ID Rpearson intercept slope N InD [%]
1 0.48*** 38.33 ± 2.42 0.70 ± 0.13 97 17.86
2 0.36*** -13.69 ± 1.81 0.67 ± 0.12 197 28.39
3 0.31 35.08 ± 5.09 0.24 ± 0.21 14 40.00
4 -0.13 19.48 ± 2.36 -0.25 ± 0.13 218 30.83
5 0.16*** 8.86 ± 2.06 0.17 ± 0.05 426 41.60
6 0.96*** -3.64 ± 2.27 1.52 ± 0.05 72 21.81
7 0.44*** -4.17 ± 0.91 1.09 ± 0.07 1022 35.50
8 0.98** 26.24 ± 2.18 0.37 ± 0.04 5 9.26
9 0.61*** 24.52 ± 3.77 0.47 ± 0.08 63 19.87
10 0.31*** -17.35 ± 4.03 0.66 ± 0.19 116 54.72
11 0.03 -33.48 ± 14.46 0.06 ± 0.81 9 27.27
12 0.66*** 6.63 ± 3.88 1.15 ± 0.12 122 22.55
13 -0.28* 167.08 ± 23.50 -0.40 ± 0.20 51 16.14
14 0.05 9.35 ± 1.57 0.02 ± 0.03 186 33.39
15 0.44*** 14.74 ± 1.50 0.26 ± 0.03 256 27.95
16 0.72*** 11.43 ± 0.47 0.24 ± 0.01 400 34.16
17 0.48*** -15.68 ± 0.47 0.49 ± 0.03 929 58.65
Table B.2: Pearson correlation coefficients, intercepts and slopes of
rCBF versus rBIS considering values outside the mean ±
σregion (step III: |rCBF|> ±σrCBF). Results are shown
individually per subject. N = total number of used data
points; InD = percentage of included data. The levels of
significance are defined as follows: *** for p < 0.001; **
for p < 0.01; * for p < 0.05.
i
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ID Rpearson intercept slope N InD [%]
1 0.70*** 38.90 ± 2.19 0.75 ± 0.01 63 11.60
2 0.78*** -12.14 ± 2.03 0.85 ± 0.01 64 9.22
3 0.44 27.24 ± 7.65 0.30 ± 0.01 8 22.86
4 -0.68*** 17.72 ± 6.21 -0.88 ± 0.01 31 4.83
5 0.80*** -30.27 ± 3.01 0.66 ± 0.01 126 12.30
6 0.97*** 2.84 ± 2.82 1.52 ± 0.01 46 13.94
7 0.40*** -2.24 ± 1.62 0.62 ± 0.01 327 11.36
8 1 1.85
9 0.30 8.23 ± 48.87 0.79 ± 0.01 19 5.99
10 0.29** -21.10 ± 3.91 0.57 ± 0.01 113 53.30
11 0.13 -35.55 ± 21.93 0.35 ± 0.01 7 21.21
12 0.84*** 9.62 ± 2.96 1.00 ± 0.01 82 15.16
13 -0.12 121.84 ± 21.33 -0.15 ± 0.01 49 15.51
14 0.80*** -22.80 ± 4.46 0.39 ± 0.01 43 7.72
15 0.58*** 10.21 ± 5.20 0.30 ± 0.01 58 6.33
16 0.89*** -0.56 ± 1.38 0.29 ± 0.01 90 7.69
17 0.48*** -15.80 ± 1.12 0.43 ± 0.01 281 17.74
Table B.3: Pearson correlation coefficients, intercepts and slopes
of rCMRO2 versus rBIS considering values outside the
mean ±σregion of rCMRO2 and rBIS (|rBIS|> ±σrBIS and
|rCMRO2|> ±σrCMRO2 ). Results are shown individually
per subject and the criteria led to absence of sufficient
data points for ID = 8. N = total number of used data
points; InD = percentage of included data. The levels of
significance are defined as follows: *** for p < 0.001; **
for p < 0.01; * for p < 0.05.
i
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ID Rpearson intercept slope N InD [%]
1 0.71*** 38.49 ± 2.22 0.75 ± 0.01 60 11.05
2 0.80*** -10.99 ± 1.92 0.85 ± 0.01 65 9.37
3 0.43 28.10 ± 7.81 0.30 ± 0.01 8 22.86
4 -0.68*** 18.00 ± 5.11 -0.79 ± 0.01 35 4.95
5 0.80*** -28.23 ± 2.98 0.66 ± 0.01 129 12.60
6 0.98*** 6.57 ± 2.78 1.43 ± 0.01 42 12.73
7 0.41*** 0.59 ± 1.64 0.63 ± 0.01 319 11.08
8 1 1.85
9 0.17 39.18 ± 40.13 0.34 ± 0.01 19 5.99
10 0.28** -19.54 ± 4.32 0.56 ± 0.01 100 47.17
11 0.06 -31.62 ± 18.19 0.15 ± 0.01 8 24.24
12 0.88*** 12.87 ± 3.31 1.16 ± 0.01 64 11.83
13 -0.14 144.66 ± 27.00 -0.22 ± 0.01 49 15.51
14 0.80*** -22.52 ± 4.33 0.38 ± 0.01 43 7.72
15 0.53*** 16.97 ± 4.71 0.23 ± 0.01 57 6.22
16 0.88*** 0.69 ± 1.65 0.33 ± 0.01 90 7.69
17 0.49*** -14.3 ± 1.09 0.44 ± 0.01 290 18.31
Table B.4: Pearson correlation coefficients, intercepts and slopes of
rCBF versus rBIS considering values outside the mean
±σregion of rCBF and rBIS (|rBIS|> ±σrBIS and |rCBF|>
±σrCBF). Results are shown individually per subject and
the criteria led to absence of sufficient data points for
ID = 8. N = total number of used data points; InD = per-
centage of included data. The levels of significance are




















BLOOD FLOW RESPONSES TO
RESP IRATORY CHALLENGES
In Chapter 7 we looked at responses of CBF to respiratory
challenges in two positions (50° and supine). These challenges
were HO, HRC and HV and their protocols were presented in
Figure 7.1.
Here additional data is presented, which were not included
in the Chapter for clarity reasons.
C.1 POS IT ION CHANGES
Apart from the challenge protocols presented in Chapter
7, each subject’s position was changed in a defined manner
prior to the challenge protocol (supine : 50° : supine : 30°
: legs at 45°). After the complete set of challenges, the en-
tire procedure was concluded with an additional baseline in
supine position followed by the subject standing up, both for
a duration of five minutes. The sequences - as shown in Sec-
tion 7.2.2 - are again illustrated in Figure 7.2 (see Figure 7.2).











Figure C.1: Start sequence: The different positions were kept for
a duration of five minutes except for the 30° and legs
at 45° positions, which lasted three minutes; End se-
quence: The procedure consisted of a supine baseline
for five minutes followed by the subject standing for five
minutes.
Similar to 7.4, here the relativemicrovascular cerebral blood
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shown. Additionally, also plotted are: absolute heart rate
(∆HR), mean arterial blood pressure (∆MAP), peripheral oxy-
gen saturation change (∆SpO2), stroke volume (∆SV), cardiac
output (∆CO) and regional oxygen saturation (∆SrO2) change.
The preceding supine position was used as a baseline (repre-
sented by the black dashed lines). The grey dashed lines sep-
arate the study start and end procedure from one another.
i
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rCBF [%] rCBFVmean [%]
ΔHR [bpm] ΔMAP [mmHg]
ΔSpO2 [%] ΔSV [ml]































































50° supine 30° legs
45°












Figure C.2: Posture changes at study start and end - separated by a
dashed grey line. The changes correspond to the proto-
cols presented in Figure C.1 and the abbreviations read
as follows: rCBF = relative microvascular cerebral blood
flow change; rCBFVmean = blood flow velocity changes;
∆HR = absolute heart rate changes; ∆MAP =mean arte-
rial blood pressure change; ∆SpO2 = peripheral oxygen
saturation change; ∆SV = stroke volume change; ∆CO =
cardiac output change; ∆SrO2 = regional oxygen satura-
tion change in the arm. Statistically significant changes
(p < 0.05) are marked by * and black dashed lines repre-
sent the baseline (preceding supine position).
C.2 CORRELAT ION TABLES
Additional correlation tables to the study presented in Chap-
ter 7 are added here (Tables C.1, C.2, C.3, C.4, C.5 and C.6).
i
i
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These are separated by manoeuvres, which include hyper-
oxia (HO), hypercapnia (HRC) and hyperventilation (HV) and
positions (supine and 50°). For details on protocols etc. please
refer to Section 7.2.
C.2.1 Hyperoxia
Tables C.1 and C.2 represent the Spearman correlations for
values obtained during hyperoxia (HO) in two different posi-
tions. Table C.1 refers to the supine and Table C.2 to the 50°
position. For the details on the protocol for this challenge




 > 70 %
5 min5 min
baseline
Figure C.3: Hyperoxia protocol. This illustration was previously
shown as part of Figure 7.1.
i
i
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C.2.2 Hypercapnia
Tables C.3 and C.4 represent the Spearman correlations for
values obtained during hypercapnia (HRC) in two different
positions. Table C.3 refers to the supine and Table C.4 to the
50° position. For the details on the protocol for this challenge








Figure C.4: Hypercapnia protocol. This illustration was previously
shown as part of Figure 7.1.
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C.2.3 Hyperventilation
Tables C.5 and C.6 represent the Spearman correlations for
values obtained during hyperventilation (HV) in two different
positions. Table C.5 refers to the supine and Table C.6 to the
50° position. For the details on the protocol for this challenge
please refer to Figure C.5.
1 min 5 min5 min
EtCO
2
   
15 mmHgbaseline
Figure C.5: Hyperventilation protocol. This illustration was previ-
ously shown as part of Figure 7.1.
i
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ADVANTAGES OF A HYBR ID
DEV ICE IN HEAD -OF -BED
PROCEDURES
In Chapter 9, the HOB angle change 30°: 0° (or “supine”)
was chosen in order to investigate the dependency of the re-
sulting BFI values for each position between different evalua-
tion types. The different methods used to analyse DCS data
were:
Method I: fix µa at 0.1 cm-1 and µ′s at 10 cm-1
Method II: population (n = 10) average of µa and µ′s
Method III: subject average of µa and µ′s (entire sequence)
Method IV: subject position average of µa and µ′s
Method V: subject individual µa and µ′s per acquisition (“one-
to-one”)
Each position was kept for five minutes.
D.1 R IGHT BRA IN HEM ISPHERE DATA
D.1.1 Blood flow index data
The BFI values calculated according to themethods explained
in Section 9.2 are presented in Figure D.1. Their median (IQR)
values are shown in Table D.1.
From the right hemisphere - as shown in Table D.1 - we ob-
tain median (IQR) values for method I of BFI
30°, I
= 6.88 (3.96)
× 10-9 cm2/s and BFIsupine, I = 11.37 (7.49) × 10




































fixed study average subject average











Figure D.1: Comparing evaluation methods I-V against each other



















Table D.1: Medians (and IQR) for the absolute BFI values taken
from the right brain hemisphere separated by methods
and positions. Data was taken in two positions according
to measurement protocol.
ones for the study averaged µa and µ
′
s values (method II) to
BFI
30°, II
= 6.58 (3.83) × 10-9 cm2/s and BFIsupine, II = 10.87 (7.14)
× 10-9 cm2/s.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the BFI median (IQR) val-
ues result in BFI
30°, III
= 6.23 (3.29) × 10-9 cm2/s and BFIsupine, III
= 9.25 (5.17) × 10-9 cm2/s. In methods IV and V we obtain me-
dian (IQR) values of BFI
30°, IV
= 5.75 (3.44) × 10-9 cm2/s and
i
i
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BFIsupine, IV = 9.25 (5.17) × 10
-9 cm2/s and BFI
30°, V
= 6.13 (3.40)
× 10-9 cm2/s and BFIsupine, V = 9.27 (5.14) × 10
-9 cm2/s.
A LME model on method influence1 revealed a significant
difference between the first twomethods (I and II) andmethod
III-V (p≤ 0.05). The according p-values are presented in Table
D.2. For better visibility, statistically significant differences be-
tween methods are marked by a grey background.
30° position
method I II III IV
II p > 0.05 -
III p < 0.01 p < 0.05 -
IV p < 0.01 p = 0.01 p > 0.05 -
V p < 0.01 p = 0.01 p > 0.05 p > 0.05
supine position
II p > 0.05 -
III p < 0.01 p < 0.01 -
IV p < 0.01 p < 0.01 p > 0.05 -
V p < 0.01 p < 0.01 p > 0.05 p > 0.05
Table D.2: Results (p-values) from a LME model with the method
factor for the absolute BFI values. Statistically signifi-
cance is marked by a grey background.
The top part of Table D.2 shows the resulting p-values for
the comparison of BFI values from the 30° position between
methods. The bottom part refers to the same test, but con-
ducting it on the BFI values taken while the volunteers was in
the supine position.
All values between positions differ significantly (p < 0.001)
independently of the used analysis method. The BFIs calcu-
lated based on methods I and II differ significantly (p < 0.05)
from the ones evaluated with method III, IV and V. Between
the latter three, no significant difference was found.
D.1.2 Relative cerebral blood flow changes
After evaluating BFI according to the fivemethods presented
in Section 9.2, for each volunteer the 30° position average
1 The fitted intercepts and their slopes are presented in Table D.6.
i
i
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was taken as a baseline and the CBF change with the HOB
angle calculated for each method individually. The resulting
rCBF values are shown in Figure D.2. The graph compares all
five methods (I:“fixed”; II: “study average”; III: “subject aver-
age”; IV:“subject position average” and V: “one-to-one” usage




















fixed study average subject average
subject position average one−to−one
Figure D.2: Comparing evaluation methods 1-4 against each other
by looking at the CBF changes with respect to the 30°
position (starting position). The dashed line represents
zero CBF change.








Table D.3: Medians (and IQR) for the relative CBF changes with re-
spect to initial 30° position separated by methods.
Table D.3 shows the rCBF values in terms of a median and
its respective IQR after the change from 30° to supine posi-
tion for each analysis method in the right hemisphere. These
values set for method I to rCBFright, I = 32.70 (36.60) % and the
ones for the study averaged µa and µ
′
s values (method II) to
rCBFright, II = 32.90 (36.36) %.
i
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In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the rCBFmedian (IQR) val-
ues result in rCBFright, III = 32.52 (35.38) %. In methods IV and
V we obtain median (IQR) values of rCBFright, IV = 33.44 (39.30)
% and rCBFright, V = 32.36 (34.90) %.
Similar to the analysis of the BFI values (Section 9.3.1), a
LME model to investigate differences between rCBF values
among different analysis methods2 was employed. Here we
only compare rCBF in the supine position between the above-
presented different analysis methods. The p-values of this in-
vestigation are shown in Table D.4. As before, statistically sig-
nificant differences between methods are marked by a grey
background for better visibility.
method I II III IV
II p > 0.05 -
III p > 0.05 p > 0.05 -
IV p < 0.01 p < 0.01 p = 0.05 -
V p > 0.05 p > 0.05 p > 0.05 p < 0.01
Table D.4: Results (p-values) from a LME model with the method
factor for the relative CBF values with respect to the ini-
tial 30° position. Statistically significance is marked by a
grey background.
According to Table 9.5, the rCBF calculated based onmethod
I-III does not differ significantly. Method IV differs significantly
(p≤ 0.05) from all other ones in the resulting rCBF for a change
from 30° to supine position. Values obtained from method V
are comparable to method I-III.
D.2 COMPAR ISON OF DCS ANALYS IS METHODS (BF I )
A LMEmodel employed on the BFI values taken in the study
presented in Chapter 9with the position factor every analysis
method used are shown in Tables D.7 and D.7.
BFI values in the left brain hemisphere fitted with µa and µ′s
values of 0.1 cm-1 and 10 cm-1 (method I) set to BFI
30°, I
= 7.36 ±
0.82 × 10-9 cm2/s and BFIsupine, I = 10.33 ± 0.70 × 10
-9 cm2/s and
the ones for the study averaged µa and µ
′
s values (method II)
2 The fitted intercepts and their slopes are presented in Tables D.7 and D.8
i
i
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method # position
LME fitted BFI ± standard error
[cm2/s] × 10-9
I
+30° 7.36 ± 0.82
supine 10.33 ± 0.70
II
+30° 7.05 ± 0.80
supine 9.94 ± 0.68
III
+30° 5.90 ± 0.79
supine 8.18 ± 0.56
IV
+30° 5.80 ± 0.79
supine 8.18 ± 0.59
V
+30° 5.78 ± 0.76
supine 8.02 ± 0.54
Table D.5: Results from a LME model with the method factor for
the absolute BFI values taken from the left brain hemi-
sphere separated by HOB position. Data was taken in
two positions according to measurement protocol.
to BFI
30°, II
= 7.05 ± 0.80 × 10-9 cm2/s and BFIsupine, II = 9.94 ±
0.68 × 10-9 cm2/s.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the BFIwas fitted to BFI30°, III
= 5.90 ± 0.79 × 10-9 cm2/s and BFIsupine, III = 8.18 ± 0.56 × 10
-9
cm2/s. In methods IV and V the LME models fit these values
to BFI
30°, IV
= 5.80 ± 0.79 × 10-9 cm2/s and BFIsupine, IV = 8.18 ±
0.59 × 10-9 cm2/s and BFI
30°, V
= 5.78 ± 0.76 × 10-9 cm2/s and
BFIsupine, V = 8.02 ± 0.54 × 10
-9 cm2/s.
BFI values in the right brain hemisphere fitted with µa and
µ′s values of 0.1 cm
-1 and 10 cm-1 (method I) set to BFI
30°, I
= 8.71
± 1.34 × 10-9 cm2/s and BFIsupine, I = 11.62 ± 0.65 × 10
-9 cm2/s and
the ones for the study averaged µa and µ
′
s values (method II)
to BFI
30°, II
= 8.33 ± 1.29 × 10-9 cm2/s and BFIsupine, II = 11.12 ±
0.63 × 10-9 cm2/s.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the BFIwas fitted to BFI30°, III
= 6.70 ± 0.82 × 10-9 cm2/s and BFIsupine, III = 9.00 ± 0.52 × 10
-9
cm2/s. In methods IV and V the LME models fit these values
to BFI
30°, IV
= 6.55 ± 0.83 × 10-9 cm2/s and BFIsupine, IV = 9.00 ±
0.52 × 10-9 cm2/s and BFI
30°, V
= 6.60 ± 0.82 × 10-9 cm2/s and
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method # position
LME fitted BFI ± standard error
[cm2/s] × 10-9
I
+30° 8.71 ± 1.34
supine 11.62 ± 0.65
II
+30° 8.33 ± 1.29
supine 11.12 ± 0.63
III
+30° 6.70 ± 0.82
supine 9.00 ± 0.48
IV
+30° 6.55 ± 0.83
supine 9.00 ± 0.52
V
+30° 6.60 ± 0.82
supine 8.88 ± 0.48
Table D.6: Results from a LME model with the position factor for
the absolute BFI values taken from the right brain hemi-
sphere separated by HOB position. Data was taken in
two positions according to measurement protocol.
D.3 RELAT IVE CBF CHANGES W ITH HOB PROTOCOL FOR D I F -
F ERENT ANALYS IS METHODS
Results of a LMEmodel with the position factor every analy-
sis method used are shown in Tables D.7 and D.8 for the rCBF
values. The values for the initial 30° position are a result of
the LME fit and therefore present a standard error.
method # LME fitted rCBF
30°
± standard error
I 40.10 ± 8.81
II 40.70 ± 8.93
III 40.60 ± 8.95
IV 44.87 ± 10.90
V 40.57 ± 8.92
Table D.7: Results from a LME model with the position factor for
the absolute rCBF values taken from the left brain hemi-
sphere separated byHOB position. All changes (30°: 0°)
are statistically significant (p < 0.001).
The rCBF values in the left brain hemisphere normalised
to the initial 30° position and fitted with µa and µ
′
s values of
0.1 cm-1 and 10 cm-1 (method I) set to rCBF
30°, I
= 40.10 ± 8.81%
i
i
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= 40.70 ± 8.93 %.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the BFIwas fitted to rCBF30°, III
= 40.60 ± 8.95 %. In methods IV and V the LME models fit
these values to rCBF
30°, IV
= 44.87 ± 10.90 % and rCBF
30°, V
=
40.57 ± 8.92 %.
method # LME fitted rCBF
30°
± standard error
I 38.96 ± 7.33
II 39.06 ± 7.30
III 39.03 ± 7.32
IV 43.97 ± 8.90
V 39.22 ± 7.43
Table D.8: Results from a LME model with the position factor for
the absolute rCBF values taken from the right brain
hemisphere separated by HOB position. All changes
(30°: 0°) are statistically significant (p < 0.001).
The rCBF values in the right brain hemisphere normalised
to the initial 30° position and fitted with µa and µ
′
s values of 0.1
cm-1 and 10 cm-1 (method I) set to rCBF
30°, I
= 38.96 ± 7.33 %





= 39.06 ± 7.30 %.
In the case of method III, where we used the individualised
µa and µ
′
s values from each subject, the BFIwas fitted to rCBF30°, III
= 39.03 ± 7.32 %. In methods IV and V the LME models fit
these values to rCBF
30°, IV
= 43.97 ± 8.90 % and rCBF
30°, V
=
39.22 ± 7.43 %.
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